<html class="gs_el_sm gs_pfcs"><head><title>‪John Gribben‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=zTBFoCoAAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Medical Oncology, Queen Mary University of London‬ - ‪‪Cited by 44,510‬‬ - ‪Hemato-oncology‬"><meta property="og:description" content="‪Professor of Medical Oncology, Queen Mary University of London‬ - ‪‪Cited by 44,510‬‬ - ‪Hemato-oncology‬"><meta property="og:title" content="John Gribben"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=zTBFoCoAAAAJ&amp;citpid=2"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"SkpAYfOfN8i1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=zTBFoCoAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUGbyrfgr1rdacDuwrJZkb_3597ap5wO"><input type="hidden" name="user" value="zTBFoCoAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">44510</td><td class="gsc_rsb_std">16436</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">120</td><td class="gsc_rsb_std">67</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">374</td><td class="gsc_rsb_std">263</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1030px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:984px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">3400</div><div class="gsc_g_xtl" style="top:73px;">1700</div><div class="gsc_g_xtl" style="top:113px;">850</div><div class="gsc_g_xtl" style="top:33px;">2550</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:152px;height:8px;z-index:30"><span class="gsc_g_al">191</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:147px;height:13px;z-index:29"><span class="gsc_g_al">294</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:136px;height:24px;z-index:28"><span class="gsc_g_al">513</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:126px;height:34px;z-index:27"><span class="gsc_g_al">743</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:120px;height:40px;z-index:26"><span class="gsc_g_al">859</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:127px;height:33px;z-index:25"><span class="gsc_g_al">717</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:118px;height:42px;z-index:24"><span class="gsc_g_al">907</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:111px;height:49px;z-index:23"><span class="gsc_g_al">1050</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:112px;height:48px;z-index:22"><span class="gsc_g_al">1030</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:113px;height:47px;z-index:21"><span class="gsc_g_al">1017</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:106px;height:54px;z-index:20"><span class="gsc_g_al">1162</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:109px;height:51px;z-index:19"><span class="gsc_g_al">1104</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:111px;height:49px;z-index:18"><span class="gsc_g_al">1056</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:112px;height:48px;z-index:17"><span class="gsc_g_al">1023</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:108px;height:52px;z-index:16"><span class="gsc_g_al">1119</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:107px;height:53px;z-index:15"><span class="gsc_g_al">1139</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:101px;height:59px;z-index:14"><span class="gsc_g_al">1255</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:100px;height:60px;z-index:13"><span class="gsc_g_al">1291</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:89px;height:71px;z-index:12"><span class="gsc_g_al">1515</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:89px;height:71px;z-index:11"><span class="gsc_g_al">1527</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:84px;height:76px;z-index:10"><span class="gsc_g_al">1622</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:72px;height:88px;z-index:9"><span class="gsc_g_al">1874</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:66px;height:94px;z-index:8"><span class="gsc_g_al">2009</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:57px;height:103px;z-index:7"><span class="gsc_g_al">2197</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:50px;height:110px;z-index:6"><span class="gsc_g_al">2353</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:46px;height:114px;z-index:5"><span class="gsc_g_al">2439</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:39px;height:121px;z-index:4"><span class="gsc_g_al">2582</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:29px;height:131px;z-index:3"><span class="gsc_g_al">2796</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:5px;height:155px;z-index:2"><span class="gsc_g_al">3313</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:28px;height:132px;z-index:1"><span class="gsc_g_al">2821</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=zTBFoCoAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dzTBFoCoAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>159 articles</span></div><div class="gsc_rsb_m_na"><div>12 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:7%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:107px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:66pt;height:80pt;}}</style><img alt="John Gribben" sizes="print 66px,107px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=zTBFoCoAAAAJ&amp;citpid=2" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=zTBFoCoAAAAJ&amp;citpid=2 107w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=zTBFoCoAAAAJ&amp;citpid=2 213w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">John Gribben</div><div class="gsc_prf_il">Professor of Medical Oncology, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=11628095156398365105" class="gsc_prf_ila">Queen Mary University of London</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at qmul.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:hemato_oncology" class="gsc_prf_inta gs_ibl">Hemato-oncology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUGbyrfgr1rdacDuwrJZkb_3597ap5wO"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=zTBFoCoAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation</a><div class="gs_gray">GJ Freeman, JG Gribben, VA Boussiotis, JW Ng, VA Restivo, LA Lombard, ...</div><div class="gs_gray">Science 262 (5135), 909-911<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10091857212505861831" class="gsc_a_ac gs_ibl">1202</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia</a><div class="gs_gray">LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ...</div><div class="gs_gray">New England Journal of Medicine 351 (9), 893-901<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7677422113540138991" class="gsc_a_ac gs_ibl">1122</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma</a><div class="gs_gray">JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ...</div><div class="gs_gray">New England Journal of Medicine 325 (22), 1525-1533<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5780920111712986048" class="gsc_a_ac gs_ibl">845</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation</a><div class="gs_gray">CD Gimmi, GJ Freeman, JG Gribben, G Gray, LM Nadler</div><div class="gs_gray">Proceedings of the National Academy of Sciences 90 (14), 6586-6590<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1016548708928317457" class="gsc_a_ac gs_ibl">763</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug</a><div class="gs_gray">AG Ramsay, AJ Johnson, AM Lee, G Gorgün, R Le Dieu, W Blum, JC Byrd, ...</div><div class="gs_gray">The Journal of clinical investigation 118 (7), 2427-2437<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=605684368163636433" class="gsc_a_ac gs_ibl">617</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.</a><div class="gs_gray">CD Gimmi, GJ Freeman, JG Gribben, K Sugita, AS Freedman, C Morimoto, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 88 (15), 6575-6579<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9931282633394236361" class="gsc_a_ac gs_ibl">596</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:FQ36aI_S1AEC" class="gsc_a_at">Chronic lymphocytic leukaemia</a><div class="gs_gray">TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ...</div><div class="gs_gray">Nature reviews Disease primers 3 (1), 1-22<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12394069768640681230,11346298404666500478" class="gsc_a_ac gs_ibl">555</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="zTBFoCoAAAAJ:FQ36aI_S1AEC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Transplantation of anergic histoincompatible bone marrow allografts</a><div class="gs_gray">EC Guinan, VA Boussiotis, D Neuberg, LLV Brennan, N Hirano, ...</div><div class="gs_gray">New England Journal of Medicine 340 (22), 1704-1714<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6109533641005314624" class="gsc_a_ac gs_ibl">532</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:uUvzmPk0f8oC" class="gsc_a_at">Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma</a><div class="gs_gray">J Okosun, C Bödör, J Wang, S Araf, CY Yang, C Pan, S Boller, D Cittaro, ...</div><div class="gs_gray">Nature genetics 46 (2), 176-181<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3371784771457095876" class="gsc_a_ac gs_ibl">527</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:Yw6v6SrDvuUC" class="gsc_a_at">Genetic and functional drivers of diffuse large B cell lymphoma</a><div class="gs_gray">A Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ...</div><div class="gs_gray">Cell 171 (2), 481-494. e15<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8417130613400804562" class="gsc_a_ac gs_ibl">511</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.</a><div class="gs_gray">GJ Freeman, GS Gray, CD Gimmi, DB Lombard, LJ Zhou, M White, ...</div><div class="gs_gray">The Journal of experimental medicine 174 (3), 625-631<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13476448708363601428" class="gsc_a_ac gs_ibl">499</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.</a><div class="gs_gray">GJ Freeman, F Borriello, RJ Hodes, H Reiser, JG Gribben, JW Ng, J Kim, ...</div><div class="gs_gray">The Journal of experimental medicine 178 (6), 2185-2192<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1730467232549348173" class="gsc_a_ac gs_ibl">491</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity</a><div class="gs_gray">EC Guinan, JG Gribben, VA Boussiotis, GJ Freeman, LM Nadler</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2063658539329017334" class="gsc_a_ac gs_ibl">483</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival</a><div class="gs_gray">OM Howard, JG Gribben, DS Neuberg, M Grossbard, C Poor, MJ Janicek, ...</div><div class="gs_gray">Journal of Clinical Oncology 20 (5), 1288-1294<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11784623932960300797" class="gsc_a_ac gs_ibl">480</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:SPgmg5JLkoEC" class="gsc_a_at">Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer</a><div class="gs_gray">A Fujimoto, M Furuta, Y Totoki, T Tsunoda, M Kato, Y Shiraishi, H Tanaka, ...</div><div class="gs_gray">Nature genetics 48 (5), 500-509<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2964840357946806792" class="gsc_a_ac gs_ibl">463</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997</a><div class="gs_gray">MR Grever, DM Lucas, GW Dewald, DS Neuberg, JC Reed, S Kitada, ...</div><div class="gs_gray">Journal of Clinical Oncology 25 (7), 799-804<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16524749965076898708" class="gsc_a_ac gs_ibl">431</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma</a><div class="gs_gray">AS Freedman, D Neuberg, P Mauch, RJ Soiffer, KC Anderson, DC Fisher, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 94 (10), 3325-3333<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2401518289130102654" class="gsc_a_ac gs_ibl">429</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells</a><div class="gs_gray">DC Taussig, F Miraki-Moud, F Anjos-Afonso, DJ Pearce, K Allen, C Ridler, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (3), 568-575<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14005147298765080709" class="gsc_a_ac gs_ibl">415</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production</a><div class="gs_gray">JC Riches, JK Davies, F McClanahan, R Fatah, S Iqbal, S Agrawal, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (9), 1612-1621<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13020824427208278334" class="gsc_a_ac gs_ibl">414</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;citation_for_view=zTBFoCoAAAAJ:ufrVoPGSRksC" class="gsc_a_at">CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.</a><div class="gs_gray">JL Schultze, S Michalak, MJ Seamon, G Dranoff, K Jung, J Daley, ...</div><div class="gs_gray">The Journal of clinical investigation 100 (11), 2757-2765<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13460670919970368027" class="gsc_a_ac gs_ibl">412</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation&nbsp;…</a><div class="gs_gray">JG Gribben, AS Freedman, SD Woo, K Blake, RS Shu, G Freeman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6779468424190160659" class="gsc_a_ac gs_ibl">407</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation&nbsp;…</a><div class="gs_gray">JG Gribben, D Neuberg, AS Freedman, CD Gimmi, KW Pesek, M Barber, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9184874214359370830" class="gsc_a_ac gs_ibl">391</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">CTLA4 mediates antigen-specific apoptosis of human T cells</a><div class="gs_gray">JG Gribben, GJ Freeman, VA Boussiotis, P Rennert, CL Jellis, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 92 (3), 811-815<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12881462190936650956" class="gsc_a_ac gs_ibl">388</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Leukemia-initiating cells from some acute myeloid leukemia patients with mutated <i>nucleophosmin</i> reside in the CD34<sup>−</sup> fraction</a><div class="gs_gray">DC Taussig, J Vargaftig, F Miraki-Moud, E Griessinger, K Sharrock, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (10), 1976-1984<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9324674453389455124" class="gsc_a_ac gs_ibl">384</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor</a><div class="gs_gray">VA Boussiotis, DL Barber, T Nakarai, GJ Freeman, JG Gribben, ...</div><div class="gs_gray">Science 266 (5187), 1039-1042<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13934145731005767374" class="gsc_a_ac gs_ibl">375</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia</a><div class="gs_gray">LZ Rassenti, S Jain, MJ Keating, WG Wierda, MR Grever, JC Byrd, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (5), 1923-1930<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5781261711679388354" class="gsc_a_ac gs_ibl">368</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age</a><div class="gs_gray">EP Alyea, HT Kim, V Ho, C Cutler, J Gribben, DJ DeAngelo, SJ Lee, ...</div><div class="gs_gray">Blood 105 (4), 1810-1814<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7352660714791809667" class="gsc_a_ac gs_ibl">337</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma</a><div class="gs_gray">A Ene–Obong, AJ Clear, J Watt, J Wang, R Fatah, JC Riches, JF Marshall, ...</div><div class="gs_gray">Gastroenterology 145 (5), 1121-1132<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4936397973680099475" class="gsc_a_ac gs_ibl">333</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible&nbsp;…</a><div class="gs_gray">AG Ramsay, AJ Clear, R Fatah, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (7), 1412-1421<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15376998724890271235" class="gsc_a_ac gs_ibl">332</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:AubyX3KqGToC" class="gsc_a_at">Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label&nbsp;…</a><div class="gs_gray">C Moreno, R Greil, F Demirkan, A Tedeschi, B Anz, L Larratt, M Simkovic, ...</div><div class="gs_gray">The Lancet Oncology 20 (1), 43-56<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17284020227784306684" class="gsc_a_ac gs_ibl">324</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells</a><div class="gs_gray">G Görgün, TAW Holderried, D Zahrieh, D Neuberg, JG Gribben</div><div class="gs_gray">The Journal of clinical investigation 115 (7), 1797-1805<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12154503888471206827" class="gsc_a_ac gs_ibl">313</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation</a><div class="gs_gray">VA Boussiotis, GJ Freeman, JG Gribben, J Daley, G Gray, LM Nadler</div><div class="gs_gray">Proceedings of the National Academy of Sciences 90 (23), 11059-11063<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8387392900961189374" class="gsc_a_ac gs_ibl">308</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX</a><div class="gs_gray">AM Krackhardt, M Witzens, S Harig, FS Hodi, AJ Zauls, M Chessia, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (6), 2123-2131<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12475803329735366018" class="gsc_a_ac gs_ibl">304</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for&nbsp;…</a><div class="gs_gray">JC Byrd, JG Gribben, BL Peterson, MR Grever, G Lozanski, DM Lucas, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (3), 437-443<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5404652830894253643,6451585818393721458" class="gsc_a_ac gs_ibl">302</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor‐α gene promoter</a><div class="gs_gray">AM Uglialoro, D Turbay, PA Pesavento, JC Delgado, FE McKenzie, ...</div><div class="gs_gray">Tissue antigens 52 (4), 359-367<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6468739171003966356" class="gsc_a_ac gs_ibl">299</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:R22Rs3tN8aoC" class="gsc_a_at">The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies</a><div class="gs_gray">JA Burger, JG Gribben</div><div class="gs_gray">Seminars in cancer biology 24, 71-81<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5440957642927800499" class="gsc_a_ac gs_ibl">291</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins</a><div class="gs_gray">GF Widhopf, LZ Rassenti, TL Toy, JG Gribben, WG Wierda, TJ Kipps</div><div class="gs_gray">Blood 104 (8), 2499-2504<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15901149021719926304" class="gsc_a_ac gs_ibl">287</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">FLT3 mutations in childhood acute lymphoblastic leukemia</a><div class="gs_gray">SA Armstrong, ME Mabon, LB Silverman, A Li, JG Gribben, EA Fox, ...</div><div class="gs_gray">Blood 103 (9), 3544-3546<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10618898708597589374" class="gsc_a_ac gs_ibl">284</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission</a><div class="gs_gray">AS Freedman, JG Gribben, D Neuberg, P Mauch, RJ Soiffer, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4101202984803487984" class="gsc_a_ac gs_ibl">279</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:Se3iqnhoufwC" class="gsc_a_at">B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.</a><div class="gs_gray">VA Boussiotis, GJ Freeman, G Gray, J Gribben, LM Nadler</div><div class="gs_gray">The Journal of experimental medicine 178 (5), 1753-1763<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9163525304847759147" class="gsc_a_ac gs_ibl">276</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">How I treat CLL up front</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (2), 187-197<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10632365495731405556" class="gsc_a_ac gs_ibl">272</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:XeErXHja3Z8C" class="gsc_a_at">Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open&nbsp;…</a><div class="gs_gray">LH Sehn, N Chua, J Mayer, G Dueck, M Trněný, K Bouabdallah, N Fowler, ...</div><div class="gs_gray">The Lancet Oncology 17 (8), 1081-1093<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11307300625583390720" class="gsc_a_ac gs_ibl">266</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up</a><div class="gs_gray">AZS Rohatiner, L Nadler, AJ Davies, J Apostolidis, D Neuberg, ...</div><div class="gs_gray">Journal of clinical oncology 25 (18), 2554-2559<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2002049246696575195" class="gsc_a_ac gs_ibl">265</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:P5F9QuxV20EC" class="gsc_a_at">ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia</a><div class="gs_gray">S Pospisilova, D Gonzalez, J Malcikova, M Trbusek, D Rossi, AP Kater, ...</div><div class="gs_gray">Leukemia 26 (7), 1458-1461<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6527779222592436296" class="gsc_a_ac gs_ibl">264</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Infectious complications associated with alemtuzumab use for lymphoproliferative disorders</a><div class="gs_gray">SI Martin, FM Marty, K Fiumara, SP Treon, JG Gribben, LR Baden</div><div class="gs_gray">Clinical Infectious Diseases 43 (1), 16-24<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4180269102201271284" class="gsc_a_ac gs_ibl">257</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Number of CD4+ cells and location of forkhead box protein P3–positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome</a><div class="gs_gray">AM Lee, AJ Clear, M Calaminici, AJ Davies, S Jordan, F MacDougall, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (31), 5052-5059<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2021079340174552557" class="gsc_a_ac gs_ibl">256</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation</a><div class="gs_gray">D Provan, L Bartlett-Pandite, C Zwicky, D Neuberg, A Maddocks, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11095764891323351476" class="gsc_a_ac gs_ibl">245</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben, D Zahrieh, K Stephans, L Bartlett-Pandite, EP Alyea, ...</div><div class="gs_gray">Blood 106 (13), 4389-4396<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14030478885406075321" class="gsc_a_ac gs_ibl">241</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Phase I study of recombinant human CD40 ligand in cancer patients</a><div class="gs_gray">RH Vonderheide, JP Dutcher, JE Anderson, SG Eckhardt, KF Stephans, ...</div><div class="gs_gray">Journal of Clinical Oncology 19 (13), 3280-3287<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5087011140244486940" class="gsc_a_ac gs_ibl">238</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:JWITY9-sCbMC" class="gsc_a_at"><i>EZH2</i> mutations are frequent and represent an early event in follicular lymphoma</a><div class="gs_gray">C Bödör, V Grossmann, N Popov, J Okosun, C O’Riain, K Tan, J Marzec, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (18), 3165-3168<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13155661609316286920" class="gsc_a_ac gs_ibl">235</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect</a><div class="gs_gray">E Alyea, E Weller, R Schlossman, C Canning, I Webb, D Doss, P Mauch, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 98 (4), 934-939<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4302414619059498917,17306072058904853136" class="gsc_a_ac gs_ibl">235</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy</a><div class="gs_gray">AG Ramsay, AJ Clear, G Kelly, R Fatah, J Matthews, F MacDougall, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (21), 4713-4720<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6312803746172552376" class="gsc_a_ac gs_ibl">232</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity</a><div class="gs_gray">JL Schultze, AA Cardoso, GJ Freeman, MJ Seamon, J Daley, GS Pinkus, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 92 (18), 8200-8204<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8967755179616605783" class="gsc_a_ac gs_ibl">229</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF</a><div class="gs_gray">JG Gribben, S Devereux, NSB Thomas, M Keim, HM Jones, AH Goldstone, ...</div><div class="gs_gray">The Lancet 335 (8687), 434-437<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15589053281358606771" class="gsc_a_ac gs_ibl">229</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Induction of cytotoxic T-cell responses against immunoglobulin V region–derived peptides modified at human leukocyte antigen–A2 binding residues</a><div class="gs_gray">S Harig, M Witzens, AM Krackhardt, A Trojan, P Barrett, R Broderick, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 98 (10), 2999-3005<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15837572460690091163" class="gsc_a_ac gs_ibl">227</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:cRMvf6lLvU8C" class="gsc_a_at">Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?</a><div class="gs_gray">P Dreger, J Schetelig, N Andersen, P Corradini, M Van Gelder, J Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (26), 3841-3849<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10691765273286922474" class="gsc_a_ac gs_ibl">224</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)</a><div class="gs_gray">M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ...</div><div class="gs_gray">Annals of Oncology 24 (3), 561-576<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11642245399334412278" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies</a><div class="gs_gray">A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, ...</div><div class="gs_gray">Nature medicine 6 (6), 667-672<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12301121904128489638" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:4TOpqqG69KYC" class="gsc_a_at">High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.</a><div class="gs_gray">AS Freedman, D Neuberg, JG Gribben, P Mauch, RJ Soiffer, DC Fisher, ...</div><div class="gs_gray">Journal of Clinical Oncology 16 (1), 13-18<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13360909017390156293" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation</a><div class="gs_gray">JG Gribben, DC Linch, CR Singer, AK McMillan, M Jarrett, AH Goldstone</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=110259566911669680" class="gsc_a_ac gs_ibl">217</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow</a><div class="gs_gray">JG Gribben, D Neuberg, M Barber, J Moore, KW Pesek, AS Freedman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1051379029912578113" class="gsc_a_ac gs_ibl">216</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:vbGhcppDl1QC" class="gsc_a_at">The role of B7 family molecules in hematologic malignancy</a><div class="gs_gray">P Greaves, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (5), 734-744<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4983508443536446644" class="gsc_a_ac gs_ibl">215</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia</a><div class="gs_gray">SN Rabinowe, RJ Soiffer, JG Gribben, H Daley, AS Freedman, J Daley, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18055522378027302278" class="gsc_a_ac gs_ibl">209</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:4DMP91E08xMC" class="gsc_a_at">Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells</a><div class="gs_gray">CD Gimmi, BW Morrison, BA Mainprice, JG Gribben, VA Boussiotis, ...</div><div class="gs_gray">Nature medicine 2 (12), 1367-1370<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2423796829470939422" class="gsc_a_ac gs_ibl">208</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia</a><div class="gs_gray">M Buchner, S Fuchs, G Prinz, D Pfeifer, K Bartholomé, M Burger, ...</div><div class="gs_gray">Cancer research 69 (13), 5424-5432<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9813919292413194291" class="gsc_a_ac gs_ibl">203</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen</a><div class="gs_gray">AA Cardoso, JL Schultze, VA Boussiotis, GJ Freeman, MJ Seamon, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14039778676310574668" class="gsc_a_ac gs_ibl">201</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:dhFuZR0502QC" class="gsc_a_at">Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma</a><div class="gs_gray">JW Friedberg, D Neuberg, RM Stone, E Alyea, H Jallow, A LaCasce, ...</div><div class="gs_gray">Journal of Clinical Oncology 17 (10), 3128-3135<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=748302617485739958" class="gsc_a_ac gs_ibl">195</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation</a><div class="gs_gray">J Patterson, HG Prentice, MK Brenner, M Gilmore, G Janossy, K Ivory, ...</div><div class="gs_gray">British journal of haematology 63 (2), 221-230<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1853176595828012521" class="gsc_a_ac gs_ibl">194</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance</a><div class="gs_gray">VA Boussiotis, JG Gribben, GJ Freeman, LM Nadler</div><div class="gs_gray">Current opinion in immunology 6 (5), 797-807<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12166916103259578049" class="gsc_a_ac gs_ibl">186</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01</a><div class="gs_gray">J Zhou, MA Goldwasser, A Li, SE Dahlberg, D Neuberg, H Wang, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (5), 1607-1611<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14842578245150797940" class="gsc_a_ac gs_ibl">185</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease</a><div class="gs_gray">NS Andersen, JW Donovan, JS Borus, CM Poor, D Neuberg, JC Aster, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 90 (10), 4212-4221<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16596959242930596603" class="gsc_a_ac gs_ibl">185</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:mB3voiENLucC" class="gsc_a_at">Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy</a><div class="gs_gray">JG Gribben, DP Ryan, R Boyajian, RG Urban, ML Hedley, K Beach, ...</div><div class="gs_gray">Clinical Cancer Research 11 (12), 4430-4436<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4371112419152330122" class="gsc_a_ac gs_ibl">181</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts</a><div class="gs_gray">R Le Dieu, DC Taussig, AG Ramsay, R Mitter, F Miraki-Moud, R Fatah, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (18), 3909-3916<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12997885424654173042" class="gsc_a_ac gs_ibl">180</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without&nbsp;…</a><div class="gs_gray">S O'Brien, JO Moore, TE Boyd, LM Larratt, AB Skotnicki, B Koziner, ...</div><div class="gs_gray">Journal of Clinical Oncology 27 (31), 5208<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5512227523332945223" class="gsc_a_ac gs_ibl">171</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:-f6ydRqryjwC" class="gsc_a_at">B7-mediated costimulation and the immune response</a><div class="gs_gray">J Schultze, LM Nadler, JG Gribben</div><div class="gs_gray">Blood reviews 10 (2), 111-127<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9983111432821670228" class="gsc_a_ac gs_ibl">171</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:MGPUR4WVBMEC" class="gsc_a_at">Mechanisms of action of lenalidomide in B-cell non-Hodgkin lymphoma</a><div class="gs_gray">JG Gribben, N Fowler, F Morschhauser</div><div class="gs_gray">Journal of Clinical Oncology 33 (25), 2803<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5118673138541081362" class="gsc_a_ac gs_ibl">169</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:koF6b02d8EEC" class="gsc_a_at">International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)</a><div class="gs_gray">A Younes, P Hilden, B Coiffier, A Hagenbeek, G Salles, W Wilson, ...</div><div class="gs_gray">Annals of Oncology 28 (7), 1436-1447<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6415457716099927553" class="gsc_a_ac gs_ibl">166</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non‐Hodgkin's lymphoma</a><div class="gs_gray">JW Friedberg, D Neuberg, JG Gribben, DC Fisher, C Canning, M Koval, ...</div><div class="gs_gray">British journal of haematology 117 (4), 828-834<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14416635356089352890" class="gsc_a_ac gs_ibl">165</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia</a><div class="gs_gray">JW Donovan, M Ladetto, G Zou, D Neuberg, C Poor, D Bowers, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 95 (8), 2651-2658<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7417728916279590285" class="gsc_a_ac gs_ibl">160</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors</a><div class="gs_gray">RE White, PC Rämer, KN Naresh, S Meixlsperger, L Pinaud, C Rooney, ...</div><div class="gs_gray">The Journal of clinical investigation 122 (4)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3057961874224265286" class="gsc_a_ac gs_ibl">159</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:NtGNdKbuCngC" class="gsc_a_at">PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia</a><div class="gs_gray">F McClanahan, B Hanna, S Miller, AJ Clear, P Lichter, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (2), 203-211<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15789723283856853976" class="gsc_a_ac gs_ibl">157</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:XUAslYVNQLQC" class="gsc_a_at">AUGMENT: a phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma</a><div class="gs_gray">JP Leonard, M Trneny, K Izutsu, NH Fowler, X Hong, J Zhu, H Zhang, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (14), 1188<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10567044080618380735" class="gsc_a_ac gs_ibl">155</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the&nbsp;…</a><div class="gs_gray">JG Gribben, EC Guinan, VA Boussiotis, XY Ke, L Linsley, C Sieff, GS Gray, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10477395410548622028" class="gsc_a_ac gs_ibl">152</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:WMtz-WDmgKQC" class="gsc_a_at">Disease evolution and outcomes in familial AML with germline <i>CEBPA</i> mutations</a><div class="gs_gray">K Tawana, J Wang, A Renneville, C Bödör, R Hills, C Loveday, A Savic, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (10), 1214-1223<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11594105414758564058" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress</a><div class="gs_gray">K Rouault-Pierre, L Lopez-Onieva, K Foster, F Anjos-Afonso, ...</div><div class="gs_gray">Cell stem cell 13 (5), 549-563<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12499087404223028672" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to&nbsp;…</a><div class="gs_gray">JG Gribben, AH Goldstone, DC Linch, G Taghipour, AK McMillan, ...</div><div class="gs_gray">Journal of Clinical Oncology 7 (11), 1621-1629<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11647045009312525173" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB&nbsp;…</a><div class="gs_gray">JA Woyach, AS Ruppert, NA Heerema, BL Peterson, JG Gribben, ...</div><div class="gs_gray">Journal of Clinical Oncology 29 (10), 1349<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18208735161403297365" class="gsc_a_ac gs_ibl">147</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:It0W0vAlS5QC" class="gsc_a_at">Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma</a><div class="gs_gray">J Okosun, RL Wolfson, J Wang, S Araf, L Wilkins, BM Castellano, ...</div><div class="gs_gray">Nature genetics 48 (2), 183-188<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4998062292986650457" class="gsc_a_ac gs_ibl">146</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:oAywNP-vUhwC" class="gsc_a_at">Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial</a><div class="gs_gray">CJ Hawkey, M Allez, MM Clark, M Labopin, JO Lindsay, E Ricart, ...</div><div class="gs_gray">Jama 314 (23), 2524-2534<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5007257999632563984" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival</a><div class="gs_gray">P Ghia, VA Boussiotis, JL Schultze, AA Cardoso, DM Dorfman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 91 (1), 244-251<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8537473864627964129" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:9CGX2owmTHMC" class="gsc_a_at">Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers</a><div class="gs_gray">OMT Pearce, RM Delaine-Smith, E Maniati, S Nichols, J Wang, S Böhm, ...</div><div class="gs_gray">Cancer discovery 8 (3), 304-319<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11267661427488072060" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the&nbsp;…</a><div class="gs_gray">JL Schultze, S Michalak, J Lowne, A Wong, MH Gilleece, JG Gribben, ...</div><div class="gs_gray">The Journal of experimental medicine 189 (1), 1-12<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15405565673028777352" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:k8to_Y4Q4_EC" class="gsc_a_at">Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia</a><div class="gs_gray">D Passaro, A Di Tullio, A Abarrategi, K Rouault-Pierre, K Foster, ...</div><div class="gs_gray">Cancer cell 32 (3), 324-341. e6<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10801404435603177688" class="gsc_a_ac gs_ibl">142</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Risk categories and refractory CLL in the era of chemoimmunotherapy</a><div class="gs_gray">T Zenz, JG Gribben, M Hallek, H Döhner, MJ Keating, S Stilgenbauer</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 119 (18), 4101-4107<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=48324702674950832" class="gsc_a_ac gs_ibl">142</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:f2IySw72cVMC" class="gsc_a_at">Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular&nbsp;…</a><div class="gs_gray">E Carlotti, D Wrench, J Matthews, S Iqbal, A Davies, A Norton, J Hart, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 113 (15), 3553-3557<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=911640711923430425" class="gsc_a_ac gs_ibl">142</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:TQgYirikUcIC" class="gsc_a_at">Ex Vivo Generation of Human Anti–Pre-B Leukemia-Specific Autologous Cytolytic T Cells</a><div class="gs_gray">AA Cardoso, MJ Seamon, HM Afonso, P Ghia, VA Boussiotis, GJ Freeman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 90 (2), 549-561<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1547725745728198192" class="gsc_a_ac gs_ibl">141</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies</a><div class="gs_gray">SN Rabinowe, RJ Soiffer, NJ Tarbell, D Neuberg, AS Freedman, J Seifter, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7691293981885568964" class="gsc_a_ac gs_ibl">141</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:aDl3D7KC1E4C" class="gsc_a_at">Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity</a><div class="gs_gray">N Shah, B Martin-Antonio, H Yang, S Ku, DA Lee, LJN Cooper, ...</div><div class="gs_gray">PloS one 8 (10), e76781<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4792905598727429554" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:ukw-9cB-YDkC" class="gsc_a_at">Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: final analysis of an open-label phase II study</a><div class="gs_gray">P Hillmen, JG Gribben, GA Follows, D Milligan, HA Sayala, P Moreton, ...</div><div class="gs_gray">Journal of clinical oncology 32 (12), 1236<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1105021792311125188" class="gsc_a_ac gs_ibl">139</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=zTBFoCoAAAAJ:s1ouQE5r0WUC" class="gsc_a_at">T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments</a><div class="gs_gray">ED Hawkins, D Duarte, O Akinduro, RA Khorshed, D Passaro, M Nowicka, ...</div><div class="gs_gray">Nature 538 (7626), 518-522<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7993795316736137476" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:35N4QoGY0k4C" class="gsc_a_at">How I treat indolent lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 109 (11), 4617-4626<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3136865181341905224" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163<sup>+</sup> macrophages within the immediate sprouting&nbsp;…</a><div class="gs_gray">AJ Clear, AM Lee, M Calaminici, AG Ramsay, KJ Morris, S Hallam, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (24), 5053-5056<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10448636149998027315" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma</a><div class="gs_gray">M Ladetto, JW Donovan, S Harig, E Weller, A Trojan, C Poor, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 6 (3), 241-253<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18004117040304623021" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Update on therapy of chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben, S O'Brien</div><div class="gs_gray">Journal of Clinical Oncology 29 (5), 544<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3218008251137477937" class="gsc_a_ac gs_ibl">136</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy.</a><div class="gs_gray">VA Boussiotis, GJ Freeman, JD Griffin, GS Gray, JG Gribben, LM Nadler</div><div class="gs_gray">The Journal of experimental medicine 180 (5), 1665-1673<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3848204691025225132" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xii_ZKWM4-0C" class="gsc_a_at">Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma</a><div class="gs_gray">ML Grossbard, JG Gribben, AS Freedman, JM Lambert, J Kinsella, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17466892681811084071" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:k_IJM867U9cC" class="gsc_a_at">Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro</a><div class="gs_gray">JL Schultze, MJ Seamon, S Michalak, JG Gribben, LM Nadler</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 89 (10), 3806-3816<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10179441467202261267" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the&nbsp;…</a><div class="gs_gray">S Montoto, K Shaw, J Okosun, S Gandhi, P Fields, A Wilson, M Shanyinde, ...</div><div class="gs_gray">Journal of clinical oncology 30 (33), 4111<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8543273606783410719" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rO6llkc54NcC" class="gsc_a_at">Eμ-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction</a><div class="gs_gray">G Gorgun, AG Ramsay, TAW Holderried, D Zahrieh, R Le Dieu, F Liu, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 106 (15), 6250-6255<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10465344084867668857" class="gsc_a_ac gs_ibl">131</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eI34FqJmdUoC" class="gsc_a_at">Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells</a><div class="gs_gray">P Greaves, A Clear, A Owen, S Iqbal, A Lee, J Matthews, A Wilson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (16), 2856-2863<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13928201157264949693" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Chronic lymphocytic leukemia cells induce defective LFA-1–directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide</a><div class="gs_gray">AG Ramsay, R Evans, S Kiaii, L Svensson, N Hogg, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (14), 2704-2714<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6368875890317662920" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:abG-DnoFyZgC" class="gsc_a_at">The presence of <i>TP53</i> mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer&nbsp;…</a><div class="gs_gray">D O'Shea, C O'Riain, C Taylor, R Waters, E Carlotti, F MacDougall, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (8), 3126-3129<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2339122155844233132" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome</a><div class="gs_gray">P Greaves, A Clear, R Coutinho, A Wilson, J Matthews, A Owen, ...</div><div class="gs_gray">Journal of clinical oncology 31 (2), 256<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4786442902918587334" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ShjGdcaqzI0C" class="gsc_a_at">Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy</a><div class="gs_gray">B Tavora, LE Reynolds, S Batista, F Demircioglu, I Fernandez, ...</div><div class="gs_gray">Nature 514 (7520), 112-116<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8562705256317331194" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse</a><div class="gs_gray">S Iyengar, A Clear, C Bödör, L Maharaj, A Lee, M Calaminici, J Matthews, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (12), 2274-2284<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3192445653462196471" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia</a><div class="gs_gray">R Claus, DM Lucas, S Stilgenbauer, AS Ruppert, L Yu, M Zucknick, ...</div><div class="gs_gray">Journal of Clinical Oncology 30 (20), 2483<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=26594459480383652" class="gsc_a_ac gs_ibl">126</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors</a><div class="gs_gray">C Voena, M Ladetto, M Astolfi, D Provan, JG Gribben, M Boccadoro, ...</div><div class="gs_gray">Leukemia 11 (10), 1793-1798<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15346980998321391983" class="gsc_a_ac gs_ibl">125</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Stem cell transplantation in chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 15 (1), 53-58<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9322909474543216861,1606663735703762116" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hMod-77fHWUC" class="gsc_a_at">Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia</a><div class="gs_gray">JR Brown, HT Kim, S Li, K Stephans, DC Fisher, C Cutler, V Ho, SJ Lee, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 12 (10), 1056-1064<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11872003604630189073" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sSrBHYA8nusC" class="gsc_a_at">EZH2 Y641 mutations in follicular lymphoma</a><div class="gs_gray">C Bödör, C O'riain, D Wrench, J Matthews, S Iyengar, H Tayyib, ...</div><div class="gs_gray">Leukemia 25 (4), 726-729<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7862171993665049829" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:maZDTaKrznsC" class="gsc_a_at">In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease</a><div class="gs_gray">JM Munro, AS Freedman, JC Aster, JG Gribben, NC Lee, KK Rhynhart, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16700447354196652890" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia</a><div class="gs_gray">AK McMillan, AH Goldstone, DC Linch, JG Gribben, KG Patterson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15064649963969116512" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DQNrXyjhriIC" class="gsc_a_at">Ofatumumab+ chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukemia (CLL): results of the phase III study complement 1 (OMB110911)</a><div class="gs_gray">P Hillmen, T Robak, A Janssens, K Govindbabu, S Grosicki, J Mayer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 528-528<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14838683800445190552,16977418785180332270" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:isC4tDSrTZIC" class="gsc_a_at">In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation</a><div class="gs_gray">DM Dorfman, JL Schultze, A Shahsafaei, S Michalak, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 90 (11), 4297-4306<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2125048868984864290" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qmtmRrLr0tkC" class="gsc_a_at">Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies</a><div class="gs_gray">R Coutinho, AJ Clear, A Owen, A Wilson, J Matthews, A Lee, R Alvarez, ...</div><div class="gs_gray">Clinical Cancer Research 19 (24), 6686-6695<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14336029863001996661" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tL5YfqkXb3gC" class="gsc_a_at">Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study</a><div class="gs_gray">P Hillmen, AC Rawstron, K Brock, S Muñoz-Vicente, FJ Yates, R Bishop, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (30), 2722<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14298943301971371691" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel</a><div class="gs_gray">BD Cheson, CM Wendtner, A Pieper, M Dreyling, J Friedberg, D Hoelzer, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 10 (1), 21-27<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11701480020877297878" class="gsc_a_ac gs_ibl">116</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BJtnxTr0fRcC" class="gsc_a_at">Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia</a><div class="gs_gray">L Jia, A Clear, FT Liu, J Matthews, N Uddin, A McCarthy, E Hoxha, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (11), 1709-1719<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16028004134467081780" class="gsc_a_ac gs_ibl">113</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome</a><div class="gs_gray">JR Brown, HT Kim, P Armand, C Cutler, DC Fisher, V Ho, J Koreth, J Ritz, ...</div><div class="gs_gray">Leukemia 27 (2), 362-369<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=158324597693612811" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5ugPr518TE4C" class="gsc_a_at">GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death</a><div class="gs_gray">MJ Streetly, L Maharaj, S Joel, SA Schey, JG Gribben, FE Cotter</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (19), 3939-3948<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6739269037513412498" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone&nbsp;…</a><div class="gs_gray">CS Zwicky, AB Maddocks, N Andersen, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1140787302977796870" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:anf4URPfarAC" class="gsc_a_at">Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis</a><div class="gs_gray">B Delage, P Luong, L Maharaj, C O’riain, N Syed, T Crook, ...</div><div class="gs_gray">Cell death &amp; disease 3 (7), e342-e342<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11264529759566392011" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and&nbsp;…</a><div class="gs_gray">JG Gribben, L Saporito, M Barber, KW Blake, RM Edwards, JD Griffin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9873938016676315120" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GnPB-g6toBAC" class="gsc_a_at">The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen</a><div class="gs_gray">P Engel, JG Gribben, GJ Freeman, LJ Zhou, Y Nozawa, M Abe, LM Nadler, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12140636187628257151" class="gsc_a_ac gs_ibl">108</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation</a><div class="gs_gray">F Miraki-Moud, F Anjos-Afonso, KA Hodby, E Griessinger, G Rosignoli, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 110 (33), 13576-13581<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14330746873973664823" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity</a><div class="gs_gray">IW Flinn, JC Byrd, N Bartlett, T Kipps, J Gribben, D Thomas, RA Larson, ...</div><div class="gs_gray">Leukemia research 29 (11), 1253-1257<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15746181589341322879" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:blknAaTinKkC" class="gsc_a_at">Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.</a><div class="gs_gray">VA Boussiotis, DL Barber, BJ Lee, JG Gribben, GJ Freeman, LM Nadler</div><div class="gs_gray">The Journal of experimental medicine 184 (2), 365-376<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11390361974133951094" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8JTMrWI6FdcC" class="gsc_a_at">Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?</a><div class="gs_gray">G Ficz, JG Gribben</div><div class="gs_gray">Genomics 104 (5), 352-357<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3290290471162831701" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wkm4DBaukwsC" class="gsc_a_at">Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo</a><div class="gs_gray">BS Hanna, F McClanahan, H Yazdanparast, N Zaborsky, V Kalter, ...</div><div class="gs_gray">Leukemia 30 (3), 570-579<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2000581471079973391" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy</a><div class="gs_gray">AM Krackhardt, S Harig, M Witzens, R Broderick, P Barrett, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (1), 167-173<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10299392016833743190" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation</a><div class="gs_gray">S Kiaii, AJ Clear, AG Ramsay, D Davies, A Sangaralingam, A Lee, ...</div><div class="gs_gray">Journal of clinical oncology 31 (21), 2654<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4685469420240978593" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mnAcAzq93VMC" class="gsc_a_at">Bone marrow niches in haematological malignancies</a><div class="gs_gray">S Méndez-Ferrer, D Bonnet, DP Steensma, RP Hasserjian, IM Ghobrial, ...</div><div class="gs_gray">Nature Reviews Cancer 20 (5), 285-298<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3229246251866445071" class="gsc_a_ac gs_ibl">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Phase II study of single‐agent bortezomib for the treatment of patients with fludarabine‐refractory B‐cell chronic lymphocytic leukemia</a><div class="gs_gray">S Faderl, K Rai, J Gribben, JC Byrd, IW Flinn, S O'Brien, S Sheng, ...</div><div class="gs_gray">Cancer: Interdisciplinary International Journal of the American Cancer&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7160461121648255529" class="gsc_a_ac gs_ibl">97</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect</a><div class="gs_gray">E Alyea, E Weller, R Schlossman, C Canning, P Mauch, A Ng, D Fisher, ...</div><div class="gs_gray">Bone marrow transplantation 32 (12), 1145-1151<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4098636254383580476" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pRWBApOjXDcC" class="gsc_a_at">Mechanisms of PD-L1/PD-1–mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model</a><div class="gs_gray">F McClanahan, JC Riches, S Miller, WP Day, E Kotsiou, D Neuberg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (2), 212-221<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14115498769700702415" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells</a><div class="gs_gray">L Jia, G Gopinathan, JT Sukumar, JG Gribben</div><div class="gs_gray">PloS one 7 (2), e32584<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6188840849118341594" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28).</a><div class="gs_gray">NL Spector, W Samson, C Ryan, J Gribben, W Urba, WJ Welch, ...</div><div class="gs_gray">The Journal of Immunology 148 (6), 1668-1673<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18246120817963922675" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation</a><div class="gs_gray">D O'Shea, C O'Riain, M Gupta, R Waters, Y Yang, D Wrench, J Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 113 (10), 2298-2301<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11532870414873182826" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:a0OBvERweLwC" class="gsc_a_at">Array-based DNA methylation profiling in follicular lymphoma</a><div class="gs_gray">C O'Riain, DM O'Shea, Y Yang, R Le Dieu, JG Gribben, K Summers, ...</div><div class="gs_gray">Leukemia 23 (10), 1858-1866<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9296326998543132586" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib</a><div class="gs_gray">FT Liu, SG Agrawal, Z Movasaghi, PB Wyatt, IU Rehman, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (9), 3835-3846<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15836245160086755187" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RGFaLdJalmkC" class="gsc_a_at">GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.</a><div class="gs_gray">S Devereaux, DC Linch, JG Gribben, A McMillan, K Patterson, ...</div><div class="gs_gray">Bone marrow transplantation 4 (1), 49-54<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9202956822406577857" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Understanding the immunodeficiency in chronic lymphocytic leukemia: potential clinical implications</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Hematology/Oncology Clinics 27 (2), 207-235<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=759136210438327168" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL</a><div class="gs_gray">FT Liu, SG Agrawal, JG Gribben, H Ye, MQ Du, AC Newland, L Jia</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (5), 2797-2805<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15243207867477181733" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:T8_be82Iz5gC" class="gsc_a_at">Ultrafiltration in the management of refractory congestive heart failure.</a><div class="gs_gray">IA Simpson, AP Rae, K Simpson, J Gribben, JMB Jones, ME Allison, ...</div><div class="gs_gray">Heart 55 (4), 344-347<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18120458235874182995" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IvSMUa3B7yYC" class="gsc_a_at">RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics</a><div class="gs_gray">E Salzer, D Cagdas, M Hons, EM Mace, W Garncarz, ÖY Petronczki, ...</div><div class="gs_gray">Nature immunology 17 (12), 1352-1360<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3577999967398850833" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:738O_yMBCRsC" class="gsc_a_at">Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4-specific antibodies</a><div class="gs_gray">JG Gribben, GJ Freeman, LM Nadler, P Rennert, CL Jellis, E Greenfield, ...</div><div class="gs_gray">US Patent 6,719,972<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5836554995071507385" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VnuxuLaQPLMC" class="gsc_a_at">Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo</a><div class="gs_gray">F Miraki-Moud, E Ghazaly, L Ariza-McNaughton, KA Hodby, A Clear, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 125 (26), 4060-4068<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4182552868379793173" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Use of <i>IGHV3–21</i> in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection</a><div class="gs_gray">EM Ghia, S Jain, GF Widhopf, LZ Rassenti, MJ Keating, WG Wierda, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (10), 5101-5108<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1090575902662829806" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia</a><div class="gs_gray">CM Wendtner, P Hillmen, D Mahadevan, A Bühler, L Uharek, S Coutré, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 53 (3), 417-423<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=72735940610656747" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oqD4_j7ulsYC" class="gsc_a_at">Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by <i>NOTCH1</i> mutations</a><div class="gs_gray">JC Riches, CJ O’Donovan, SJ Kingdon, F McClanahan, AJ Clear, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (26), 4101-4110<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12799837512382326245" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:e84hm74t-eoC" class="gsc_a_at">A niche‐like culture system allowing the maintenance of primary human acute myeloid leukemia‐initiating cells: a new tool to decipher their chemoresistance and self‐renewal&nbsp;…</a><div class="gs_gray">E Griessinger, F Anjos-Afonso, I Pizzitola, K Rouault-Pierre, J Vargaftig, ...</div><div class="gs_gray">Stem cells translational medicine 3 (4), 520-529<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5999118973048945607" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies</a><div class="gs_gray">JW Friedberg, D Neuberg, JG Gribben, P Mauch, KC Anderson, RJ Soiffer, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 5 (4), 262-268<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11433322793263739851" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DwWRdx-KAo4C" class="gsc_a_at">Overall survival benefit in patients with rituximab-refractory indolent non-Hodgkin lymphoma who received obinutuzumab plus bendamustine induction and obinutuzumab maintenance&nbsp;…</a><div class="gs_gray">BD Cheson, N Chua, J Mayer, G Dueck, M Trneny, K Bouabdallah, ...</div><div class="gs_gray">Springer Healthcare Ibérica SL 36 (22)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11706520698341158770,15984904395088346545" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pxXbYLTb8EgC" class="gsc_a_at">Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia on behalf of the Guidelines Committee of the American&nbsp;…</a><div class="gs_gray">MA Kharfan-Dabaja, A Kumar, M Hamadani, S Stilgenbauer, P Ghia, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (12), 2117-2125<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14198154218455458916" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gFrPXmx1TSsC" class="gsc_a_at">High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia</a><div class="gs_gray">B Cui, EM Ghia, L Chen, LZ Rassenti, C DeBoever, GF Widhopf, J Yu, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (25), 2931-2940<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3937631650425217703" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas-and Bax-mediated programmed cell death.</a><div class="gs_gray">VA Boussiotis, BJ Lee, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">The Journal of Immunology 159 (7), 3156-3167<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12304708463809990344" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies</a><div class="gs_gray">JK Davies, JG Gribben, LL Brennan, D Yuk, LM Nadler, EC Guinan</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (6), 2232-2241<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4766368691477835197" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for&nbsp;…</a><div class="gs_gray">A Li, J Zhou, D Zuckerman, M Rue, V Dalton, C Lyons, LB Silverman, ...</div><div class="gs_gray">Blood 102 (13), 4520-4526<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11340613218808034682" class="gsc_a_ac gs_ibl">77</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gV6rEsy15s0C" class="gsc_a_at">Validation of <i>ZAP-70</i> methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia</a><div class="gs_gray">R Claus, DM Lucas, AS Ruppert, KE Williams, D Weng, K Patterson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (1), 42-48<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16323545832581165358" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">The role of the tumor microenvironment in hematological malignancies and implication for therapy</a><div class="gs_gray">J Zhou, K Mauerer, L Farina, JG Gribben</div><div class="gs_gray">Front Biosci 10 (5), 1581-1596<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8881327718664818865" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin’s lymphoma</a><div class="gs_gray">ML Grossbard, PS Multani, AS Freedman, S O’Day, JG Gribben, C Rhuda, ...</div><div class="gs_gray">Clinical cancer research 5 (9), 2392-2398<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3720955696859226687" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab</a><div class="gs_gray">T Elter, JJ Vehreschild, J Gribben, OA Cornely, A Engert, M Hallek</div><div class="gs_gray">Annals of hematology 88 (2), 121-132<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10699971413761060284" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients</a><div class="gs_gray">M Ladetto, S Sametti, JW Donovan, D Ferrero, M Astolfi, M Mitterer, ...</div><div class="gs_gray">Experimental hematology 29 (2), 183-193<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3496953639079267771" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests</a><div class="gs_gray">M Ladetto, P Omedè, S Sametti, JW Donovan, M Astolfi, D Drandi, ...</div><div class="gs_gray">Experimental hematology 30 (6), 529-536<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15532208280935505749" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia</a><div class="gs_gray">K Mauerer, D Zahrieh, G Gorgun, A Li, J Zhou, S Ansén, LZ Rassenti, ...</div><div class="gs_gray">British journal of haematology 129 (4), 499-510<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11115064927072725322" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission</a><div class="gs_gray">JR Brown, Y Feng, JG Gribben, D Neuberg, DC Fisher, P Mauch, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 13 (9), 1057-1065<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6733197846830309998" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ldfaerwXgEUC" class="gsc_a_at">Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A* 0201 restricted epitopes from the human epithelial cell adhesion molecule</a><div class="gs_gray">A Trojan, M Witzens, JL Schultze, RH Vonderheide, S Harig, ...</div><div class="gs_gray">Cancer research 61 (12), 4761-4765<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8046100612502738451" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vjZqxyZ7hS4C" class="gsc_a_at">Role of the tumor microenvironment in mature B-cell lymphoid malignancies</a><div class="gs_gray">NH Fowler, CY Cheah, RD Gascoyne, J Gribben, SS Neelapu, P Ghia, ...</div><div class="gs_gray">Haematologica 101 (5), 531<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15729499121432581776" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study</a><div class="gs_gray">DL Longo, PL Duffey, JG Gribben, ES Jaffe, BD Curti, BL Gause, JE Janik, ...</div><div class="gs_gray">Cancer Journal from Scientific American 6 (3), 146-150<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10266882902137869853" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Molecular hematology</a><div class="gs_gray">D Provan, J Gribben</div><div class="gs_gray">John Wiley &amp; Sons<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1987305495994502910" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Rediscovering alemtuzumab: current and emerging therapeutic roles</a><div class="gs_gray">JG Gribben, M Hallek</div><div class="gs_gray">British journal of haematology 144 (6), 818-831<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17607529092456720659" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AkvegQHRDQ8C" class="gsc_a_at">Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium</a><div class="gs_gray">A Rosenwald, S Bens, R Advani, S Barrans, C Copie-Bergman, ...</div><div class="gs_gray">Journal of Clinical Oncology, JCO1900743<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2528071810390295779" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XtJa11BXPS4C" class="gsc_a_at">The European hematology association roadmap for European hematology research: a consensus document</a><div class="gs_gray">A Engert, C Balduini, A Brand, B Coiffier, C Cordonnier, H Döhner, ...</div><div class="gs_gray">haematologica 101 (2), 115<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5347877743089048542" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Rituximab plus chlorambucil in patients with CD20-positive B-cell chronic lymphocytic leukemia (CLL): final response analysis of an open-label phase II study</a><div class="gs_gray">P Hillmen, JG Gribben, GA Follows, D Milligan, HA Sayala, P Moreton, ...</div><div class="gs_gray">Blood 116 (21), 697<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10590325864934313369" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study</a><div class="gs_gray">S Mach-Pascual, RD Legare, D Lu, M Kroon, D Neuberg, R Tantravahi, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 91 (12), 4496-4503<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=562264380243826442" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WHBERAHVdrEC" class="gsc_a_at">Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial</a><div class="gs_gray">J Trotman, SF Barrington, D Belada, M Meignan, R MacEwan, C Owen, ...</div><div class="gs_gray">The Lancet Oncology 19 (11), 1530-1542<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7414039186246798148,17585769188424093749" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xlVdBZVQT58C" class="gsc_a_at">Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies</a><div class="gs_gray">G Thanarajasingam, LM Minasian, F Baron, F Cavalli, RA De Claro, ...</div><div class="gs_gray">The Lancet Haematology 5 (11), e563-e598<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14834039053568106713" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors</a><div class="gs_gray">RJ Soiffer, E Weller, EP Alyea, P Mauch, IL Webb, DC Fisher, ...</div><div class="gs_gray">Journal of clinical oncology 19 (4), 1152-1159<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13999889868473378401" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CmbFvBriOyMC" class="gsc_a_at">Clinical outcome of coronavirus disease 2019 in haemato-oncology patients</a><div class="gs_gray">JA Aries, JK Davies, RL Auer, SL Hallam, S Montoto, M Smith, B Sevillano, ...</div><div class="gs_gray">British journal of haematology<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12564995679840934726" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1Aeql8wG3wEC" class="gsc_a_at">Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors</a><div class="gs_gray">EA Saunderson, P Stepper, JJ Gomm, L Hoa, A Morgan, MD Allen, ...</div><div class="gs_gray">Nature communications 8 (1), 1-15<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7722353569276705080" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:h1pkognVyKwC" class="gsc_a_at">Versatile humanized niche model enables study of normal and malignant human hematopoiesis</a><div class="gs_gray">A Abarrategi, K Foster, A Hamilton, SA Mian, D Passaro, J Gribben, ...</div><div class="gs_gray">The Journal of clinical investigation 127 (2), 543-548<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16914660009948366769" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia</a><div class="gs_gray">FT Liu, J Giustiniani, T Farren, L Jia, A Bensussan, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (15), 3079-3088<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15889409748277484047" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CRzUtm-VnGAC" class="gsc_a_at">Empirical inference of circuitry and plasticity in a kinase signaling network</a><div class="gs_gray">EH Wilkes, C Terfve, JG Gribben, J Saez-Rodriguez, PR Cutillas</div><div class="gs_gray">Proceedings of the National Academy of Sciences 112 (25), 7719-7724<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15764341478598965795" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells</a><div class="gs_gray">CS Gricks, D Zahrieh, AJ Zauls, G Gorgun, D Drandi, K Mauerer, ...</div><div class="gs_gray">Blood 104 (13), 4002-4009<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18382040984742135269" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cx97FdCJQX8C" class="gsc_a_at">Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma</a><div class="gs_gray">S Araf, J Wang, K Korfi, C Pangault, E Kotsiou, A Rio-Machin, T Rahim, ...</div><div class="gs_gray">Leukemia 32 (5), 1261-1265<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14508086957560897473,272140176407616564" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug</a><div class="gs_gray">AG Ramsay, JG Gribben</div><div class="gs_gray">haematologica 94 (9), 1198<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17518824827117538144" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JTtNqH-x4gYC" class="gsc_a_at">Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial</a><div class="gs_gray">JO Lindsay, M Allez, M Clark, M Labopin, E Ricart, G Rogler, M Rovira, ...</div><div class="gs_gray">The lancet Gastroenterology &amp; hepatology 2 (6), 399-406<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15303211772062694374" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 ex vivo expansion</a><div class="gs_gray">D Xing, AG Ramsay, JG Gribben, WK Decker, JK Burks, M Munsell, S Li, ...</div><div class="gs_gray">Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (7), 684<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7822219588891330184" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Utilization of Ig heavy chain variable, diversity, and joining gene segments in children with B-lineage acute lymphoblastic leukemia: implications for the mechanisms of VDJ&nbsp;…</a><div class="gs_gray">A Li, M Rue, J Zhou, H Wang, MA Goldwasser, D Neuberg, V Dalton, ...</div><div class="gs_gray">Blood 103 (12), 4602-4609<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16361430116733001240" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qsWQJNntlusC" class="gsc_a_at">The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium</a><div class="gs_gray">B Sander, D de Jong, A Rosenwald, W Xie, O Balagué, M Calaminici, ...</div><div class="gs_gray">haematologica 99 (4), 715<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17554416467656042874" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:60iIaj97TE0C" class="gsc_a_at">Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late&nbsp;…</a><div class="gs_gray">P Greaves, SJ Sarker, K Chowdhury, R Johnson, J Matthews, R Matthews, ...</div><div class="gs_gray">British journal of haematology 164 (4), 526-535<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13906614604317558689" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8AbLer7MMksC" class="gsc_a_at">SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL</a><div class="gs_gray">R Proto-Siqueira, RA Panepucci, FP Careta, A Lee, A Clear, K Morris, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (2), 394-397<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=76496396737415812" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UxriW0iASnsC" class="gsc_a_at">Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3</a><div class="gs_gray">GF Widhopf, CJ Goldberg, TL Toy, LZ Rassenti, WG Wierda, JC Byrd, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (6), 3137-3144<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14977488106291380932" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:geHnlv5EZngC" class="gsc_a_at">Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells</a><div class="gs_gray">LD Vallat, Y Park, C Li, JG Gribben</div><div class="gs_gray">Blood 109 (9), 3989-3997<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10971597499423319456" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HAmI6pRF5skC" class="gsc_a_at">Single cell analysis of clonal architecture in acute myeloid leukaemia</a><div class="gs_gray">N Potter, F Miraki-Moud, L Ermini, I Titley, G Vijayaraghavan, ...</div><div class="gs_gray">Leukemia 33 (5), 1113-1123<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4038318341312869224" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IHkkN1K1AlAC" class="gsc_a_at">Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions</a><div class="gs_gray">CL Freeman, F Morschhauser, L Sehn, M Dixon, R Houghton, T Lamy, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (24), 2646-2649<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3769315272617838326" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:u9iWguZQMMsC" class="gsc_a_at">HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation</a><div class="gs_gray">VT Ho, HT Kim, D Liney, E Milford, J Gribben, C Cutler, SJ Lee, JH Antin, ...</div><div class="gs_gray">Bone marrow transplantation 37 (9), 845-850<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=238418144479197074" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SdhP9T11ey4C" class="gsc_a_at">T-cell function in chronic lymphocytic leukaemia</a><div class="gs_gray">JC Riches, AG Ramsay, JG Gribben</div><div class="gs_gray">Seminars in cancer biology 20 (6), 431-438<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1225642822050571978" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:d4tt_xEv1X8C" class="gsc_a_at">Inhibitors of BCR signalling interrupt the survival signal mediated by the micro‐environment in mantle cell lymphoma</a><div class="gs_gray">S Bernard, D Danglade, L Gardano, C Laguillier, G Lazarian, C Roger, ...</div><div class="gs_gray">International journal of cancer 136 (12), 2761-2774<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13886464248804808970" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:09LM3QYkMKUC" class="gsc_a_at">Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice</a><div class="gs_gray">JG Gribben, F Bosch, F Cymbalista, CH Geisler, P Ghia, P Hillmen, ...</div><div class="gs_gray">British journal of haematology 180 (5), 666-679<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17568865380842150988" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Differential and tumor-specific expression of CD160 in B-cell malignancies</a><div class="gs_gray">TW Farren, J Giustiniani, FT Liu, DA Tsitsikas, MG Macey, JD Cavenagh, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (8), 2174-2183<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1611982293933598873" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LPZeul_q3PIC" class="gsc_a_at">CD40 activation: potential for specific immunotherapy in B-CLL</a><div class="gs_gray">M von Bergwelt-Baildon, B Maecker, J Schultze, JG Gribben</div><div class="gs_gray">Annals of oncology 15 (6), 853-857<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13661767067235605395" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Nw_I7GeUguwC" class="gsc_a_at">Enhanced activation of an amino-terminally truncated isoform of the voltage-gated proton channel HVCN1 enriched in malignant B cells</a><div class="gs_gray">E Hondares, MA Brown, B Musset, D Morgan, VV Cherny, C Taubert, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 111 (50), 18078-18083<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15279845214377003867" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone&nbsp;…</a><div class="gs_gray">A Freedman, D Neuberg, P Mauch, J Gribben, R Soiffer, K Anderson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 90 (12), 4996-5001<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6019817887444803302" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sbeIDTyQOFgC" class="gsc_a_at">Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia</a><div class="gs_gray">F Manodoro, J Marzec, T Chaplin, F Miraki-Moud, E Moravcsik, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (13), 2066-2074<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16095197075925133679" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3htObqc8RwsC" class="gsc_a_at">The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies</a><div class="gs_gray">K Liapis, A Clear, A Owen, R Coutinho, P Greaves, AM Lee, S Montoto, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (3), 424-433<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13966140561873483715" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w9ZB08sdvuUC" class="gsc_a_at">Growth dynamics in naturally progressing chronic lymphocytic leukaemia</a><div class="gs_gray">M Gruber, I Bozic, I Leshchiner, D Livitz, K Stevenson, L Rassenti, ...</div><div class="gs_gray">Nature 570 (7762), 474-479<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16121688810851686148" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LlXTz_FrCmAC" class="gsc_a_at">Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD eradication&nbsp;…</a><div class="gs_gray">P Hillmen, T Munir, A Rawstron, K Brock, S Munoz Vicente, F Yates, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 428-428<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5329277881284632270" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yIeBiWEAh44C" class="gsc_a_at">Immunomodulation and immune reconstitution in chronic lymphocytic leukemia</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Seminars in hematology 51 (3), 228-234<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8279528823909147279" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:p2g8aNsByqUC" class="gsc_a_at">CD34 selection as a stem cell purging strategy for neuroblastoma: preclinical and clinical studies</a><div class="gs_gray">J Donovan, J Temel, A Zuckerman, J Gribben, J Fang, G Pierson, A Ross, ...</div><div class="gs_gray">Medical and Pediatric Oncology: The Official Journal of SIOP—International&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12468625274837625544" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:inmFHauC9wsC" class="gsc_a_at">Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3&nbsp;…</a><div class="gs_gray">R Coutinho, AJ Clear, E Mazzola, A Owen, P Greaves, A Wilson, ...</div><div class="gs_gray">haematologica 100 (3), 363<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5551527318679451722" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Frequency of leukemic initiating cells does not depend on the xenotransplantation model used</a><div class="gs_gray">J Vargaftig, DC Taussig, E Griessinger, F Anjos-Afonso, TA Lister, ...</div><div class="gs_gray">Leukemia 26 (4), 858-860<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12182989380797924778" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eflP2zaiRacC" class="gsc_a_at">Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma</a><div class="gs_gray">NS Andersen, JW Donovan, A Zuckerman, L Pedersen, C Geisler, ...</div><div class="gs_gray">Experimental hematology 30 (7), 703-710<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16413224113252423580" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eLRq4zTgah0C" class="gsc_a_at">Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia</a><div class="gs_gray">IW Flinn, JG Gribben, MJS Dyer, W Wierda, MB Maris, RR Furman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 133 (26), 2765-2775<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3351234049406483513" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Chronic lymphocytic leukemia: planning for an aging population</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Expert review of anticancer therapy 10 (9), 1389-1394<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3181541519107388110" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RXiHnyRawswC" class="gsc_a_at">Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors</a><div class="gs_gray">A Korszun, SJ Sarker, K Chowdhury, C Clark, P Greaves, R Johnson, ...</div><div class="gs_gray">British journal of haematology 164 (6), 790-803<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13175814046106874864" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation</a><div class="gs_gray">DG Gilliland, JG Gribben</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 8 (1), 9-16<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5215892610527252410" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">The gene for B7, a costimulatory signal for T-cell activation, maps to chromosomal region 3ql3. 3-3q21</a><div class="gs_gray">GJ Freeman, CM Disteche, JG Gribben, DA Adler, AS Freedman, ...</div><div class="gs_gray">Blood 79 (2), 489-494<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9108561709526311061" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XiSMed-E-HIC" class="gsc_a_at">CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma</a><div class="gs_gray">RJ Soiffer, AS Freedman, D Neuberg, DC Fisher, EP Alyea, J Gribben, ...</div><div class="gs_gray">Bone marrow transplantation 21 (12), 1177-1181<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17517319189589807179" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide</a><div class="gs_gray">KM Zirlik, D Zahrieh, D Neuberg, JG Gribben</div><div class="gs_gray">Blood 108 (12), 3865-3870<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10316279017393128522" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Molecular profiling in CLL</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">ASH Education Program Book 2008 (1), 444-449<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6921580122115153475" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SP6oXDckpogC" class="gsc_a_at">A pilot study of combined immunotherapy with autologous adoptive tumour‐specific T‐cell transfer, vaccination with CD40‐activated malignant B cells and interleukin 2</a><div class="gs_gray">JL Schultze, KC Anderson, MH Gilleece, JG Gribben, LM Nadler</div><div class="gs_gray">British journal of haematology 113 (2), 455-460<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1807515735235886981" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vxA22ZmNLkoC" class="gsc_a_at">GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin&nbsp;…</a><div class="gs_gray">LH Sehn, NS Chua, J Mayer, GS Dueck, M Trněný, K Bouabdallah, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (18_suppl), LBA8502-LBA8502<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5972742152418304142" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia–CXCR4 antagonists as potential adjuvants for monoclonal antibodies</a><div class="gs_gray">M Buchner, P Brantner, N Stickel, G Prinz, M Burger, C Bär, C Dierks, ...</div><div class="gs_gray">British journal of haematology 151 (2), 167-178<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12523756435729053056" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">The evolving role of alemtuzumab in management of patients with CLL</a><div class="gs_gray">S Faderl, S Coutre, JC Byrd, C Dearden, A Denes, MJS Dyer, SA Gregory, ...</div><div class="gs_gray">Leukemia 19 (12), 2147-2152<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2970426962855795840" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Implications of the tumor microenvironment on survival and disease response in follicular lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Current opinion in oncology 22 (5), 424-430<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6131082526516189316" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dshw04ExmUIC" class="gsc_a_at">Efficacy and safety of alemtuzumab (Campath-1H) in refractory B-CLL patients treated on a compassionate basis.</a><div class="gs_gray">KR Rai, S Coutre, D Rizzieri, JG Gribben, I Flinn, S Rabinowe, MJ Keating</div><div class="gs_gray">Blood 98 (11), 365A-365A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=814591071821484146" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kQqwFFzsCTwC" class="gsc_a_at">How and when I do allogeneic transplant in CLL</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 132 (1), 31-39<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12292506512283829881" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups</a><div class="gs_gray">T Marafioti, C Copie‐Bergman, M Calaminici, JC Paterson, VH Shende, ...</div><div class="gs_gray">Histopathology 62 (6), 860-875<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7352576976184495222" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation</a><div class="gs_gray">E Alyea, D Neuberg, P Mauch, K Marcus, A Freedman, I Webb, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 8 (3), 139-144<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18408779148022358925" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j8pvxH-kN2QC" class="gsc_a_at">Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation&nbsp;…</a><div class="gs_gray">R Vrhovac, M Labopin, F Ciceri, J Finke, E Holler, J Tischer, B Lioure, ...</div><div class="gs_gray">Bone marrow transplantation 51 (2), 186-193<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14297939169800783453" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Salvage therapy for CLL and the role of stem cell transplantation</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">ASH Education Program Book 2005 (1), 292-298<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18327147125543672386" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Early neutrophil engraftment following autologous BMT provides a functional predictor of long‐term hematopoietic reconstitution</a><div class="gs_gray">A Zubair, D Zahrieh, H Daley, D Schott, JG Gribben, A Freedman, J Ritz</div><div class="gs_gray">Transfusion 43 (5), 614-621<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11567309064729555882" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia</a><div class="gs_gray">JL Schultze, JW Donovan, JG Gribben</div><div class="gs_gray">Journal of molecular medicine 77 (2), 259-265<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13813978342818822188" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas</a><div class="gs_gray">JG Gribben, BV Hudson, DC Linch</div><div class="gs_gray">Hematological oncology 5 (4), 281-293<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9008164259171677269" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ujxm2eEBZHIC" class="gsc_a_at">Life expectancy of young adults with follicular lymphoma</a><div class="gs_gray">A Conconi, C Lobetti-Bodoni, S Montoto, A Lopez-Guillermo, R Coutinho, ...</div><div class="gs_gray">Annals of Oncology 26 (11), 2317-2322<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=595876696656507367" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:D_sINldO8mEC" class="gsc_a_at">Stem cell transplantation for non-Hodgkin's lymphoma</a><div class="gs_gray">D Wrench, JG Gribben</div><div class="gs_gray">Hematology/oncology clinics of North America 22 (5), 1051-1079<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11096624461484349514" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Rituxan/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma</a><div class="gs_gray">O Howard</div><div class="gs_gray">Blood 94 (1), 631a<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10926337103376555376" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nU66GSXDKhoC" class="gsc_a_at">Safety and efficacy of a combination of venetoclax (GDC-0199/ABT-199) and obinutuzumab in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia&nbsp;…</a><div class="gs_gray">IW Flinn, M Brunvand, MY Choi, MJS Dyer, J Gribben, P Hillmen, J Jones, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 494-494<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5165235889138513274" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uWiczbcajpAC" class="gsc_a_at">A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia</a><div class="gs_gray">A Perrot, C Pionneau, S Nadaud, F Davi, V Leblond, F Jacob, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (4), e1-e15<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11190160993474142115" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IyxfXMz2bNAC" class="gsc_a_at">NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome</a><div class="gs_gray">TA Eyre, R Clifford, A Bloor, L Boyle, C Roberts, M Cabes, GP Collins, ...</div><div class="gs_gray">British journal of haematology 175 (1), 43-54<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2017304293086214319" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YGhAHpnIhDoC" class="gsc_a_at">Obinutuzumab plus bendamustine followed by obinutuzumab maintenance prolongs overall survival compared with bendamustine alone in patients with rituximab-refractory indolent&nbsp;…</a><div class="gs_gray">BD Cheson, M Trněný, K Bouabdallah, G Dueck, J Gribben, ...</div><div class="gs_gray">Blood 128 (22), 615<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13599481535448646243" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tgTmbKTkO1IC" class="gsc_a_at">Analysis of minimal residual disease in follicular lymphoma patients in GADOLIN, a phase III study of obinutuzumab plus bendamustine versus bendamustine in relapsed/refractory&nbsp;…</a><div class="gs_gray">C Pott, D Belada, N Danesi, G Fingerle-Rowson, J Gribben, C Harbron, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3978-3978<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2304503404747604798" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Immune reconstitution in chronic lymphocytic leukemia</a><div class="gs_gray">JC Riches, AG Ramsay, JG Gribben</div><div class="gs_gray">Current hematologic malignancy reports 7 (1), 13-20<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11107142591626267251" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation</a><div class="gs_gray">EP Alyea, E Weller, DC Fisher, AS Freedman, JG Gribben, S Lee, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 8 (11), 601-607<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9887424556388257608" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia</a><div class="gs_gray">L Vallat, CA Kemper, N Jung, M Maumy-Bertrand, F Bertrand, N Meyer, ...</div><div class="gs_gray">Proceedings of the National Academy of Sciences 110 (2), 459-464<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3575635365247186966" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yNlG6JgpFqoC" class="gsc_a_at">Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the bloodwise TAP clarity study</a><div class="gs_gray">P Hillmen, A Rawstron, K Brock, SM Vicente, F Yates, R Bishop, ...</div><div class="gs_gray">Blood 132, 182<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16144469217025720385" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JqN3CTdJtl0C" class="gsc_a_at">Safety, efficacy and MRD negativity of a combination of venetoclax and obinutuzumab in patients with previously untreated chronic lymphocytic leukemia-results from a phase 1b&nbsp;…</a><div class="gs_gray">IW Flinn, JG Gribben, MJS Dyer, WG Wierda, MB Maris, RR Furman, ...</div><div class="gs_gray">Blood 130, 430<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=770305778196816166" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:u0Mu_IsstPMC" class="gsc_a_at">High throughput sequencing analysis of the immunoglobulin heavy chain gene from flow-sorted B cell sub-populations define the dynamics of follicular lymphoma clonal evolution</a><div class="gs_gray">E Carlotti, D Wrench, G Rosignoli, J Marzec, A Sangaralingam, ...</div><div class="gs_gray">PLoS One 10 (9), e0134833<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14214536010462843908" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:evX43VCCuoAC" class="gsc_a_at">Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia</a><div class="gs_gray">T Butler, JG Gribben</div><div class="gs_gray">Blood reviews 24 (3), 135-141<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6289069263031569034" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia</a><div class="gs_gray">SG Agrawal, FT Liu, C Wiseman, S Shirali, H Liu, D Lillington, MQ Du, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (5), 2790-2796<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13918379074373836119" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Prediction of therapy‐related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma</a><div class="gs_gray">RD Legare, JG Gribben, M Maragh, A Hermanowski‐Vosatka, S Roach, ...</div><div class="gs_gray">American journal of hematology 56 (1), 45-51<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14391559768450469563" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6Zm5LS9gQ5UC" class="gsc_a_at">Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium</a><div class="gs_gray">WBC Stevens, M Mendeville, R Redd, AJ Clear, R Bladergroen, ...</div><div class="gs_gray">haematologica 102 (8), 1413<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11112064612810121224" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9tXw7Op4-u0C" class="gsc_a_at">Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)</a><div class="gs_gray">A Chanan-Khan, M Egyed, T Robak, FAM De Oliveira, MA Echeveste, ...</div><div class="gs_gray">Leukemia 31 (5), 1240-1243<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10375467741900855665" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:urP0JZOBBUsC" class="gsc_a_at">Immunotherapy in chronic lymphocytic leukaemia (CLL)</a><div class="gs_gray">CL Freeman, JG Gribben</div><div class="gs_gray">Current hematologic malignancy reports 11 (1), 29-36<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11219021948781841114" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Mobilized peripheral blood stem cells compared with bone marrow from HLA‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, GJ Mufti, JJ Cornelissen, D Blaise, ...</div><div class="gs_gray">European journal of haematology 89 (3), 206-213<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3434914616830771868" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5awf1xo2G04C" class="gsc_a_at">An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic&nbsp;…</a><div class="gs_gray">P Hillmen, JG Gribben, GA Follows, DW Milligan, HA Sayala, P Moreton, ...</div><div class="gs_gray">Blood 114 (22), 3428<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14631980693536805200,17994729992545084220" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia</a><div class="gs_gray">BT Messmer, BJ Raphael, SJ Aerni, GF Widhopf, LZ Rassenti, JG Gribben, ...</div><div class="gs_gray">Leukemia research 33 (3), 368-376<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14368861762111311661" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NJ774b8OgUMC" class="gsc_a_at">The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study</a><div class="gs_gray">MH Gilleece, R Pearce, DC Linch, M Wilson, K Towlson, S Mackinnon, ...</div><div class="gs_gray">Hematology 13 (2), 119-127<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5161513077876332255" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Plasma from patients with severe Lassa fever profoundly modulates f‐met‐leu‐phe induced superoxide generation in neutrophils</a><div class="gs_gray">PJ Roberts, D Cummins, AL Bainton, KJ Walshe, SP Fisher‐Hoch, ...</div><div class="gs_gray">British journal of haematology 73 (2), 152-157<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=412296497213935136" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oYwriLWYh5YC" class="gsc_a_at">The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia</a><div class="gs_gray">A Di Tullio, K Rouault-Pierre, A Abarrategi, S Mian, W Grey, J Gribben, ...</div><div class="gs_gray">Nature communications 8 (1), 1-12<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8224460936363433100" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo</a><div class="gs_gray">JW Friedberg, DA Dong, S Li, H Kim, K Stephans, K Noonan, D Neuberg, ...</div><div class="gs_gray">Leukemia research 28 (2), 139-147<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11898152336077414427" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Attainment of molecular remission: a worthwhile goal?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Journal of clinical oncology 12 (8), 1532-1534<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1180215901770650634" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WM2K3OHRCGMC" class="gsc_a_at">Pixantrone–rituximab versus gemcitabine–rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma</a><div class="gs_gray">D Belada, P Georgiev, S Dakhil, LF Inhorn, D Andorsky, JT Beck, D Quick, ...</div><div class="gs_gray">Future oncology 12 (15), 1759-1768<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17746764167270457273,2854850292323826528" class="gsc_a_ac gs_ibl">24</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="zTBFoCoAAAAJ:WM2K3OHRCGMC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zdX0sdgBH_kC" class="gsc_a_at">Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma</a><div class="gs_gray">T Zhao, H Ren, X Wang, P Liu, F Yan, W Jiang, Y Li, J Li, JG Gribben, ...</div><div class="gs_gray">Oncotarget 6 (29), 27816<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1599884372815527796" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Chronic lymphocytic leukemia: an update on biology and treatment</a><div class="gs_gray">JC Riches, AG Ramsay, JG Gribben</div><div class="gs_gray">Current oncology reports 13 (5), 379-385<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2621544458806746133" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Self‐administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia</a><div class="gs_gray">WG Wierda, TJ Kipps, MJ Keating, JR Brown, JG Gribben, M Browning, ...</div><div class="gs_gray">Cancer 117 (1), 116-124<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17995118924077338083" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eH23hyXCXa4C" class="gsc_a_at">CD40 ligand therapy of lymphoma patients</a><div class="gs_gray">A Younes, RH Vonderheide, JP Dutcher, JE Anderson, SG Eckhardt, ...</div><div class="gs_gray">Journal of Clinical Oncology 19 (23), 4351-4353<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5826188016389912767" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HE397vMXCloC" class="gsc_a_at">Autologous versus allogeneic bone marrow transplantation for patients with poor prognosis CLL.</a><div class="gs_gray">JG Gribben, D Neuberg, RJ Soiffer, DC Fisher, R Schlossman, EP Alyea, ...</div><div class="gs_gray">Blood 92 (10), 322A-322A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13978699581293232377" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">Important advances in oncology, 117-129<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12531260262655675546" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cNe27ouKFcQC" class="gsc_a_at">5TH REPORT OF EBMTG EXPERIENCE OF ABMT IN MALIGNANT-LYMPHOMA</a><div class="gs_gray">AH Goldstone, CRJ Singer, JG Gribben, M Jarrett</div><div class="gs_gray">Bone Marrow Transplantation 3, 33-36<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2474817808683563201" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xa5BkEQK8BgC" class="gsc_a_at">Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients</a><div class="gs_gray">E Griessinger, F Anjos-Afonso, J Vargaftig, DC Taussig, F Lassailly, ...</div><div class="gs_gray">Cancer research 76 (8), 2082-2086<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4756479856384688246" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w7CBUyPWg-0C" class="gsc_a_at">CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia</a><div class="gs_gray">E Barragán, MC Chillón, R Castelló-Cros, N Marcotegui, MI Prieto, ...</div><div class="gs_gray">Haematologica 100 (5), e183<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=624870865796444693,2814024497174287887" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben, C Hosing, DG Maloney</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 17 (1), S63-S70<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2980352916632164100" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Emerging therapy for chronic lymphocytic leukaemia</a><div class="gs_gray">RL Auer, J Gribben, FE Cotter</div><div class="gs_gray">British journal of haematology 139 (5), 635-644<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7051990780857134131" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bnK-pcrLprsC" class="gsc_a_at">High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma</a><div class="gs_gray">AS Freedman, JG Gribben, LM Nadler</div><div class="gs_gray">Leukemia &amp; lymphoma 28 (3-4), 219-230<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7453600898115230958" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_B80troHkn4C" class="gsc_a_at">EXPERIENCE OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE 1ST 100 LYMPHOMAS</a><div class="gs_gray">AH Goldstone, DC Linch, JG Gribben, A McMillan</div><div class="gs_gray">Bone Marrow Transpl 3, 65-66<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8465090144894910224" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WgvcDLhf7hwC" class="gsc_a_at">Ibrutinib+ obinutuzumab versus chlorambucil+ obinutuzumab as first-line treatment in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL): results&nbsp;…</a><div class="gs_gray">C Moreno, R Greil, F Demirkan, A Tedeschi, B Anz, L Larratt, M Simkovic, ...</div><div class="gs_gray">Blood 132, 691<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5393770849192429540" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SWgZeABleR0C" class="gsc_a_at">Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter&nbsp;…</a><div class="gs_gray">CM Wendtner, M Hallek, GAM Fraser, AS Michallet, P Hillmen, J Dürig, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 57 (6), 1291-1299<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4107469615798746265" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hefNtdE4IMkC" class="gsc_a_at">The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective&nbsp;…</a><div class="gs_gray">I El-Najjar, A Boumendil, JJ Luan, R Bouabdallah, K Thomson, M Mohty, ...</div><div class="gs_gray">Annals of oncology 25 (11), 2224-2229<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7709734956196981787" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0N-VGjzr574C" class="gsc_a_at">Single-agent activity of GCS-100, a first-in-class galectin-3 antagonist, in elderly patients with relapsed chronic lymphocytic leukemia</a><div class="gs_gray">F Cotter, DA Smith, TE Boyd, DA Richards, C Alemany, D Loesch, ...</div><div class="gs_gray">Journal of Clinical Oncology 27 (15_suppl), 7006-7006<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14105104567037031196" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab&nbsp;…</a><div class="gs_gray">DA Tsitsikas, H Oakervee, JD Cavenagh, J Gribben, SG Agrawal, ...</div><div class="gs_gray">British journal of haematology 146 (5), 574-576<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9839448998009622297" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Bone marrow purging for autologous bone marrow transplantation</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">Leukemia &amp; lymphoma 11 (sup2), 141-148<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14293410174874583055" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Oj-SLI0tZTcC" class="gsc_a_at">Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL</a><div class="gs_gray">T Munir, DR Howard, L McParland, C Pocock, AC Rawstron, A Hockaday, ...</div><div class="gs_gray">Leukemia 31 (10), 2085-2093<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=235470148165229752" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uoRD4RTSUPoC" class="gsc_a_at"><i>TNFRSF14</i> aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses</a><div class="gs_gray">E Kotsiou, J Okosun, C Besley, S Iqbal, J Matthews, J Fitzgibbon, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (1), 72-81<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2717397724725003891" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kvJssbFybhEC" class="gsc_a_at">Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy</a><div class="gs_gray">J C Riches, A G Ramsay, J G Gribben</div><div class="gs_gray">Current pharmaceutical design 18 (23), 3389-3398<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13877416766271263746" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VLnqNzywnoUC" class="gsc_a_at">SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma</a><div class="gs_gray">D Wrench, P Leighton, CF Skibola, L Conde, JB Cazier, J Matthews, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 117 (11), 3147-3150<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3248403146643337696" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders</a><div class="gs_gray">R Letestu, V Ugo, F Valensi, I Radford-Weiss, J Nataf, V Levy, JG Gribben, ...</div><div class="gs_gray">Leukemia 18 (5), 953-961<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15355083540941049021" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma</a><div class="gs_gray">JR Brown, G Gaudet, JW Friedberg, D Neuberg, P Mauch, JL Kutok, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 45 (2), 315-320<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3009960928344371861" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:olpn-zPbct0C" class="gsc_a_at">The critical role of CD28 signalling in the prevention of human T-cell anergy</a><div class="gs_gray">VA Boussiotis, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">Research in immunology (Paris) 146 (3), 140-149<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4258614221486326129" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uGrg30pLAbkC" class="gsc_a_at">Umbralisib plus ublituximab (U2) is superior to obinutuzumab plus chlorambucil (O+ Chl) in patients with treatment naïve (TN) and relapsed/refractory (R/R) chronic lymphocytic&nbsp;…</a><div class="gs_gray">JG Gribben, W Jurczak, RW Jacobs, S Grosicki, K Giannopoulos, ...</div><div class="gs_gray">Blood 136, 37-39<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=508938482597229179" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CC3C2HR4nz8C" class="gsc_a_at">Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies</a><div class="gs_gray">T Robak, JA Burger, A Tedeschi, PM Barr, C Owen, O Bairey, P Hillmen, ...</div><div class="gs_gray">American journal of hematology 93 (11), 1402-1410<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9160362928407584736" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oXKBmVzQOggC" class="gsc_a_at">Managing Patients With <i>TP53</i>-Deficient Chronic Lymphocytic Leukemia</a><div class="gs_gray">J Edelmann, JG Gribben</div><div class="gs_gray">Journal of oncology practice 13 (6), 371-377<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3209379971283159692" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ufKn5pxu7C0C" class="gsc_a_at">Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer</a><div class="gs_gray">C Walsh, JJ Bonner, TN Johnson, S Neuhoff, EA Ghazaly, JG Gribben, ...</div><div class="gs_gray">British journal of clinical pharmacology 81 (5), 989-998<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12647267319080500988" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8uzoZH4hB9AC" class="gsc_a_at">Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2</a><div class="gs_gray">A McCarthy, J Marzec, A Clear, RD Petty, R Coutinho, J Matthews, ...</div><div class="gs_gray">Oncotarget 5 (22), 11653<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6476094723006377502" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma</a><div class="gs_gray">D Wrench, R Waters, E Carlotti, S Iqbal, J Matthews, M Calaminici, ...</div><div class="gs_gray">Haematologica 94 (1), 148<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9788109738834303853" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cdwqcPQS8ssC" class="gsc_a_at">Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial</a><div class="gs_gray">A Buehler, CM Wendtner, TJ Kipps, L Rassenti, GAM Fraser, AS Michallet, ...</div><div class="gs_gray">Blood cancer journal 6 (3), e404-e404<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12590609193906669800" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Autografting CLL: the game is over!</a><div class="gs_gray">E Montserrat, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 117 (23), 6057-6058<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9024938252773225415" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q0uBw5dMOAkC" class="gsc_a_at">Analysis of rejection in HLA matched T-depleted bone marrow transplants</a><div class="gs_gray">J Patterson, HG Prentice, M Gilmore, H Blacklock, MK Brenner, G Janossy, ...</div><div class="gs_gray">11th Annual meeting of the EBMT, 117-117<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5553372000630882319" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QI7uKX5mnFEC" class="gsc_a_at">Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study</a><div class="gs_gray">EW Petersdorf, M Carrington, C O'hUigin, M Bengtsson, D De Santis, ...</div><div class="gs_gray">The Lancet Haematology 7 (1), e50-e60<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3338126601800783408" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CMPXdcK5v8EC" class="gsc_a_at">Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells</a><div class="gs_gray">P Casado, EH Wilkes, F Miraki-Moud, MM Hadi, A Rio-Machin, V Rajeeve, ...</div><div class="gs_gray">Leukemia 32 (8), 1818-1822<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4745232854363430878" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bkKuixW_xMkC" class="gsc_a_at">Immune reconstitution after autologous hematopoietic stem cell transplantation in crohn’s disease: current status and future directions. a review on behalf of the ebmt&nbsp;…</a><div class="gs_gray">AG Pockley, JO Lindsay, GA Foulds, S Rutella, JG Gribben, T Alexander, ...</div><div class="gs_gray">Frontiers in immunology 9, 646<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15511589423432161577" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5rMqqAh47xYC" class="gsc_a_at">Mechanistic and clinical aspects of lenalidomide treatment for chronic lymphocytic leukemia</a><div class="gs_gray">J C Riches, J G Gribben</div><div class="gs_gray">Current cancer drug targets 16 (8), 689-700<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12039439545518310372" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BPS1z4jHU5cC" class="gsc_a_at">Microenvironment abnormalities and lymphomagenesis: Immunological aspects</a><div class="gs_gray">JG Taylor, JG Gribben</div><div class="gs_gray">Seminars in cancer biology 34, 36-45<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1362791397526859297" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy</a><div class="gs_gray">AC Zubair, D Zahrieh, H Daley, D Schott, JG Gribben, EP Alyea, ...</div><div class="gs_gray">Transfusion 44 (2), 253-261<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1084552079103010442" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Cytotoxic T cell reponses against immunoglobulin in malignant and normal B cells: Implications for tumor immunity and autoimmunity</a><div class="gs_gray">CS Gricks, JG Gribben</div><div class="gs_gray">Current pharmaceutical design 9 (23), 1889-1903<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7771519902886235803" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rUnQDpM0TEQC" class="gsc_a_at">Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia</a><div class="gs_gray">A Waclawiczek, A Hamilton, K Rouault-Pierre, A Abarrategi, MG Albornoz, ...</div><div class="gs_gray">The Journal of clinical investigation 130 (6), 3038-3050<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10860841985894459536" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:s2G-WRnXBicC" class="gsc_a_at">Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus&nbsp;…</a><div class="gs_gray">BD Cheson, PC Trask, JG Gribben, N Dimier, E Kimby, PJ Lugtenburg, ...</div><div class="gs_gray">Annals of hematology 96 (2), 253-259<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13905333770543645469" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JH5k92_tO-AC" class="gsc_a_at">Immunotherapeutic strategies including transplantation: eradication of disease</a><div class="gs_gray">JG Gribben, JC Riches</div><div class="gs_gray">Hematology 2013, the American Society of Hematology Education Program Book&nbsp;…<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13325041031752857319" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract</a><div class="gs_gray">NM Joshi, S Hassan, P Jasani, S Dixon, JD Cavenagh, HE Oakervee, ...</div><div class="gs_gray">British journal of haematology 157 (3), 403-407<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=372197116727459862" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IRz6iEL74y4C" class="gsc_a_at">One step back but 2 steps forward</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (16), 3359-3360<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4287924420407337093" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Alemtuzumab for minimal residual disease in CLL.</a><div class="gs_gray">SM O'Brien, JG Gribben, DA Thomas, M Albitar, W Wierda, A Ferrajoli, ...</div><div class="gs_gray">Blood 102 (11), 109A-109A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15060529260787347277" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">High-dose therapy for follicular lymphoma.</a><div class="gs_gray">A Freedman, JW Friedberg, J Gribben</div><div class="gs_gray">Oncology (Williston Park, NY) 14 (3), 321-6, 329; discussion 330<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14837797539179121426" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZJ-noXUx9mkC" class="gsc_a_at">Cancer burden is controlled by mural cell-β3-integrin regulated crosstalk with tumor cells</a><div class="gs_gray">PP Wong, JM Muñoz-Félix, M Hijazi, H Kim, SD Robinson, ...</div><div class="gs_gray">Cell 181 (6), 1346-1363. e21<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9143388214353161065" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jRIwE-1ttnoC" class="gsc_a_at">Frequent evolution of copy number alterations in CLL following first-line treatment with FC (R) is enriched with TP53 alterations: results from the CLL8 trial</a><div class="gs_gray">J Edelmann, E Tausch, DA Landau, S Robrecht, J Bahlo, K Fischer, ...</div><div class="gs_gray">Leukemia 31 (3), 734-738<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1593053210944858741" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oldoQiaHq2UC" class="gsc_a_at">The role of the tumor microenvironment in HIV-associated lymphomas</a><div class="gs_gray">JG Taylor, K Liapis, JG Gribben</div><div class="gs_gray">Biomarkers in medicine 9 (5), 473-482<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12417422135319837795" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ej9njvOgR2oC" class="gsc_a_at">The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma</a><div class="gs_gray">I El-Najjar, S Montoto, A McDowell, J Matthews, J Gribben, TA Szyszko</div><div class="gs_gray">Nuclear medicine communications 35 (3), 311-315<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14542420757467111804" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Y9VhQm-5nPIC" class="gsc_a_at">Long‐term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non‐myeloablative conditioning without T cell depletion</a><div class="gs_gray">JK Davies, D Taussig, H Oakervee, M Smith, S Agrawal, JD Cavenagh, ...</div><div class="gs_gray">British journal of haematology 162 (4), 525-529<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17877879963821477691" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Treatment with Fludarabine and Rituximab Produces Extended Overall Survival (OS) and Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) without Increased&nbsp;…</a><div class="gs_gray">JA Woyach, AS Ruppert, NA Heerema, B Peterson, JG Gribben, ...</div><div class="gs_gray">Blood 114 (22), 539<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17508583269143166774" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:W5xh706n7nkC" class="gsc_a_at">Monitoring disease in lymphoma and CLL patients using molecular techniques</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 15 (1), 179-195<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5920482148893659645" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity</a><div class="gs_gray">RH Vonderheide, MO Butler, JF Liu, TE Battle, N Hirano, JG Gribben, ...</div><div class="gs_gray">International journal of oncology 19 (4), 791-798<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4945386960632047777" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nOiSByfp82kC" class="gsc_a_at">Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab</a><div class="gs_gray">CL Freeman, M Dixon, R Houghton, KA Kreuzer, G Fingerle-Rowson, ...</div><div class="gs_gray">Leukemia 30 (8), 1763-1766<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10602617024643288573" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a&nbsp;…</a><div class="gs_gray">P Greaves, A Wilson, J Matthews, DLP Brown, R Auer, S Montoto, ...</div><div class="gs_gray">British journal of haematology 157 (2), 201-204<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6876310053423844900" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Targeting the microenvironment</a><div class="gs_gray">J Gribben, A Rosenwald, R Gascoyne, G Lenz</div><div class="gs_gray">Leukemia &amp; lymphoma 51 (sup1), 34-40<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8544872321869017166" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Methods of inducing a T cell mediated immune response by administering antigen presenting B cells</a><div class="gs_gray">JL Schultze, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">US Patent 7,195,758<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12864183563636039327,17494088880827402675" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function</a><div class="gs_gray">A Craiu, Y Saito, A Limon, HM Eppich, DP Olson, N Rodrigues, GB Adams, ...</div><div class="gs_gray">Blood 105 (5), 2235-2238<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5250118404738268751" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with&nbsp;…</a><div class="gs_gray">IJ Webb, JW Friedberg, JG Gribben, DC Fisher, T Spitzer, D Neuberg, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 8 (8), 429-434<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5172182188661687560" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Tumor-specific adoptive T-cell therapy for CD40+ B-cell malignancies.</a><div class="gs_gray">JL Schultze, JG Gribben, LM Nadler</div><div class="gs_gray">Current opinion in oncology 10 (6), 542-547<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4306845835927194701" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Monitoring minimal residual disease</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">Seminars in oncology 20 (5), 143-155<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9195935797901707451" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-LHtoeeytlUC" class="gsc_a_at">Obinutuzumab-based immunochemotherapy prolongs progression-free survival and time to next anti-lymphoma treatment in patients with previously untreated follicular lymphoma&nbsp;…</a><div class="gs_gray">W Townsend, C Buske, G Cartron, D Cunningham, MJS Dyer, JG Gribben, ...</div><div class="gs_gray">Blood 132, 1597<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11977306803055349777" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ynsZFq2pu0MC" class="gsc_a_at">Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition</a><div class="gs_gray">M Dermit, P Casado, V Rajeeve, EH Wilkes, DE Foxler, H Campbell, ...</div><div class="gs_gray">Oncogene 36 (19), 2762-2774<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10919252869172235199" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J3LtWjKFLicC" class="gsc_a_at">Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse</a><div class="gs_gray">S Montoto, J Matthews, P Greaves, D Lillington, D Anderson, JG Gribben, ...</div><div class="gs_gray">haematologica 98 (4), 620<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18425384468705492098" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RmcNAhKkducC" class="gsc_a_at">Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma</a><div class="gs_gray">T Zhang, XW Guan, JG Gribben, FT Liu, L Jia</div><div class="gs_gray">Cell death &amp; disease 10 (5), 1-15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13087990643315358011" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q09DtPQ_434C" class="gsc_a_at">Interim results from an ongoing phase 2 multicenter study of tazemetostat, an EZH2 inhibitor, in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL)</a><div class="gs_gray">V Ribrag, F Morschhauser, P McKay, GA Salles, CL Batlevi, A Schmitt, ...</div><div class="gs_gray">Blood 132, 4196<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12374912454490331500" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sfsSB7lKuh0C" class="gsc_a_at">Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin</a><div class="gs_gray">C Dürr, BS Hanna, A Schulz, F Lucas, M Zucknick, A Benner, A Clear, ...</div><div class="gs_gray">haematologica 103 (4), 688<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13290999801130477216" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0izLItjtcgwC" class="gsc_a_at">Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a&nbsp;…</a><div class="gs_gray">G Lozanski, AS Ruppert, NA Heerema, A Lozanski, DM Lucas, A Gordon, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 53 (9), 1743-1748<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11290935880591432038" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:z_wVstp3MssC" class="gsc_a_at">Vaccine therapy and chronic lymphocytic leukaemia</a><div class="gs_gray">AG Ramsay, JG Gribben</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 21 (3), 421-436<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11774390721097012380" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ipzZ9siozwsC" class="gsc_a_at">The role of stem cell transplantation in chronic lymphocytic leukemia</a><div class="gs_gray">V Rizouli, JG Gribben</div><div class="gs_gray">Seminars in hematology 41 (3), 246-253<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13830696867038617242" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin</a><div class="gs_gray">JL Schultze, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">US Patent 6,465,251<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6636370287708908109" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Double autologous bone marrow transplantation in acute myeloid leukaemia</a><div class="gs_gray">JG Gribben, AH Goldstone, DC Linch, AK MacMillan, JD Richards</div><div class="gs_gray">Bone marrow transplantation 4, 209-211<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8462452486246860520" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eJD0kABLposC" class="gsc_a_at">Autologous stem cell transplantation in refractory Crohn’s disease–low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial&nbsp;…</a><div class="gs_gray">JA Snowden, C Hawkey, D Hind, L Swaby, K Mellor, R Emsley, ...</div><div class="gs_gray">BMC gastroenterology 19 (1), 1-14<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1222831886847773329" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:71d7Y1FijdoC" class="gsc_a_at">AUGMENT: A phase III randomized study of lenalidomide plus rituximab (R2) vs rituximab/placebo in patients with relapsed/refractory indolent non-Hodgkin lymphoma</a><div class="gs_gray">JP Leonard, M Trněný, K Izutsu, NH Fowler, X Hong, J Zhu, H Zhang, ...</div><div class="gs_gray">Blood 132, 445<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=498448553099628015" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4tNoA7Af41QC" class="gsc_a_at">Lamin B1 regulates somatic mutations and progression of B-cell malignancies</a><div class="gs_gray">T Klymenko, J Bloehdorn, J Bahlo, S Robrecht, G Akylzhanova, K Cox, ...</div><div class="gs_gray">Leukemia 32 (2), 364-375<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12311624268709402700" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_n8fIOMweQoC" class="gsc_a_at">An integrated safety analysis of the next generation PI3Kδ inhibitor umbralisib (TGR-1202) in patients with relapsed/refractory lymphoid malignancies</a><div class="gs_gray">MS Davids, IW Flinn, AR Mato, OA O'Connor, DM Brander, MA Lunning, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 4037-4037<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8068981452557028650" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:onKP9CxGSkIC" class="gsc_a_at">Follicular lymphoma: State‐of‐the‐art ICML workshop in Lugano 2015</a><div class="gs_gray">RD Gascoyne, B Nadel, L Pasqualucci, J Fitzgibbon, JE Payton, ...</div><div class="gs_gray">Hematological oncology 35 (4), 397-407<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12850847548298853500" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tBlTYpvFGQIC" class="gsc_a_at">The genetics of acute myeloid leukemias</a><div class="gs_gray">CJ Owen, J Fitzgibbon</div><div class="gs_gray">Molecular Hematology. 3rd edition. London: Wiley-Blackwell, 42-50<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14146873242003019421" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M7yex6snE4oC" class="gsc_a_at">Distinctive <i>IGH</i> gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemias</a><div class="gs_gray">A Li, MA Goldwasser, J Zhou, SA Armstrong, H Wang, V Dalton, ...</div><div class="gs_gray">British journal of haematology 131 (2), 185-192<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17575648804977527511" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wuD5JclIwkYC" class="gsc_a_at">Beginnings: the molecular pathology of hemoglobin</a><div class="gs_gray">D Weatherall</div><div class="gs_gray">Molecular Hematology, 1-20<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=590865939311501303" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:C5mqfHIFIucC" class="gsc_a_at">Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells</a><div class="gs_gray">MR Goulart, SI Hlavaty, YM Chang, G Polton, A Stell, J Perry, Y Wu, ...</div><div class="gs_gray">Scientific reports 9 (1), 1-14<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5056525133957203637" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Refining the treatment of follicular lymphoma</a><div class="gs_gray">C Buske, C Gisselbrecht, J Gribben, T Letai, P McLaughlin, W Wilson</div><div class="gs_gray">Leukemia &amp; lymphoma 49 (sup1), 18-26<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2378477568573249676" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Antibody mediated purging</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Thomas' Hematopoietic Cell Transplantation, 244-253<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10230854957243421983" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Stem-cell transplantation for indolent lymphoma.</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Seminars in hematology 36 (4 Suppl 5), 18-25<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16087654648506039321" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Bone marrow transplantation for low-grade B-cell malignancies.</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Current opinion in oncology 9 (2), 117-121<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18154971618752435599" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:35r97b3x0nAC" class="gsc_a_at">The role of autologous bone marrow transplantation in the treatment of malignant disease</a><div class="gs_gray">AH Goldstone, JG Gribben</div><div class="gs_gray">Blood reviews 1 (3), 193-200<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6650201466528332843" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BKYZGPsuSFYC" class="gsc_a_at">Continued long term responses to ibrutinib+ venetoclax treatment for relapsed/refractory CLL in the blood cancer UK TAP clarity trial</a><div class="gs_gray">P Hillmen, RH Boucher, N Webster, S Dalal, K Brock, F Yates, ...</div><div class="gs_gray">Blood 136, 17-18<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17389935875549238963" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yL7DKRohVA8C" class="gsc_a_at">IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution</a><div class="gs_gray">M Odabashian, E Carlotti, S Araf, J Okosun, F Spada, JG Gribben, ...</div><div class="gs_gray">blood 135 (11), 834-844<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1896088411061539589" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:r56sNq9gaawC" class="gsc_a_at">Acute myeloid leukemia xenograft success prediction: Saving time</a><div class="gs_gray">E Griessinger, J Vargaftig, S Horswell, DC Taussig, J Gribben, D Bonnet</div><div class="gs_gray">Experimental hematology 59, 66-71. e4<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17468205000617330791" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mgoTDWlsYNUC" class="gsc_a_at">The initial report of the bloodwise tap clarity study combining ibrutinib and venetoclax in relapsed, refractory Cll shows acceptable safety and promising early indications of&nbsp;…</a><div class="gs_gray">P Hillmen, A Rawstron, T Munir, K Brock, S Vincente, Y Jefferson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10204737339491701050" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Nnq8S6OXqDYC" class="gsc_a_at">Randomized, multicenter, open-label, phase 3 study of the BTK inhibitor ibrutinib in combination with obinutuzumab vs. chlorambucil in combination with obinutuzumab in patients&nbsp;…</a><div class="gs_gray">I Flinn, C Moreno, DS Gill, TJ Kipps, Y Shaw, Y Li, LA Styles, DF James, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), TPS7095-TPS7095<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5969139538345612555" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Outcome of Treatment with Fludarabine Versus Fludarabine and Cyclophosphamide in Chronic Lymphocytic Leukemia (CLL) Is Adversely Impacted by High Risk Genetic Features: Results&nbsp;…</a><div class="gs_gray">MR Grever, DM Lucas, GW Dewald, DS Neuberg, IW Flinn, MS Tallman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 3487-3487<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18271740495725355727" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EkHepimYqZsC" class="gsc_a_at">Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma</a><div class="gs_gray">JW Friedberg, H Kim, S Li, D Neuberg, K Boyd, H Daley, DC Fisher, ...</div><div class="gs_gray">Bone marrow transplantation 32 (7), 681-686<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13898614067531489959" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis</a><div class="gs_gray">TE Battle, H Castro-Malaspina, JG Gribben, DA Frank</div><div class="gs_gray">Leukemia research 27 (9), 859-863<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2046462344139836858" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Similar disease-free survival (DFS) after allografting and autografting for multiple myeloma (MM).</a><div class="gs_gray">RL Schlossman, I Webb, EP Alyea, RJ Soiffer, D Fisher, E Vance, ...</div><div class="gs_gray">Blood 90 (10), 994-994<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14061114181662322126" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Disease free status and absence of PCR detectable minimal residual disease suggests eradication of B-CLL following autologous and allogeneic BMT.</a><div class="gs_gray">JG Gribben, L BarlettPandite, A Provan, C Zwicky, D Neuberg, ...</div><div class="gs_gray">Blood 86 (10), 1815-1815<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10212021108211244465" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Weau3kkTRIMC" class="gsc_a_at">Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription</a><div class="gs_gray">J Edelmann, K Holzmann, E Tausch, EA Saunderson, BMC Jebaraj, ...</div><div class="gs_gray">haematologica 105 (5), 1379<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5729850515545937880" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tSVUDDkujAIC" class="gsc_a_at">Single-agent ibrutinib vs chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia (CLL): a cross-trial comparison</a><div class="gs_gray">T Robak, JA Burger, A Tedeschi, PM Barr, CJ Owen, O Bairey, P Hillmen, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 1750-1750<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17610223411629203152" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ojlX30-wUrgC" class="gsc_a_at">Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or&nbsp;…</a><div class="gs_gray">DM Lucas, AS Ruppert, G Lozanski, GW Dewald, A Lozanski, R Claus, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 56 (11), 3031-3037<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6639550081691880717" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rFyVMFCKTwsC" class="gsc_a_at">Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes</a><div class="gs_gray">R Nakagawa, M Vukovic, A Tarafdar, E Cosimo, K Dunn, AM McCaig, ...</div><div class="gs_gray">haematologica 100 (4), 499<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1298312108802118526" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8VtEwCQfWZkC" class="gsc_a_at">Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Discovery medicine 16 (90), 295-302<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10983657653407695569" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials</a><div class="gs_gray">CLLTC Group</div><div class="gs_gray">haematologica 97 (3), 428<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8714537029139049850" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Vaccine-and immune-based therapy in chronic lymphocytic leukemia</a><div class="gs_gray">R Le Dieu, J Gribben</div><div class="gs_gray">Seminars in oncology 33 (2), 220-229<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3284155475856411602" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Prospective analysis of minimal residual disease detection in patients with CLL undergoing autologous and allogeneic BMT.</a><div class="gs_gray">JW Donovan, NS Andersen, C Poor, D Bowers, JG Gribben</div><div class="gs_gray">Blood 92 (10), 652A-652A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18025290597337818576" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Detection of minimal residual disease</a><div class="gs_gray">J Gribben, L Nadler</div><div class="gs_gray">Technical and Biological Components of Marrow Transplantation, 249-270<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4063041194349138669" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">ALLOANTIGEN AND CONCOMITANT CTLA4 SIGNALING INDUCES CLONAL DELETION OF ALLOREACTIVE T-CELLS-A NOVEL METHOD TO PREVENT GVHD</a><div class="gs_gray">JG GRIBBEN, VA BOUSSIOTIS, GJ FREEMAN, P RENNERT, CL JELLIS, ...</div><div class="gs_gray">Blood 84 (10), A397-A397<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4261442064692793350" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Autologous bone marrow transplantation in advanced low grade B-cell non-Hodgkin's lymphoma in first remission</a><div class="gs_gray">A Freedman</div><div class="gs_gray">Blood 82 (1), 332a (abstr)<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16500872874494979022" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bVQMTfhMCi4C" class="gsc_a_at">Percutaneous muscle biopsy with conchotome</a><div class="gs_gray">J Coakley, PEM Smith, P Dietrichson, T Helliwell, RHT Edwards</div><div class="gs_gray">Clinical Science 71 (s15), 23P-23P<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12238345339151137103,8562544261722472427" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pwA0zy_liR0C" class="gsc_a_at">Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma</a><div class="gs_gray">G Lazarian, C Friedrich, A Quinquenel, J Tran, S Ouriemmi, E Dondi, ...</div><div class="gs_gray">Oncogene 39 (14), 2934-2947<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11958048983342904544" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jPVjDSAV6m0C" class="gsc_a_at">MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial</a><div class="gs_gray">C Pott, LH Sehn, D Belada, J Gribben, E Hoster, B Kahl, B Kehden, ...</div><div class="gs_gray">Leukemia 34 (2), 522-532<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4996780192383645718" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZpgFv6i7Z4gC" class="gsc_a_at">A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgery</a><div class="gs_gray">T Wodehouse, M Demopoulos, R Petty, F Miraki-Moud, A Belhaj, ...</div><div class="gs_gray">Pain 160 (12), 2691-2698<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16802246675133851408" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eAUscmXIlQ8C" class="gsc_a_at">History and development of molecular biology</a><div class="gs_gray">P Moss</div><div class="gs_gray">Molecular hematology, 353-362<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15375960418662657594" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tfDI-GPdlUQC" class="gsc_a_at">Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice</a><div class="gs_gray">Y Wu, YM Chang, AJ Stell, SL Priestnall, E Sharma, MR Goulart, ...</div><div class="gs_gray">Scientific reports 9 (1), 1-12<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13291132849379047293" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RJNGbXJAtMsC" class="gsc_a_at">Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?</a><div class="gs_gray">F McClanahan, TG Sharp, JG Gribben</div><div class="gs_gray">haematologica 101 (10), 1144<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13652871301076746733" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1paMEeroeoQC" class="gsc_a_at">Allogeneic transplantation for chronic lymphocytic leukemia in the age of novel treatment strategies</a><div class="gs_gray">MA Schwarzbich, F McClanahan, J Gribben</div><div class="gs_gray">Oncology 30 (6), 526-526<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12751978296982408505" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bCjgOgSFrM0C" class="gsc_a_at">Obinutuzumab plus bendamustine versus bendamustine alone in patients with rituximab-refractory follicular lymphoma: results from the GADOLIN study</a><div class="gs_gray">M Trneny, K Bouabdallah, G Dueck, J Gribben, P Lugtenburg, O Press, ...</div><div class="gs_gray">Haematologica 101, 155-156<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6841343295428999573" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KIRwYnRZzWQC" class="gsc_a_at">Integrative genetic and clinical analysis through whole exome sequencing in 1001 diffuse large B cell lymphoma (DLBCL) patients reveals novel disease drivers and risk groups</a><div class="gs_gray">J Zhang, A Reddy, C Love, AB Moffitt, D Rajagopalan, S Leppä, ...</div><div class="gs_gray">Blood 128 (22), 1087<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11155863010786980908" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xyvS_IvSCKsC" class="gsc_a_at">Cutaneous cryptococcosis in Hodgkin lymphoma</a><div class="gs_gray">K Liapis, D Taussig, FE Cotter, JG Gribben</div><div class="gs_gray">British journal of haematology 164 (4), 467-467<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=257713654221928126" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w2UhwfzvF0QC" class="gsc_a_at">ProGem1: Phase 1 first-in-human study of the novel nucleotide analogue NUC-1031 in adult patients with advanced solid tumors</a><div class="gs_gray">EA Ghazaly, J Simon, JG Gribben, T Mohammad, E Oluwadunni, ...</div><div class="gs_gray">2013 ASCO Annual Meeting J. Clin. Oncol 31<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12730403187420220508" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">T‐cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies</a><div class="gs_gray">RL Auer, F MacDougall, HE Oakervee, D Taussig, JK Davies, ...</div><div class="gs_gray">British journal of haematology 157 (5), 580-585<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5009161758568918415" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma</a><div class="gs_gray">PJ Greaves, JG Gribben</div><div class="gs_gray">J Clin Oncol 29 (8), 952-3<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16235656562023202021" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas</a><div class="gs_gray">M Czuczman, D Straus, J Gribben, H Bredenfeld, J Friedberg, C Bollard</div><div class="gs_gray">Leukemia &amp; lymphoma 51 (sup1), 41-49<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11455383858428679398" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimens</a><div class="gs_gray">R Le Dieu, D Taussig, TA Lister, JG Gribben</div><div class="gs_gray">Journal of immunological methods 348 (1-2), 95-100<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15319331297724493132" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Preliminary results of a phase 1/2, multi-center, open-label study (CLL-001) investigating a stepwise dose-escalation schedule of lenalidomide in relapsed or refractory chronic&nbsp;…</a><div class="gs_gray">CM Wendtner, D Mahadevan, S Stilgenbauer, O Frankfurt, A Bloor, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2104-2104<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7961191046013498496" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus&nbsp;…</a><div class="gs_gray">JK Davies, DC Taussig, H Oakervee, AJ Davies, SG Agrawal, JG Gribben, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (14), e23-e25<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4743071733630997868" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Innovative strategies for the treatment of CLL</a><div class="gs_gray">M Keating, B Cheson, JG Gribben, B Robertson, L Nadler</div><div class="gs_gray">Leukemia &amp; lymphoma 22 (sup2), 53-64<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5208633287110546814" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Minimal residual disease in non-Hodgkin's lymphoma</a><div class="gs_gray">JL Schultze, JG Gribben</div><div class="gs_gray">Biomedicine &amp; pharmacotherapy 50 (9), 451-458<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5376248799773283660" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vDijr-p_gm4C" class="gsc_a_at">AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA</a><div class="gs_gray">A Freedman, D Neuberg, J Gribben, P Mauch, K Anderson, R Soiffer, ...</div><div class="gs_gray">Blood 84 (10), A203-A203<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4963579431128629116" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR B-CELL CLL-BALANCE BETWEEN TOXICITY AND EFFICACY</a><div class="gs_gray">L BARTLETTPANDITE, R Soiffer, JG Gribben, K Anderson, M Robertson, ...</div><div class="gs_gray">Blood 84 (10), A536-A536<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12999890990076367583" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KqW5X_olkfQC" class="gsc_a_at">The role of stem cell transplant for lymphoma in 2017</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Hematological oncology 35, 25-29<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6468960221862146984" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rzmi0EmCOGEC" class="gsc_a_at">Stem cell transplantation for refractory Crohn disease—reply</a><div class="gs_gray">CJ Hawkey, J Lindsay, J Gribben</div><div class="gs_gray">Jama 315 (23), 2620-2621<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4060854744696621087" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8p8iYwVyaVcC" class="gsc_a_at">Primary results of the health-related quality of life assessment from the phase III GADOLIN study of obinutuzumab plus bendamustine compared with bendamustine alone in patients&nbsp;…</a><div class="gs_gray">BD Cheson, PC Trask, J Gribben, N Dimier, E Kimby, PJ Lugtenburg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 1532-1532<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4193758335253940758" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uAPFzskPt0AC" class="gsc_a_at">Dangerous power: mitochondria in CLL cells</a><div class="gs_gray">L Jia, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (17), 2596-2597<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14721051364012336230" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Development of original donor cell leukemia after successful engraftment from a second donor</a><div class="gs_gray">JM Stevens, D Syndercombe-Court, HE Oakervee, D McCloskey, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (13), 4621-4622<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1110490539158163392" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Detection of minimal residual disease in hematological malignancies</a><div class="gs_gray">D Provan, JG Gribben</div><div class="gs_gray">Molecular Hematology, 53-71<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8832868717978499502" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TNEldfgDb5MC" class="gsc_a_at">Aryl hydrocarbon receptor interacting protein maintains germinal center B cells through suppression of BCL6 degradation</a><div class="gs_gray">D Sun, U Stopka-Farooqui, S Barry, E Aksoy, G Parsonage, ...</div><div class="gs_gray">Cell reports 27 (5), 1461-1471. e4<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18320191353084671007" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yKzB5RS27GgC" class="gsc_a_at">Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a&nbsp;…</a><div class="gs_gray">L Bento, A Boumendil, H Finel, S Le Gouill, S Amorim, H Monjanel, ...</div><div class="gs_gray">Bone marrow transplantation 52 (8), 1120-1125<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18154824063885150221" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Q3-QASNKTMEC" class="gsc_a_at">Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors</a><div class="gs_gray">SJ Sarker, SK Smith, K Chowdhury, PA Ganz, S Zimmerman, J Gribben, ...</div><div class="gs_gray">Supportive Care in Cancer 25 (3), 739-748<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14405679125195822364" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hEXC_dOfxuUC" class="gsc_a_at">Obinutuzumab for the treatment of indolent lymphoma</a><div class="gs_gray">J Edelmann, JG Gribben</div><div class="gs_gray">Future oncology 12 (15), 1769-1781<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11048689254533893345" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GYcXSSpN504C" class="gsc_a_at">Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants</a><div class="gs_gray">CC Laurie, CA Laurie, SA Smoley, EE Carlson, I Flinn, BL Fridley, ...</div><div class="gs_gray">Cancer genetics 207 (1-2), 19-30<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3753192694551306808" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wyM6WWKXmoIC" class="gsc_a_at">Effect of inactivation of argininosuccinate synthetase on sensitivity of lymphomas to caspase-dependent apoptosis following treatment with arginine deiminase.</a><div class="gs_gray">PW Szlosarek, B Delage, C O'Riain, E Hatzimichael, T Crook, ...</div><div class="gs_gray">Journal of Clinical Oncology 28 (15_suppl), 8093-8093<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17136594705877666268" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:T_0gP6tLVL0C" class="gsc_a_at">Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies</a><div class="gs_gray">JG Gribben, GJ Freeman, LM Nadler, P Rennert, CL Jellis, E Greenfield, ...</div><div class="gs_gray">US Patent 7,592,007<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8249348186724853977" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Chronic lymphocytic leukemia</a><div class="gs_gray">S O'Brien, JG Gribben</div><div class="gs_gray">CRC Press<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17868526116705734559" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Clinical caspase activation in CLL by GCS-100, a novel carbohydrate, in a phase 2 study</a><div class="gs_gray">FE Cotter, J Gribben, M Streetly, R Auer, D Smith, C Alemany, D Loesch, ...</div><div class="gs_gray">Annals of Oncology 19, 90-90<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14930510148307411481" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Phase 2 study of three doses of single agent bortezomib in patients with fludarabine-refractory B-cell CLL.</a><div class="gs_gray">S Faderl, KR Rai, J Gribben, I Flinn, JC Byrd, D McConkey, D Schenkein, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 4841-4841<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=534265364254130105" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gsN89kCJA0AC" class="gsc_a_at">High similarity between familial and sporadic cases of chroni lymphocytic leukemia.</a><div class="gs_gray">LZ Rassenti, TL Toy, L Huynh, A Greaves, JG Gribben, MJ Keating, ...</div><div class="gs_gray">Blood 102 (11), 670A-670A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1285449916070403909" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Lack of correlation between immunoglobulin somatic mutation and expression of CD38 in chronic lymphocytic leukemia.</a><div class="gs_gray">GF Widhopf, CM Marathe, LZ Rassenti, JC Byrd, IW Flinn, JG Gribben, ...</div><div class="gs_gray">Blood 96 (11), 367A-367A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7763813407787726085" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Autologous bone marrow transplantation following histologic transformation of indolent B cell non-Hodgkin's lymphoma.</a><div class="gs_gray">J Friedberg, D Neuberg, J Gribben, P Mauch, K Anderson, R Soiffer, ...</div><div class="gs_gray">Blood 92 (10), 727A-727A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16196089321204109406" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:URolC5Kub84C" class="gsc_a_at">Biologic response modifiers in acute lymphoblastic leukemia.</a><div class="gs_gray">JG Gribben, AA Cardoso, JL Schultze, LM Nadler</div><div class="gs_gray">Leukemia (08876924) 11<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12324277255396825181" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">Important advances in oncology, 139-156<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15770821396499810103" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JoHZYnTS1h4C" class="gsc_a_at">KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas</a><div class="gs_gray">JA Heward, L Konali, A D’Avola, K Close, A Yeomans, M Philpott, ...</div><div class="gs_gray">Blood<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16665345116904721231" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZZwcLRaXOV4C" class="gsc_a_at">Reducing bureaucracy in clinical research: A call for action</a><div class="gs_gray">J Gribben, E Macintyre, P Sonneveld, J Doorduijn, C Gisselbrecht, ...</div><div class="gs_gray">HemaSphere 4 (2)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16655240157569636196" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bxPAEoiBajcC" class="gsc_a_at">A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma</a><div class="gs_gray">A Tedeschi, R Greil, F Demirkan, T Robak, C Moreno, PM Barr, B Anz, ...</div><div class="gs_gray">haematologica 105 (4), e164<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17558023989336216836" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vkz5F8TaVKkC" class="gsc_a_at">AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R<sup>2</sup>) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY&nbsp;…</a><div class="gs_gray">J Leonard, M Trneny, K Izutsu, N Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">Hematological Oncology 37, 114-115<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17840320504929328247" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yaBp1wUtcLsC" class="gsc_a_at">Ibrutinib decreases obinutuzumab‐induced secretion of cytokines associated with infusion‐related reactions in patients with CLL: analysis from the ILLUMINATE study</a><div class="gs_gray">R Greil, A Tedeschi, C Moreno, B Anz, L Larratt, M Simkovic, D Gill, ...</div><div class="gs_gray">Hematological Oncology 37, 210-212<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13080352085350332190" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:d6JCS5z0ckYC" class="gsc_a_at">Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study</a><div class="gs_gray">A McDonald, E Thomas, S Daigle, F Morschhauser, G Salles, V Ribrag, ...</div><div class="gs_gray">Blood 132, 4097<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11880854531705821603" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tFzHCjejgA0C" class="gsc_a_at">Durable graft‐versus‐leukaemia effects without donor lymphocyte infusions–results of a phase II study of sequential T‐replete allogeneic transplantation for high‐risk acute&nbsp;…</a><div class="gs_gray">JK Davies, S Hassan, SJ Sarker, C Besley, H Oakervee, M Smith, ...</div><div class="gs_gray">British journal of haematology 180 (3), 346-355<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16763310668491092525" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NZNkWSpQBv0C" class="gsc_a_at">Characteristics of human primary mantle cell lymphoma engraftment in NSG mice</a><div class="gs_gray">S Iyengar, L Ariza‐McNaughton, A Clear, D Taussig, R Auer, A Roe, ...</div><div class="gs_gray">British journal of haematology 173 (1), 165<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10892824164066683912" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mVC4hKzE2FoC" class="gsc_a_at">Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.</a><div class="gs_gray">SP Blagden, I Rizzuto, C Stavraka, D O'Shea, P Suppiah, M Patel, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 2514-2514<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10148468650362081232" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GiYFt9mpioMC" class="gsc_a_at">A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.</a><div class="gs_gray">SP Blagden, I Rizzuto, C Stavraka, D O'Shea, P Suppiah, M Patel, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), 2547-2547<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7301636715252784665" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7VEv-pLvLSsC" class="gsc_a_at">Abstract CT401: NUC-1031: A novel ProTide that overcomes the key cancer resistance mechanisms associated with poor survival</a><div class="gs_gray">EA Ghazaly, M Slusarczyk, M Mason, J Gribben, C McGuigan, S Blagden</div><div class="gs_gray">Cancer Research 74 (19 Supplement), CT401-CT401<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8590098521485351389" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:h168fVGZblEC" class="gsc_a_at">Primary refractory T‐cell prolymphocytic leukaemia treated with daily administration of A lemtuzumab plus high‐dose methylprednisolone</a><div class="gs_gray">E Renaudon‐Smith, JG Gribben, SG Agrawal</div><div class="gs_gray">European journal of haematology 92 (4), 360-361<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12707407699979036612" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis</a><div class="gs_gray">R Coutinho, J Gribben</div><div class="gs_gray">Current Biomarker Findings 3, 17-34<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10026601052292165708" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC</a><div class="gs_gray">WK Decker, N Shah, D Xing, R Lapushin, S Li, SN Robinson, H Yang, ...</div><div class="gs_gray">PloS one 7 (12), e51390<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10816202330667089402" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">The kiss of death in FL</a><div class="gs_gray">AG Ramsay, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (20), 5365-5366<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6181935324143260962" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-FonjvnnhkoC" class="gsc_a_at">An immunohistochemical score based on CD68 and FOXP3 expression in the tumour microenvironment at diagnosis defines prognostic groups in both early and advanced stage classical&nbsp;…</a><div class="gs_gray">P Greaves, AJ Clear, DA Owen, F Macdougall, A Wilson, A Lister, ...</div><div class="gs_gray">Blood 116 (21), 750<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2697928546234032608" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">J Clin Oncol 26 (30), 4864-4865<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7422346072443636736" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Fludarabine and alemtuzumab versus fludarabine and rituximab in the treatment of relapsed B-cell chronic lymphocytic leukemia: Results from a phase II study.</a><div class="gs_gray">J Gribben, K Stephans, B Marshal</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 5046-5046<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11670333769355333342" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">ZAP-70 protein expression varies by interphase cytogenetic group and may predict disease progression to requirement of treatment among select genetic groups in patients with&nbsp;…</a><div class="gs_gray">MR Grever, GW Dewald, DM Lucas, DS Neuberg, ME Baird, ...</div><div class="gs_gray">Blood 102 (11), 73A-73A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8513699268666150302" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Successful haploidentical BMT post ex vivo anergization of donor BM alloreactive T cells.</a><div class="gs_gray">EC Guinan, VA Boussiotis, N Hirano, LL Brennan, LM Nadler, JG Gribben</div><div class="gs_gray">Blood 92 (10), 687A-687A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10647529278941792507" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Autologous adoptive T cell transfer for a patient with plasma cell leukemia: Results of a pilot phase I trial.</a><div class="gs_gray">JL Schultze, KA Anderson, MH Gilleece, S Michalak, A Hickey, I Webb, ...</div><div class="gs_gray">Blood 92 (10), 109A-109A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1130240178506999602" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Potential for cure of B-cell CLL and SLL: Prolonged disease free survival and molecular remissions following autologous and allogeneic bone marrow transplantation.</a><div class="gs_gray">L BartlettPandite, JG Gribben, R Soiffer, NS Andersen, K Anderson, ...</div><div class="gs_gray">Blood 88 (10), 2718-2718<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12469867722193473801" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:i2xiXl-TujoC" class="gsc_a_at">CD40 activated follicular lymphoma cells are resistant to and can overcome generalized T cell unresponsiveness induced by IL-10 and TGF beta.</a><div class="gs_gray">JL Schultze, S Michalak, MJ Seamon, JG Gribben, LM Nadler</div><div class="gs_gray">Blood 88 (10), 2534-2534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3557774248504568822" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">EXPRESSION AND INDUCTION OF B7 ON LEUKEMIC-CELLS ISOLATED FROM PATIENTS WITH HEMATOLOGIC MALIGNANCIES</a><div class="gs_gray">A Lundberg, J Gribben, S Lazo, L Nadler</div><div class="gs_gray">Blood 82 (10), A123-A123<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13471014931512054539" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Bone marrow transplantation in the treatment of Hodgkin’s lymphoma: problems, remaining challenges, and future prospects</a><div class="gs_gray">JO Armitage, MJ Barnett, AM Carella, KA Dicke, V Diehl, JG Gribben, ...</div><div class="gs_gray">New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease, 246-253<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11035160493393197874" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UEFpDhwOD2kC" class="gsc_a_at">EU-wide access to high-quality, affordable precision diagnostics: an EHA position paper</a><div class="gs_gray">E Macintyre, J Gribben, K Döhner</div><div class="gs_gray">HemaSphere 4 (3)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10052459946934930147" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:iWL_APfBKHwC" class="gsc_a_at">Characterising the immunological microenvironment in newly diagnosed multiple myeloma bone marrow by time of flight cytometry reveals abnormalities in antigen presenting and&nbsp;…</a><div class="gs_gray">F Seymour, J Cavenagh, JG Gribben</div><div class="gs_gray">Blood 132, 58<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5894424873302931759" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hrkNWuzUpWwC" class="gsc_a_at">Single-agent ibrutinib versus chlorambucil-obinutuzumab as first-line treatment in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL): results&nbsp;…</a><div class="gs_gray">A Tedeschi, R Greil, F Demirkan, T Robak, C Moreno, P Barr, B Anz, ...</div><div class="gs_gray">Blood 132, 5565<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17541574456677708871" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_AkkBXT-jcoC" class="gsc_a_at">Safety and efficacy of idelalisib treatment of chronic lymphocytic leukemia (CLL) or lymphoma relapsing after allogeneic hematopoietic cell transplantation (alloHCT): a survey&nbsp;…</a><div class="gs_gray">P Dreger, L Koster, JR Passweg, M Collin, C Scheid, A Charbonnier, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 3273&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1336416996241862160" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Vztgr1qGG8IC" class="gsc_a_at">Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?</a><div class="gs_gray">F McClanahan, J Gribben</div><div class="gs_gray">Hematology/Oncology Clinics 28 (6), 1055-1071<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5160439121505123237" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lK9BDNCuzFgC" class="gsc_a_at">Immune responses and outcome in follicular lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Journal of Clinical Oncology 32 (17), 1757-1759<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10762965803319916561" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:aVq8r21TQD4C" class="gsc_a_at">Prognostic and predictive factors in chronic lymphocytic leukemia</a><div class="gs_gray">J Gribben</div><div class="gs_gray">EHA Learning Center Hematology Education 8 (1), 59-74<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5787029083321898065" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:v_tt_AnqfNMC" class="gsc_a_at">T-cell dysfunction in CLL is mediated not only by PD-1/PD-L1 but also by PD-1/PD-L2 interactions-partial functionality is maintained in PD-1 defined CD8 subsets and this can be&nbsp;…</a><div class="gs_gray">F McClanahan, S Miller, JC Riches, E Ghazaly, WP Day, M Capasso, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 4120-4120<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11192916073678897086" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QsKbpXNoaWkC" class="gsc_a_at">Laser-capturing the essence of Hodgkin lymphoma</a><div class="gs_gray">P Greaves, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (23), 4451-4452<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15457562279335156991" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">PI3K Inhibition with GDC-0941 has greater efficacy compared to p110δ-selective inhibition with CAL-101 in mantle cell lymphoma and may be particularly advantageous in multiply&nbsp;…</a><div class="gs_gray">S Iyengar, AJ Clear, A Owen, L Maharaj, J Matthews, M Calaminici, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 1654-1654<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14396603095942056777" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Stem cell transplantation in chronic lymphocytic leukaemia–steering a safe course over shifting sands</a><div class="gs_gray">S Hallam, JG Gribben</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 23 (1), 109-119<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7987046534723254193" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo&nbsp;…</a><div class="gs_gray">M Mohty, M Labopin, JJWM Janssen, GJ Mufti, JJ Cornelissen, NJ Milpied, ...</div><div class="gs_gray">Blood 114 (22), 1190<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14563413572452387856" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.</a><div class="gs_gray">JR Brown, K Stevenson, HT Kim, P Armand, C Cutler, DC Fisher, V Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 972-972<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16220134182160496787" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WZBGuue-350C" class="gsc_a_at">High Levels of Early Donor Chimerism and Treatment-Responsive Disease Predict Improved Progression-Free Survival Following Non-Myeloablative Transplantation for Advanced CLL.</a><div class="gs_gray">JR Brown, S Li, H Kim, DC Fisher, C Cutler, V Ho, SJ Lee, J Ritz, JH Antin, ...</div><div class="gs_gray">Blood 106 (11), 560<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1557973992441696265" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Follicular Lymphoma</a><div class="gs_gray">A Darby, JG Gribben</div><div class="gs_gray">Lymphoma, 315-331<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13838358326840100936" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8d8msizDQcsC" class="gsc_a_at">Quantitative Analysis of Minimal Residual Disease at the Completion of Induction Therapy Predicts Relapse in Children with B-Lineage Acute Lymphoblastic Leukemia in DFCI ALL&nbsp;…</a><div class="gs_gray">J Zhou, A Li, MA Goldwasser, H Wang, V Dalton, C Lyons, KD McBride, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 323-323<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9337617066710670437" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD) Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute&nbsp;…</a><div class="gs_gray">EP Alyea, S Li, H Kim, C Cutler, V Ho, SJ Lee, J Gribben, J Ritz, DC Fisher, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 730-730<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6737019965642373862" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">CD38 compared with ZAP-70 or immmunoglobulin mutation status as predictor of disease progression in chronic lymphocytic leukemia.</a><div class="gs_gray">LZ Rassenti, DS Neuberg, MJ Keating, JG Gribben, IW Flinn, KR Rai, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 2805-2805<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5521878189743252748" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Zap-70 is a more reliable marker of disease progression risk than immunoglobulin mutation status in chronic lymphocytic leukemia.</a><div class="gs_gray">LZ Rassenti, L Huynh, TL Toy, JG Gribben, MJ Keating, KR Rai, IW Flinn, ...</div><div class="gs_gray">Blood 102 (11), 34A-34A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3112453371633179192" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Outcome following autologous or allogeneic stem cell transplantation in Chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben, L Sequist, D Zahrieh, D Neuberg, EP Alyea, DC Fisher, ...</div><div class="gs_gray">Blood 102 (11), 980A-981A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1002712716371869955" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Role of autologous stem cell transplantation in chronic lymphocytic leukemia</a><div class="gs_gray">V Rizouli, JG Gribben</div><div class="gs_gray">Current opinion in hematology 10 (4), 306-311<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15650420628494150463" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XAp-VaTZjjwC" class="gsc_a_at">The identical effects of B7-1 and B7-2 on regulation of human IL-2 gene transcription factors NF-kappa B and AP-1</a><div class="gs_gray">XY Ke, J Gribben, J Wang, DB Wang</div><div class="gs_gray">Zhongguo shi yan xue ye xue za zhi 10 (6), 512-518<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10178485823597374366" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Autologous hematopoietic transplantation for low-grade lymphomas</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Cytotherapy 4 (3), 205-215<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5331969212745246452" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Efficacy and safety of alemtuzumab (Campath-1H) used on a compassionate basis in refractory T-PLL.</a><div class="gs_gray">S Coutre, KR Rai, MJ Keating, JG Gribben, I Flinn, S Rabinowe, D Rizzieri</div><div class="gs_gray">Blood 98 (11), 366A-366A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3979580502927713115" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Ligation of CD40 on B-cell chronic lymphocytic leukemia (B-CLL) cells promotes increased survival but does not impair fludarabine induced apoptosis.</a><div class="gs_gray">M Grdisa, RP Tang, A Delmer, V Levy, JG Gribben, ...</div><div class="gs_gray">Blood 96 (11), 159A-159A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14313291783213317935" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Phase II study of combination immunotherapy with interleukin-2 (IL-2) and rituximab in patients with relapsed or refractory follicular non-Hodgkin's lymphoma (NHL).</a><div class="gs_gray">JW Friedberg, D Neuberg, JG Gribben, C Canning, JF Daley, C Kuhlman, ...</div><div class="gs_gray">Blood 96 (11), 730A-731A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3814329870542601016" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tYavs44e6CUC" class="gsc_a_at">A pilot study of CD8+ cell depletion of donor lymphocyte infusions (DLI) using CD8 monoclonal antibody coated high density microparticles (HDM).</a><div class="gs_gray">EP Alyea, CM Canning, H Houde, RJ Soiffer, S Giralt, IJ Webb, J Donovan, ...</div><div class="gs_gray">Blood 94 (10), 161A-161A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=579199500318419672" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:foquWX3nUaYC" class="gsc_a_at">Adoptive immunotherapy for B-cell lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Haematologica 84, S67-69<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7312614515613286526" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">No evidence for MUC 1-induced apoptosis</a><div class="gs_gray">V Boussiotis, G Freeman, J Gribben, D Hayes, L Nadler</div><div class="gs_gray">Nature medicine 4 (10), 1093-1093<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12359381247639007618" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rmuvC79q63oC" class="gsc_a_at">Molecular basis for stem cell transplantation in indolent lymphomas.</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">The cancer journal from Scientific American 4, S37-45<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4124836658876243380" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uWy0R8PweswC" class="gsc_a_at">B7 (CD80 and CD86)</a><div class="gs_gray">GJ Freeman, VA Boussiotis, JG Gribben, AH Sharpe, LM Nadler</div><div class="gs_gray">Elsevier<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14090347282735511901" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9pM33mqn1YgC" class="gsc_a_at">The role of growth factors in bone-marrow transplantation</a><div class="gs_gray">A Golidstone, J Gribben, A Mcmillan</div><div class="gs_gray">Leukemia &amp; lymphoma 1 (2), 87-93<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8129428319473304542" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Gpwnp1kGG20C" class="gsc_a_at">ULTRAFILTRATION IN REFRACTORY CONGESTIVE HEART-FAILURE</a><div class="gs_gray">IA Simpson, AP Rae, J Gribben, MEM Allison, JMB JONES, I Hutton</div><div class="gs_gray">British Heart Journal 53 (6), 673-673<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7596891267829907880" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:K4-iKlO5MD4C" class="gsc_a_at">Arteriovenous haemofiltration.</a><div class="gs_gray">AC Leung, K Simpson, J Gribben, J Wallace, R Mactier, ME Allison, ...</div><div class="gs_gray">British medical journal (Clinical research ed.) 287 (6406), 1722<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8200839302858531970" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M7C5BM2v8n8C" class="gsc_a_at">Comparison of efficacy and safety with obinutuzumab plus chemotherapy versus rituximab plus chemotherapy in patients with previously untreated follicular lymphoma: Updated&nbsp;…</a><div class="gs_gray">W Townsend, C Buske, G Cartron, D Cunningham, MJS Dyer, JG Gribben, ...</div><div class="gs_gray">Journal of Clinical Oncology 38 (15_suppl), 8023-8023<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5699936260549698717" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wH03y5nBhxsC" class="gsc_a_at">Gene expression profiling of B cell lymphoma in dogs reveals dichotomous metabolic signatures distinguished by oxidative phosphorylation</a><div class="gs_gray">Y Wu, YM Chang, G Polton, AJ Stell, B Szladovits, M Macfarlane, ...</div><div class="gs_gray">Frontiers in oncology 10, 307<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3374748033204942151" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kiex5tMzGo8C" class="gsc_a_at">Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">British journal of haematology 188 (6), 844-851<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9366703946464978314" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:K-tzbvM8PMoC" class="gsc_a_at">Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017</a><div class="gs_gray">PJ Hayden, DJ Eikema, L Koster, H Goldschmidt, D Blaise, M Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11171356907990629767" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MSzX15-gZgkC" class="gsc_a_at">Subgroup Analyses of Elderly Patients Aged ≥ 70 Years in AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R<sup>2</sup>) vs Rituximab Plus&nbsp;…</a><div class="gs_gray">M Trněný, JP Leonard, H Zhang, G Nowakowski, K Izutsu, NH Fowler, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6803735225265011127" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:aCwMkEyfDy8C" class="gsc_a_at">First in human, phase I/II trial of the Bruton's tyrosine kinase inhibitor (BTKi) M7583 in patients with B cell malignancies: study design and initial outcomes</a><div class="gs_gray">W Jurczak, S Rule, W Townsend, D Tucker, M Dyroff, B Sarholz, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2778&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8063725273941861156" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yZoBfgUKqwcC" class="gsc_a_at">New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective.</a><div class="gs_gray">F McClanahan, J Gribben</div><div class="gs_gray">Clinical advances in hematology &amp; oncology: H&amp;O 13 (9), 586-594<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12441735121111981010" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5F1dSjz1ScoC" class="gsc_a_at">PRIMARY RESULTS FROM THE PHASE III GADOLIN STUDY OF OBINUTUZUMAB PLUS BENDAMUSTINE VERSUS BENDAMUSTINE ALONE IN RITUXIMAB-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: 123</a><div class="gs_gray">B Cheson, N Chua, J Mayer, G Dueck, M Trneny, K Bouabdallah, ...</div><div class="gs_gray">Hematological Oncology 33<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=441636740837674811" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:txeM2kYbVNMC" class="gsc_a_at">Hanging tough: CMV-specific CD8<sup>+</sup> T cells in CLL</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 123 (5), 608-609<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=512447053455514389" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:as0KMg8qHbkC" class="gsc_a_at">Concurrent follicular lymphoma at diagnosis has a negative impact on the outcome of patients with diffuse large B cell lymphoma</a><div class="gs_gray">D Wrench, H Rizvi, A Wilson, C O'Riain, A Clear, J Matthews, D Laszlo, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 4260-4260<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3581005572387021818" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Impact of lenalidomide on gene expression profiles of malignant and immune cells in patients with chronic lymphocytic leukemia</a><div class="gs_gray">JC Riches, A Sangaralingam, S Kiaii, T Chaplin, D Cekdemir, S Iqbal, ...</div><div class="gs_gray">Blood 118 (21), 976<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5921856084454463758" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YohjEiUPhakC" class="gsc_a_at">Exploring the Immune Microenvironment of Diffuse Large B Cell Lymphoma in a Tissue Microarray: Predicting Survival with a Score That Incorporates Macrophages, Cytotoxic and&nbsp;…</a><div class="gs_gray">R Coutinho, AJ Clear, DA Owen, P Greaves, SL Hallam, A Wilson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 951-951<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4355561258627101506" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Are prognostic factors in CLL overrated?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Oncology 25 (8), 703<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12075801469033903943" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Rituximab plus chlorambucil (R-Chlorambucil) as first-line treatment for chronic lymphocytic leukaemia (CLL): final analysis of an open-label phase II study</a><div class="gs_gray">P Hillmen, JG Gribben, GA Follows, D Milligan, HA Sayala, P Moreton, ...</div><div class="gs_gray">Ann Oncol 22 (Suppl 4)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8142228025914505718" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Final results of the phase I study of lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia (CLL-001 study)</a><div class="gs_gray">C Wendtner, P Hillmen, D Mahadevan, S Stilgenbauer, L Uharek, ...</div><div class="gs_gray">Blood 116 (21), 1376<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17882044060149997406" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Increased incidence of therapy related myeloid neoplasia (t-MN) after initial therapy for CLL with fludarabine-cyclophosphamide (FC) vs fludarabine (F): long-term follow-up of&nbsp;…</a><div class="gs_gray">MR Smith, D Neuberg, IW Flinn, MR Grever, JM Bennett, G Dewald, ...</div><div class="gs_gray">Blood 116 (21), 924<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10450540366709772421" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FAceZFleit8C" class="gsc_a_at">The 3 Rs in CLL immune dysfunction</a><div class="gs_gray">AG Ramsay, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 115 (13), 2563-2564<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8873921217244394183" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Dramatic Reduction of Chronic Lymphocytic Leukemia (CLL) Cells Following Adoptive Transfer of Cord Blood (CB) Natural Killer (NK) Cells Using CB-Engrafted NOD-SCID IL2Rγnull&nbsp;…</a><div class="gs_gray">D Xing, AG Ramsay, W Decker, S Li, S Robinson, H Yang, N Shah, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (22), 2370-2370<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8298428289130261538" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Transplantation in chronic lymphocytic leukemia: timing and expectations</a><div class="gs_gray">S Hallam, JG Gribben</div><div class="gs_gray">Clinical Lymphoma and Myeloma 9, S186-S193<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14035158244113808790" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oFn-K-OQSCAC" class="gsc_a_at">Peripheral blood T cells in AML patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts</a><div class="gs_gray">R Le Dieu, DC Taussig, AG Ramsay, R Mitter, F Miraki-Moud, R Fatah, ...</div><div class="gs_gray">Blood 114 (18), 3909-3916<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9110994474253789478" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:x2hKVfJWtf0C" class="gsc_a_at">Co-treatment with panobinostat enhances bortezomib-induced unfolded protein response, endoplasmic reticulum stress and apoptosis of human mantle cell lymphoma cells</a><div class="gs_gray">R Rao, W Fiskus, Y Yang, R Joshi, P Fernandez, P Lee, A Jillella, J Tao, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 887-887<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1396058491026857418" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:umqufdRvDiIC" class="gsc_a_at">Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma.</a><div class="gs_gray">E Carlotti, D Wrench, S Iqbal, D O’Shea, A Davies, P Virappane, J Hart, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 181-181<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=484907043376582774" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Self-Administered, Subcutaneous (SQ) Alemtuzumab To Eliminate Residual Disease in Patients (pts) with CLL.</a><div class="gs_gray">WG Wierda, TJ Kipps, MJ Keating, JR Brown, JG Gribben, ML Browning, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2839-2839<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4209839210047922589" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">A phase II study of Xcellerated T cells™ in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL)</a><div class="gs_gray">JG Gribben, NL Bartlett, JJ Stephenson, MS Milder, RV Boccia, C Redfern, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 11 (2), 76<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5580058956578535533" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Array-based comparative genomic hybridization identifies deletion at 14q32 as a new prognostic marker in chronic lymphocytic leukemia (CLL).</a><div class="gs_gray">D Drandi, C Lee, P Dal Cin, JG Gribben</div><div class="gs_gray">Blood 102 (11), 186A-186A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11154508052679932898" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">High-dose therapy and stem cell support in chronic lymphocytic leukemia</a><div class="gs_gray">AM Krackhardt, JG Gribben</div><div class="gs_gray">BASIC AND CLINICAL ONCOLOGY 26, 393-416<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=964485883240710559" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Effective purging of autologus hematopoietic stem cell (HSC) transplants for non-hodgkin's lymphoma (NHL) using high density microparticles coated with anti-CD19 and anti-CD20&nbsp;…</a><div class="gs_gray">A Freedman, J Gribben, C Kuhlman, H Jallow, H Houde, M Jarpe, ...</div><div class="gs_gray">Blood 94 (10), 638A-638A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8195709246960523470" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Limitations of quantitative detection of immunoglobulin heavy chain (IgH) gene rearrangements in multiple myeloma (MM) patients using real-time PCR</a><div class="gs_gray">M Ladetto, JW Donovan, R Schlossman, K Anderson, JG Gribben</div><div class="gs_gray">Blood 92 (10), 258A-258A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4366382113627133565" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">The detection of minimal residual disease: implications for bone marrow transplantation</a><div class="gs_gray">JG Gribben, JL Schultze</div><div class="gs_gray">Blood Stem Cell Transplantation, 99-120<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4621278291486663151" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Failing B7 costimulation engenders a peripheral clonal T-cell anergy in a human antigen-specific model</a><div class="gs_gray">CD Gimmi, JG Gribben, GJ Freeman, LM Nadler</div><div class="gs_gray">Schweizerische medizinische Wochenschrift 123 (47), 2255-2256<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1692041199154930814" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_axFR9aDTf0C" class="gsc_a_at">The immunological treatment of human marrow in vitro in transplantation biology</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">Leukemia: Advances in Research and Treatment, 189-211<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3442661438878559441" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980–89</a><div class="gs_gray">AK McMillan, JG Gribben, DC Linch, C Anderson, JDM Richards, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 1 (3-4), 157-162<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14592165981980886535" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">EBMT experience of autologous bone marrow transplantation in lymphoma</a><div class="gs_gray">AH Goldstone, JG Gribben</div><div class="gs_gray">Folia haematologica (Leipzig, Germany: 1928) 116 (3-4), 505-508<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2507057229618080772" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:V_vSwabWVtYC" class="gsc_a_at">GRAFT-REJECTION FOLLOWING T-CELL DEPLETED BMT</a><div class="gs_gray">J Patterson, HG Prentice, MK Brenner, M Gilmore, H Blacklock, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 61 (3), 562-562<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3060953848776908071" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:43B52WW2E64C" class="gsc_a_at">Phase I, first-in-human trial of Bruton’s tyrosine kinase inhibitor M7583 in patients with B-cell malignancies</a><div class="gs_gray">W Jurczak, S Rule, W Townsend, D Tucker, B Sarholz, J Scheele, ...</div><div class="gs_gray">Leukemia &amp; Lymphoma, 1-8<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10054185964354359058" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:S_fw-_riRmcC" class="gsc_a_at">Fair pricing of innovative medicines: an EHA position paper</a><div class="gs_gray">A Hagenbeek, J Gribben, U Jäger, P Kapitein, G Merlini, M Piggin, ...</div><div class="gs_gray">HemaSphere 4 (5)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1103292573372455221" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RZBefGmQYygC" class="gsc_a_at">Personalized treatment for hematologic diseases in Europe: an EHA position paper</a><div class="gs_gray">U Jäger, P Kapitein, J Gribben</div><div class="gs_gray">HemaSphere 4 (5)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16993316480032745280" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:P2d6BWbXU0IC" class="gsc_a_at">Open access is the plan S way forward in hematology research</a><div class="gs_gray">J Cools, A Engert, J Gribben, E Macintyre</div><div class="gs_gray">HemaSphere 4 (1)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14831006795450625170" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PQY3Tb_h0-cC" class="gsc_a_at">Subgroup Analyses of Elderly Patients Aged&gt;= 70 Years in AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) vs Rituximab Plus Placebo (R-Placebo) in&nbsp;…</a><div class="gs_gray">M Trneny, JP Leonard, H Zhang, G Nowakowski, K Izutsu, NH Fowler, ...</div><div class="gs_gray">Blood 134<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11915865756295728751" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:G887dSk7Sz8C" class="gsc_a_at">Comparison of different upfront transplant strategies in multiple myeloma-a large registry study from Chronic Malignancies Working Party of EBMT</a><div class="gs_gray">SO Schönland, S Iacobelli, L Koster, D Blaise, M Potter, JJ Cornelissen, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4808238038339446972" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0urtJCGzaFQC" class="gsc_a_at">PF483 EFFICACY WAS IMPROVED WITH LENALIDOMIDE/RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH FOLLICULAR LYMPHOMA IRRESPECTIVE OF POD24 STATUS IN THE PHASE III AUGMENT STUDY</a><div class="gs_gray">JP Leonard, M Trneny, K Izutsu, NH Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">HemaSphere 3 (S1), 193-194<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2826266557369430595" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3pYxbvHKFu8C" class="gsc_a_at">HEALTH‐RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2) VERSUS R PLUS PLACEBO</a><div class="gs_gray">JP Leonard, M Trněny, K Izutsu, NH Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">Hematological Oncology 37, 232-234<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9518464792866142226" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xIusEVNJREcC" class="gsc_a_at">Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma</a><div class="gs_gray">MJ Baptista, G Tapia, M Morgades, J Muncunill, AM Muñoz-Marmol, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 60 (4), 1087-1091<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2939266274239002381" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M8meJADSprsC" class="gsc_a_at">Programmed cell death protein-1 (PD1) expression in the microenvironment of classical Hodgkin lymphoma is similar between favorable and adverse outcome and does not enrich over&nbsp;…</a><div class="gs_gray">JG Taylor, A Clear, M Calaminici, JG Gribben</div><div class="gs_gray">haematologica 104 (1), e42<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10616927939176206269" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-qpA3cGbmHsC" class="gsc_a_at">Modulation of T-cell function in the microenvironment of emu-TCL1 CLL bearing mice by Btki appears independent of ITK</a><div class="gs_gray">MA Schwarzbich, A Romero-Toledo, M Frigault, JG Gribben</div><div class="gs_gray">Blood 132, 3139<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10637042567913261836" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4uoR24qA-WYC" class="gsc_a_at">Immune microenvironment analysis of bone marrow by mass cytometry and RNA sequencing in multiple myeloma patients treated with daratumumab and durvalumab</a><div class="gs_gray">F Seymour, MH Young, M Tometsko, J Cavenagh, EG Thompson, ...</div><div class="gs_gray">Blood 132, 3296<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6139474945573071673" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w0odbtu79TwC" class="gsc_a_at">Single centre experience of ZarzioTM biosimilar Granulocyte-colony stimulating factor (GCSF) for the mobilisation of healthy donors demonstrates good leukapheresis yields and&nbsp;…</a><div class="gs_gray">J Taylor, T Seddon, K Alizadeh, C Agrawal, L Kempster, J Gribben, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=717633969331203835" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-38epGy1wY0C" class="gsc_a_at">Reduction of Mitochondrial Membrane Potential Leads to Enhancement of Type-II CD20-Antibody Cytotoxicity in Diffuse Large B-Cell Lymphoma</a><div class="gs_gray">E Vilventhraraja, T Klymenko, J Edelmann, J Gribben, A Ivanov</div><div class="gs_gray">Blood 128 (22), 1763<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18177184517704802647" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GtqhT-R7ZnwC" class="gsc_a_at">High-level expression of ROR1 associates with early disease progression in patients with chronic lymphocytic leukemia</a><div class="gs_gray">B Cui, L Chen, LZ Rassenti, EM Ghia, J Yu, L Zhang, DS Neuberg, ...</div><div class="gs_gray">Blood 126 (23), 1713<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8116267390095758383" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hKjooKYXoHIC" class="gsc_a_at">Single arm NCRI feasibility phase II study of CHOP in combination with ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome</a><div class="gs_gray">T Eyre, R Clifford, A Bloor, L Boyle, M Cabes, GP Collins, S Devereux, ...</div><div class="gs_gray">Eur Hematol Assoc Annu Meet 324<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11642754125710030657" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZysSsiWj_g4C" class="gsc_a_at">Physical examination and MRD assessment rather than CT-scans is effective to assess responses in patients treated with fludarabine-based chemoimmunotherapy. Analysis of&nbsp;…</a><div class="gs_gray">T Munir, D Cohen, C Pocock, A Rawstron, L Collet, L McParland, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12092783988667242337" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1EqfMoDn7-AC" class="gsc_a_at">High resolution genomic profiling of primary “ultra high risk” and refractory chronic lymphocytic leukemia: results from the CLL2O Trial</a><div class="gs_gray">J Edelmann, J Saub, S Ibach, K Holzmann, E Tausch, J Bloehdorn, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3288-3288<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17017959972821187788" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Kqc1aDSOPooC" class="gsc_a_at">Arginine deprivation with pegylated arginine deiminase induces death of acute myeloid leukaemia cells in vivo</a><div class="gs_gray">F Miraki-Moud, L Ariza-McNaughton, EA Ghazaly, KA Hodby, P Luong, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 1458-1458<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15241083449338876044" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jtOrAYjvdewC" class="gsc_a_at">RESULTS OF THE RANDOMISED PHASE II NCRI ADMIRE TRIAL OF FCR AND FCM-R IN PREVIOUSLY UNTREATED CLL: ORAL FCR IS HIGHLY EFFECTIVE AND SAFE BUT THE ADDITION OF MITOXANTRONE DOES&nbsp;…</a><div class="gs_gray">P Hillmen, C Pocock, A Rawstron, L McParland, A Chalmers, A Varghese, ...</div><div class="gs_gray">Haematologica 98, 473-474<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6334146452771104709" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gVv57TyPmFsC" class="gsc_a_at">IL-6, IL-8 and VEGF Neutralisation Restores Drug Sensitivity to Conventional and Novel Treatment Combinations in a Multiple Myeloma Bone Marrow Micro-Environment Model.</a><div class="gs_gray">L Maharaj, R Popat, JG Gribben, S Joel</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2949-2949<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3996785865258837887" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Blockade of chemotaxis in graft-versus-host disease.</a><div class="gs_gray">JK Davies, JG Gribben</div><div class="gs_gray">The New England journal of medicine 367 (17), 1667; author reply 1667-8<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4061841362339306782" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HGTzPopzzJcC" class="gsc_a_at">Activation of Mitochondrial STAT3 Increases Mitochondrial Respiration and Inhibits Oxidative Stress in Chronic Lymphocytic Leukemic Cells</a><div class="gs_gray">L Jia, N Uddin, JG Gribben</div><div class="gs_gray">Blood 118 (21), 287<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2704203178453489444" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Lenalidomide Treatment Enhances Immunological Synapse Formation of Cord Blood Natural Killer Cells with B Cells Derived From Chronic Lymphocytic Leukemia</a><div class="gs_gray">D Xing, AG Ramsay, S Robinson, CM Bollard, N Shah, R Champlin, ...</div><div class="gs_gray">Blood 118 (21), 1794<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=489460595334297213" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Manipulating tumor associated macrophages (TAM) in a mouse model of B-cell non-hodgkin lymphoma (NHL)</a><div class="gs_gray">SL Hallam, J Candido, R Coutinho, E Maniati, RG Thompson, ...</div><div class="gs_gray">Blood 118 (21), 1657<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=463462182071470063" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">The PD1/PD-L1 axis in the classical hodgkin lymphoma microenvironment: PD-1 is rarely expressed but identifies patients with high-risk disease</a><div class="gs_gray">P Greaves, AJ Clear, A Owen, A Wilson, J Matthews, M Calaminici, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 1560-1560<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5329959875363322251" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">TNFRSF14 and EZH2 mutations, Chr2p gain and copy number changes targeting genes whose proteins interact with the microenvironment in transformed follicular lymphoma</a><div class="gs_gray">D Wrench, A Sangaralingam, H Tayyib, MK Kang, C O'Riain, M Gupta, ...</div><div class="gs_gray">Blood 116 (21), 799<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15493110028136610258" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ALROH1vI_8AC" class="gsc_a_at">A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute&nbsp;…</a><div class="gs_gray">DA Tsitsikas, D Warcel-Sibony, HE Oakervee, SG Agrawal, M Smith, ...</div><div class="gs_gray">Blood 116 (21), 3480<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12303459593797615869" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Comparison of low-dose TBI-Based reduced-intensity conditioning (RIC) vs. chemotherapy-based RIC prior to allogeneic stem cell transplantation from an HLA identical sibling&nbsp;…</a><div class="gs_gray">M Mohty, M Labopin, J Janssen, G Mufti, JJ Cornelissen, N Milpied, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S38-S39<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1428061533328230555" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">A phase I dose-escalation of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia</a><div class="gs_gray">CM Wendtner, D Mahadevan, S Coutré, P Hillmen, S Stilgenbauer, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 371-372<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1896291562415951553" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">5-year follow-up of heavily pretreated patients with relapsed/refractory CLL in phase 3 study: significant survival benefit with oblimersen plus fludarabine/cyclophosphamide in&nbsp;…</a><div class="gs_gray">M O'Brien, J Gribben, T Cousin, K Rai</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 141-142<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=557883745023905002" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TeJ9juy8vcMC" class="gsc_a_at">Lenalidomide repairs suppressed T cell immunological synapse formation in follicular lymphoma</a><div class="gs_gray">AG Ramsay, AJ Clear, R Fatah, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 885-885<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14160846907796638643" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Characteristics of familial CLL evaluated in the CLL Research Consortium cohort</a><div class="gs_gray">JR Brown, L Rassenti, D Neuberg, A Greaves, JC Byrd, MR Grever, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3125-3125<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8187793246366003003" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients</a><div class="gs_gray">T Butler, JG Gribben</div><div class="gs_gray">Expert opinion on medical diagnostics 2 (1), 101-112<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18382893194855521125" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bKqednn6t2AC" class="gsc_a_at">Chronic lymphocytic leukemia: an historical perspective</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">ASH Education Program Book 2008 (1), 443-443<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8790004210241464207" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Select high risk genetic features predict earlier progression following chemotherapy in chronic lymphocytic leukemia: Prospective randomized trial (Intergroup E2997) to&nbsp;…</a><div class="gs_gray">MR Grever, GW Dewald, DS Neuberg, JC Reed, S Kitada, IW Flinn, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 6521-6521<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2689128418951381483" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Patients (Pts) Surviving Haploidentical Stem Cell Transplantation (SCT) after Ex Vivo Costimulatory Blockade To Induce Anergy Experience Few Long-Term Complications.</a><div class="gs_gray">EC Guinan, JG Gribben, LL Brennan, LM Nadler</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 599-599<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17160152114678192211" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">CD40 activation: lessons for HIV immunotherapy from malignancies?</a><div class="gs_gray">R Le Dieu, J Gribben</div><div class="gs_gray">Journal of HIV therapy 10 (3), 51-55<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9824600364888433883" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Critical Molecular Studies to Strategically Plan Therapy in Chronic Lymphocytic Leukemia (CLL): Correlating Cellular Proteins with Defined Prognostic Patient Subsets and Their&nbsp;…</a><div class="gs_gray">S Kitada, JC Reed, DM Lucas, DS Neuberg, JG Gribben, GW Dewald, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 956-956<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13578070919216506648" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">High levels of donor chimerism early after non-myeloablative transplantation predictive of overall and progression free survival but not risk of acute graft versus host disease&nbsp;…</a><div class="gs_gray">EP Alyea, S Li, H Kim, VT Ho, C Cutler, SJ Lee, J Gribben, RM Stone, ...</div><div class="gs_gray">Blood 104 (11), 185<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18356056688074255562" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Similar Outcome of Non-Myeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients Greater Than Fifty Years of Age.</a><div class="gs_gray">EP Alyea, H Kim, C Cutler, VT Ho, J Gribben, DJ DeAngelo, SJ Lee, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 300-300<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4762485373534495969" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VBDT71xRUdcC" class="gsc_a_at">Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients greater than fifty years of age</a><div class="gs_gray">EP Alyea, HT Kim, VT Ho, C Cutler, J Gribben, DJ DeAngelo, SJ Lee, ...</div><div class="gs_gray">Blood. Prepublished September 30<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10193881412375065162" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Sirolimus, tacrolimus and low dose methotrexate as graft versus host disease prophylaxis after matched related and unrelated nonmyeloablative transplantation is well tolerated&nbsp;…</a><div class="gs_gray">EP Alyea, D Neuberg, C Cutler, B Parik, S Windawi, D Fisher, V Ho, ...</div><div class="gs_gray">Blood 102 (11), 711A-711A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17441950479700957529" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RJujIP1NYNUC" class="gsc_a_at">Quantitative analysis of residual disease levels by TaqMan PCR following bone marrow transplantation in chronic lymphocytic leukemia.</a><div class="gs_gray">JW Donovan, A Zuckerman, K Stephans, JC Gribben</div><div class="gs_gray">Blood 96 (11), 714A-714A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8092796562960642154" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">CD34+ cell, CFU-GM and nucleated cell dose predict engraftment but not survival following autologous purged bone marrow transplantation (BMT), yet do not predict outcomes&nbsp;…</a><div class="gs_gray">IJ Webb, E Weller, JG Gribben, A Freedman, RJ Soiffer, JH Antin, J Ritz</div><div class="gs_gray">Blood 94 (10), 147A-147A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6614311395982629418" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Concordance of MRD results in matched bone marrow and peripheral blood samples indicate that peripheral blood could be a sole sample source for MRD detection in pediatric acute&nbsp;…</a><div class="gs_gray">JW Donovan, C Poor, D Bowers, S Waters, GY Zou, D Neuberg, ...</div><div class="gs_gray">Blood 94 (10), 626A-626A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6253079997817779592" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Stem cell transplantation for indolent lymphoma</a><div class="gs_gray">A Krackhardt, JG Gribben</div><div class="gs_gray">Current opinion in hematology 6 (6), 388<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16878784680807311965" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Soluble CD40 ligand induces proliferation rather than apoptosis in primary human low-grade lymphoma: Implications for immunotherapy.</a><div class="gs_gray">PWM Johnson, JG Gribben, LM Nadler, JL Schultze</div><div class="gs_gray">Blood 92 (10), 484A-484A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5787786233403101679" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">High Density Particles: A Novel, Highly Efficient Cell Separation Technology</a><div class="gs_gray">N Kenyon, R Zwerner, J Gribben, L Nadler, C Ricordi, T Russell</div><div class="gs_gray">Cell Separation Methods and Applications, 103<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5186404359389592038" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-95Q15plzcUC" class="gsc_a_at">Increased fyn kinase activity initiates a cascade of signals that ultimately results in selective RAP1 activation blockade of Ras, and T cell anergy.</a><div class="gs_gray">VA Boussiotis, DL Barber, A Berezovskaya, GJ Freeman, JG Gribben, ...</div><div class="gs_gray">Blood 88 (10), 1847-1847<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3926066743944079044" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.</a><div class="gs_gray">RD Legare, JG Gribben, LM Nadler, DG Gilliland</div><div class="gs_gray">Blood 86 (10), 1586-1586<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6555794842069699776" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Absence of anti-follicular lymphoma (FL) specific T cell mediated immunity is associated with significant reduction of T cell receptor xi chain end granzyme B expression</a><div class="gs_gray">JL Schultze, VA Boussiotis, D Dorfman, AA Cardoso, MJ Seamon, ...</div><div class="gs_gray">Blood 86 (10), 1074-1074<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12305819510628207237" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GJVTs2krol4C" class="gsc_a_at">Anti-B cell monoclonal antibody treated autologous bone marrow transplantation in patients with low-grade non-Hodgkin’s lymphomas</a><div class="gs_gray">A Freedman, D Neuberg, J Gribben, K Dicke, A Keating</div><div class="gs_gray">Autologous Marrow and Blood Transplantation Proceedings of the Seventh&nbsp;…<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4639055215179100188" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8xutWZnSdmoC" class="gsc_a_at">CTLA4 BINDING REQUIRES ONLY THE B7-1 IG-V DOMAIN BUT COSTIMULATION REQUIRES BOTH IG-V AND IG-C DOMAINS</a><div class="gs_gray">GJ Freeman, J Ng, A Anumanthan, JG Gribben, VA Boussiotis, ...</div><div class="gs_gray">Blood 84 (10), A528-A528<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1306080202929825125" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OTTXONDVkokC" class="gsc_a_at">Immunologic purging of marrow assessed by polymerase chain reaction</a><div class="gs_gray">A Murgo, B Weinberger, J Johnson</div><div class="gs_gray">The New England journal of medicine 326 (17)<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4688411459858202315" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Timing of autologous bone marrow transplantation in Hodgkin's disease. The experience of the Bloomsbury Transplant Group</a><div class="gs_gray">AH Goldstone, JG Gribber, AK McMillan</div><div class="gs_gray">Autologous Bone Marrow Transplantation. Proceedings of the Fourth Internal&nbsp;…<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1160076983573794033" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Preliminary results of autologous bone marrow transplantation in the management of resistant Hodgkin’s disease: experience of the Bloomsbury Transplant Group at University&nbsp;…</a><div class="gs_gray">JG Gribben, AH Goldstone, DC Linch</div><div class="gs_gray">New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease, 242-245<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14455973708384045844" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Bloomsbury Transplant Group experience with double autologous bone marrow transplantation in first remission acute myeloid leukemia</a><div class="gs_gray">AH Goldstone, AK McMillan, JG Gribben, JDM Richards, DC Linch</div><div class="gs_gray">Autologous Bone Marrow transplantation, 119<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6742369650833227467" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_AeoHAGD03cC" class="gsc_a_at">PHASE-I PHASE-II STUDIES OF RH GM-CSF AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE</a><div class="gs_gray">S Devereux, A MacMillan, J Gribben, K Patterson, AH Goldstone, ...</div><div class="gs_gray">BONE MARROW TRANSPL 3, 91-91<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11790910222024718708" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Double autografting as potential curative therapy for acute leukemia</a><div class="gs_gray">AH Goldstone, JG Gribben, DC Linch</div><div class="gs_gray">Autologous Bone Marrow Transplantation, 111<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12757336071577761859" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MvIMIWP2nqIC" class="gsc_a_at">Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients-a single centre experience</a><div class="gs_gray">A Jurgensen-Rauch, S Gibbs, M Farrell, J Aries, M Grantham, L Eccersley, ...</div><div class="gs_gray">British journal of haematology 193 (2), 420-423<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10944695295108958396" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g9YHGIZn7mcC" class="gsc_a_at">Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD</a><div class="gs_gray">JA Ball, A Clear, J Aries, S Charrot, C Besley, M Mee, A Stagg, JO Lindsay, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 137 (5), 702-717<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9861008903057462180" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FtNbRaqWXr4C" class="gsc_a_at">Association of Low Tumor Endothelial Cell pY397–Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer</a><div class="gs_gray">M Roy-Luzarraga, T Abdel-Fatah, LE Reynolds, A Clear, JG Taylor, ...</div><div class="gs_gray">JAMA network open 3 (10), e2019304-e2019304<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9381249512872537896" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:f13iAvnbnnYC" class="gsc_a_at">Access to affordable orphan medicines in Europe: An EHA position paper</a><div class="gs_gray">G Merlini, J Gribben, E Macintyre, M Piggin, R Doeswijk</div><div class="gs_gray">HemaSphere 4 (5)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7110479013840971068" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q7LczdTNAjsC" class="gsc_a_at">Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative</a><div class="gs_gray">C Anthias, J Apperley, A Bloor, J Byrne, M Collin, C Crawley, C Craddock, ...</div><div class="gs_gray">Bone marrow transplantation 55 (9), 1840-1843<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3466340028305034908" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xckinRaLORAC" class="gsc_a_at">Do we need to analyse everything at diagnosis in chronic lymphocytic leukaemia?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">British journal of haematology 189 (4), 603-604<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5485313023425164875" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:o0eFlWRwRSUC" class="gsc_a_at">Repression of sphingosine kinase (SK)-interacting protein (SKIP) in acute myeloid leukemia diminishes SK activity and its re-expression restores SK function</a><div class="gs_gray">EA Ghazaly, F Miraki-Moud, P Smith, C Gnanaranjan, L Koniali, A Oke, ...</div><div class="gs_gray">Journal of Biological Chemistry 295 (16), 5496-5508<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17623124322437550681" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3jqAvCjcdfEC" class="gsc_a_at">Co-activation of NF-κB and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability</a><div class="gs_gray">RR Barbosa, AQ Xu, D D’Andrea, F Copley, H Patel, P Chakravarty, ...</div><div class="gs_gray">bioRxiv<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1081632283000023166" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:H-3wYkpcA84C" class="gsc_a_at">Here to Stay: Biosimilars in Hematology</a><div class="gs_gray">J Gribben, G Merlini, A Hagenbeek</div><div class="gs_gray">HemaSphere 3 (6)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14152345263372374845" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pbQCAAeKvsAC" class="gsc_a_at">Sustained overall survival benefit of obinutuzumab plus bendamustine followed by obinutuzumab maintenance compared with bendamustine alone in patients with rituximab-refractory&nbsp;…</a><div class="gs_gray">LH Sehn, M Trněný, K Bouabdallah, G Dueck, JG Gribben, PJ Lugtenburg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7386189086813715678" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zGWyAL6qfKUC" class="gsc_a_at">Low treatment related mortality and relapse leading to excellent outcomes after allogeneic transplantation for acute lymphoblastic leukaemia using a non-myeloablative&nbsp;…</a><div class="gs_gray">ML Savoie, JK Davies, J Cavenagh, H Oakervee, J Sive, M Smith, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 144-145<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16815442554737819386" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:djft3U1LymYC" class="gsc_a_at">S844 KDM5 inhibition offers a novel therapeutic strategy for the treatment of kmt2d mutant lymphomas</a><div class="gs_gray">J Heward, L Koniali, A D’Avola, K Close, A Yeomans, P Johnson, ...</div><div class="gs_gray">HemaSphere 3 (S1), 376-377<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3097790857311940770,11095982253971115586" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PazO6pb-sMwC" class="gsc_a_at">PS1135 MONOCYTIC BUT NOT GRANULOCYTIC MDSCS INCREASE WITH IBRUTINIB BUT NOT ACALABRUTINIB TREATMENT IN EM-TCL1 MICE WITH CLL, SUGGESTING A ROLE FOR ITK INHIBITION IN MONOCYTIC&nbsp;…</a><div class="gs_gray">A Romero-Toledo, M Schwarzbich, R Sanderson, J Gribben</div><div class="gs_gray">HemaSphere 3 (S1), 514<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8385980295668652542" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SEKBqlyTJecC" class="gsc_a_at">AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO</a><div class="gs_gray">J Gribben, M Trneny, K Izutsu, NH Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">Hematological Oncology 37, 227-229<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16908943372913365961" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JhbybO29vGQC" class="gsc_a_at">LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA</a><div class="gs_gray">K Korfi, S Araf, F Bewicke‐Copley, E Kumar, T Cummin, M Ashton‐Key, ...</div><div class="gs_gray">Hematological Oncology 37, 142-143<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8604563116708216999" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0paDrhnEFY0C" class="gsc_a_at">Post hoc analyses of patients with relapsed/refractory marginal zone lymphoma who received lenalidomide plus rituximab (R2) vs rituximab/placebo (AUGMENT)</a><div class="gs_gray">C Thieblemont, J Leonard, M Trneny, K Izutsu, N Fowler, X Hong, ...</div><div class="gs_gray">Hematological Oncology 37, 226-227<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8446011312795502608" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QYmifXMdJWgC" class="gsc_a_at">Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma</a><div class="gs_gray">S Araf, J Wang, K Korfi, C Pangault, E Kotsiou, A Rio-Machin, T Rahim, ...</div><div class="gs_gray">Leukemia 33 (6), 1540<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12184547959972544831" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j6V8Syvup0UC" class="gsc_a_at">Tocilizumab to Prevent Infusion-Related Events in Patients with Chronic Lymphocytic Leukemia and Co-Morbidities Treated with Obinutuzumab and Chlorambucil: Results from the&nbsp;…</a><div class="gs_gray">CL Freeman, S Böttcher, J De la Serna, J Delgado, F Falzetti, M Gobbi, ...</div><div class="gs_gray">Blood 132, 4419<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10072102826467845699" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0Kh4an1R61UC" class="gsc_a_at">Modulation of T-Cell Function and Immune Phenotype in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Ibrutinib</a><div class="gs_gray">MA Schwarzbich, A Romero-Toledo, JG Gribben</div><div class="gs_gray">Blood 132, 3138<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6489843342256338633" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Dmoar05iI2YC" class="gsc_a_at">Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies</a><div class="gs_gray">W Jurczak, S Rule, W Townsend, D Tucker, B Sarholz, J Scheele, ...</div><div class="gs_gray">Annals of Oncology 29, viii362-viii363<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7689711965819986629" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8rLWgkbgOXQC" class="gsc_a_at">No longer too exhausted to run</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 132 (5), 464-465<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17486788719609149546" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J6OZcwVsj5AC" class="gsc_a_at">Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD eradication&nbsp;…</a><div class="gs_gray">T Munir, A Rawstron, K Brock, S Vicente, F Yates, R Bishop, C Fegan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6715571275583897811" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EsrhoZGmrkoC" class="gsc_a_at">Clinical manifestations, staging, and treatment of follicular lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Hematology, 1288-1297. e3<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2229471925151333472" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ON9TkA72AHEC" class="gsc_a_at">Longitudinal analyses of the genomic, transcriptomic, and T cell repertoire in diffuse large B cell lymphoma demonstrates changes in signaling and immune recognition at relapse</a><div class="gs_gray">S Araf, K Korfi, A Nagano, TEC Cummin, M Bentley, AR Thorner, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2734&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18402719214307028393" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:aU4yMueWZ3QC" class="gsc_a_at">Recurrent gene mutations and clinical outcome in the context of lenalidomide treatment of relapsed/refractory CLL—results from Multicenter Phase II Trial CLL-009</a><div class="gs_gray">V Opatrna, E Tausch, G Fraser, AS Michallet, P Hillmen, J Dürig, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 4311-4311<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10224673761720641158" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UKB2i6g6GNMC" class="gsc_a_at">Human Gastro-Intestinal Graft-Versus-Host Disease Is Mediated By Retinoic Acid-Responsive CD8<sup>+</sup> Effector T-Cells Under IL-23 Polarising Conditions</a><div class="gs_gray">JA Ball, AJ Clear, M Calaminici, A Stagg, J Lindsay, JG Gribben, J Davies</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 77-77<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7917579242784025017" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MqTxh1vmwXEC" class="gsc_a_at">Integrative Analysis of 1001 Diffuse Large B Cell Lymphoma Identifies Novel Oncogenic Roles for Rhoa</a><div class="gs_gray">J Zhang, A Reddy, N Davis, A Moffitt, C Love, A Waldrop, S Leppa, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 37-37<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5101621340615701400" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dhpJJ7xvgBgC" class="gsc_a_at">APPLICATION OF CELL‐OF‐ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV‐RELATED DIFFUSE LARGE B‐CELL LYMPHOMAS</a><div class="gs_gray">M Baptista, G Tapia, A Muñoz‐Marmol, J Muncunill, S Montoto, J Gribben, ...</div><div class="gs_gray">Hematological Oncology 35, 156-157<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14938202475958171411" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RgznTc0nqo4C" class="gsc_a_at">Minimal residual disease and outcomes in relapsed/refractory follicular lymphoma in the Phase III GADOLIN trial of obinutuzumab and bendamustine vs bendamustine</a><div class="gs_gray">C Pott, D Belada, N Danesi, GR Fingerle-Rowson, J Gribben, CG Harbron, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17976667130023406701" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J4E9jCG1tHUC" class="gsc_a_at">Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules</a><div class="gs_gray">E Kotsiou, JG Gribben, JK Davies</div><div class="gs_gray">Molecular Therapy 24 (6), 1126-1134<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4726343473961955445" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cOfwuRB03ygC" class="gsc_a_at">Proteomic Analysis Directs Effective Drug Selection in Relapsed AML By Quantifying Drug Targets</a><div class="gs_gray">DJ Britton, E Wilkes, P Casado, V Rajeeve, J Fitzgibbon, J Gribben, ...</div><div class="gs_gray">Blood 128 (22), 5265<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12266237157653051258" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j7XjBeKFbTsC" class="gsc_a_at">Genomic profiling reveals spatial heterogeneity in follicular lymphoma: implications for precision medicine</a><div class="gs_gray">S Araf, J Wang, C Pangault, E Kotsiou, E Hoxha, S Iqbal, J Davies, ...</div><div class="gs_gray">Haematologica 101, 270--270<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12006485500563036073" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Cvh0bltMcLgC" class="gsc_a_at">Overexpression of HMGB1 Receptor RAGE Is Associated with Worse Clinical Outcome in Patients with Chronic Lymphocytic Leukemia</a><div class="gs_gray">F Norster, AJ Clear, J Matthews, E Hoxha, J Gribben, L Jia</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 617-617<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10341829080399577421" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:B2rIPIGFPLEC" class="gsc_a_at">Validating the RNAscope for molecular profiling of key biomarkers associated with gemcitabine resistance</a><div class="gs_gray">EA Ghazaly, C Gnanaranjan, B Greenhalf, SP Blagden, P Mullen, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 3390-3390<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12117493373378130266" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uPCvBZYD9qUC" class="gsc_a_at">RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE 3 STUDY OF IBRUTINIB/OBINUTUZUMAB VS. CHLORAMBUCIL/OBINUTUZUMAB FOR TREATMENT-NAïVE CLL/SLL (PCYC-1130; ILLUMINATE): OT06</a><div class="gs_gray">C Moreno, I Flinn, D Gill, Y Shaw, Y Li, L Styles, D James, J Gribben</div><div class="gs_gray">Hematological Oncology 33<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17967976028689545632" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LWqeokA2EBkC" class="gsc_a_at">XV. Clinical aspects of transformed lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Hematological oncology 33, 80-83<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5769989890243185260" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jq04SsiGh3QC" class="gsc_a_at">AUGMENT: A randomized, phase 3 trial in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) to compare efficacy and safety of lenalidomide plus&nbsp;…</a><div class="gs_gray">J Leonard, JG Gribben, M Trněný, P Scheinberg, K Tobinai, NH Fowler, ...</div><div class="gs_gray">Journal of Clinical Oncology 33 (15_suppl), TPS8603-TPS8603<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9564158290848426115" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:a2necdfpwlEC" class="gsc_a_at"><i>TNFRSF14</i> aberrations in Follicular Lymphoma B Cells Result in Increased Alloresponses <i>in Vitro</i> and <i>in Vivo</i></a><div class="gs_gray">E Kotsiou, J Okosun, AJ Clear, S Iqbal, J Fitzgibbon, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2426-2426<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5217259867895703679" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BW2nPTmhBn4C" class="gsc_a_at">Aberrant PD-L1 expression in CLL as a result of adaptive immune resistance mediated by tumor-secreted circulating miRNA binding to Toll-like receptor 7</a><div class="gs_gray">F McClanahan, F Calore, N Zanesi, JG Gribben, CM Croce</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 716-716<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5162770854454210691" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zzCxg_vo7cAC" class="gsc_a_at">Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model</a><div class="gs_gray">B Hanna, F McClanahan, N Zaborsky, C Dürr, V Kalter, A Egle, ...</div><div class="gs_gray">Blood 124 (21), 3298<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2239653213261038947,836199380221152515" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin&nbsp;…</a><div class="gs_gray">A Davies, A Gopal, B Kahl, S de Vos, N Wagner-Johnston, S Schuster, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17716783121904051414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MDX3w3dAD3YC" class="gsc_a_at">Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma-response to Meissner et al.</a><div class="gs_gray">P Greaves, TA Lister, JG Gribben</div><div class="gs_gray">British journal of haematology 166 (4), 615-616<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9095606518667844043" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HqhvjgTjE9cC" class="gsc_a_at">SECOND RIC ALLOGENEIC TRANSPLANT AS A RESCUE STRATEGY FOR ACUTE LEUKAEMIA PATIENTS WHO RELAPSE AFTER AN INITIAL RIC ALLOGENEIC TRANSPLANTATION: ANALYSIS OF RISK FACTORS AND&nbsp;…</a><div class="gs_gray">R Vrhovac, M Labopin, F Ciceri, J Finke, E Holler, J Tischer, B Lioure, ...</div><div class="gs_gray">Bone Marrow Transplantation 49 (Suppl1), S194-S195<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7298777645316943544" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:17ZO-CJnx_8C" class="gsc_a_at">PD-1/PD-L1 mediated T-cell dysfunction in CLL is not absolute and can be at least partially reversed in vivo by the immune-modulatory drug lenalidomide</a><div class="gs_gray">F McClanahan, JC Riches, S Miller, E Ghazaly, W Day, M Capasso, ...</div><div class="gs_gray">Oncology Research and Treatment<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17220782046883572360" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:unp9ATQDT5gC" class="gsc_a_at">The sequence of events in diffuse large B-cell lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (7), 1097-1098<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9374369738675306128" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ehoypfNsBj8C" class="gsc_a_at">HMGB1 Activates TLR9/RAGE Signalling Pathway and Sustains Chronic Lymphocytic Leukemic Cell in Vitro Survival</a><div class="gs_gray">A Al-Malti, JG Gribben, L Jia</div><div class="gs_gray">Blood 120 (21), 3860<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11803570896115649510" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GHsHDPAyICYC" class="gsc_a_at">High Incidence of <i>EZH2</i> Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy</a><div class="gs_gray">C Böodöor, G Vera, A Kohlmann, K Tan, J Okosun, N Popov, S Araf, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 545-545<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15685131316563794417" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xGWFX6Gbr9MC" class="gsc_a_at">Inhibition of Autophagy by Chloroquine Sensitises Lymphoma Cells to ABT-737-Induced Apoptosis</a><div class="gs_gray">A McCarthy, V Yeung, JG Gribben, L Jia</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1625-1625<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17044793117327580270" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">The Clinical Course of Patients with Follicular Lymphoma in the Rituximab Era: A Paradigm Shift</a><div class="gs_gray">I El-Najjar, J Matthews, A Wilson, JG Gribben, S Montoto</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1580-1580<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13010371682586632874" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">Increased tonic PI3K signaling through p110α can limit the efficacy of P110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse</a><div class="gs_gray">S Iyengar, AJ Clear, C Bödör, L Maharaj, J Matthews, R Auer, S Iqbal, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1652-1652<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10033100762575647054" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Human Primary Mantle Cell Lymphoma Can Be Established in NOD/SCID/IL2Rγ-Null Mice</a><div class="gs_gray">S Iyengar, L Ariza-McNaughton, AJ Clear, A Roe, D Lillington, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 1565-1565<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5446916889388426123" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tz746QTLzJkC" class="gsc_a_at">Less expensive CARs?</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Cytotherapy 14 (7), 773-774<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16602705424504753313" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">The outcome of patients with follicular lymphoma in the rituximab era treated with autologous stem cell transplant according to the high-dose regimen received. A retrospective&nbsp;…</a><div class="gs_gray">I El-Najjar, A Boumendil, J Luan, C Thieblemont, D Blaise, K Thomson, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11945512456971638863" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qwy9JoKyICEC" class="gsc_a_at">Transplant in chronic lymphocytic leukemia: to do it or not and if so, when and how?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">American Society of Clinical Oncology Educational Book 32 (1), 399-404<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7314654294566691875" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Autocrine IL-6 production indicates the level of activated STAT3 and NF-kB of chronic lymphocytic leukemia cells</a><div class="gs_gray">F Liu, L Jia, TW Farren, JG Gribben, SG Agrawal</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 1784-1784<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13512936458146942539" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">CD137L reverse the immunological synapse defects of natural killer cells in acute myeloid leukemia</a><div class="gs_gray">D Xing, AG Ramsay, W Decker, DA Lee, S Robinson, N Shah, S Parmar, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 246-246<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11208537970795816353" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">The role of total body irradiation (TBI) in the high-dose regimen of patients with follicular lymphoma (FL) treated with autologous stem cell transplant (ASCT) in the rituximab&nbsp;…</a><div class="gs_gray">I El-Najjar, A Boumendil, JJ Luan, C Thieblemont, D Blaise, K Thomson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 502-502<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6353462831794489588" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yeL6HyUMUGUC" class="gsc_a_at">2.21 Autocrine Interleukin-6 Production Correlated with Survival of Chronic Lymphocytic Leukaemia Cells</a><div class="gs_gray">F Liu, L Jia, T Farren, J Gribben, S Agrawal</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 11, S172<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16863757449056884586" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OlbiQ0ttILcC" class="gsc_a_at">Clinical roundtable monograph</a><div class="gs_gray">MG Kris, SG Urba, LS Schwartzberg</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15336480473815938472" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Functional screening studies identify combinational activity of PD-L1 and CD200 in mediating dysfunctional T cell immunological synapse formation in chronic lymphocytic leukemia</a><div class="gs_gray">AG Ramsay, AJ Clear, A Davenport, R Fatah, JG Gribben</div><div class="gs_gray">Blood 116 (21), 696<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9081220216947616109" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Potentiation of bortezomib-induced killing of lymphoma cells by inhibition of autophagy and prevention of I-κBα degradation</a><div class="gs_gray">L Jia, G Gopinathan, JT Sukumar, JG Gribben</div><div class="gs_gray">Blood 116 (21), 116<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7417199747484210661" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jFemdcug13IC" class="gsc_a_at">Secondary myelodysplasia/acute myelogenous leukemia: Assessment of risk</a><div class="gs_gray">DG Gilliland, JG Gribben</div><div class="gs_gray">Molecular Hematology, 51-56<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2251172979751571804" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5bfplxN71z4C" class="gsc_a_at">Leukemia initiating cells from some acute myeloid leukemia patients with</a><div class="gs_gray">DC Taussig, J Vargaftig, F Miraki-Moud, E Griessinger, K Sharrock, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=690622729507360911" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DXE8ND7PrJAC" class="gsc_a_at">Interesting Times in the Diagnosis and Treatment of CLL</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray">Oncology 23 (12), 1043<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15414373723996038392" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Stem cell mimicry: key to transformation?</a><div class="gs_gray">E Carlotti, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (15), 3133-3134<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2535465849839630305" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Compared to Adult Peripheral Blood T Cells, Cord Blood T Cells Show Enhanced Immunological Recognition of Chronic Lymphocytic Leukemia Tumor Cells.</a><div class="gs_gray">AG Ramsay, DX Xing, WK Decker, JK Burks, WG Wierda, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2333-2333<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13313877130497960505" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Spleen Tyrosine Kinase (SYK) Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia</a><div class="gs_gray">M Buchner, S Fuchs, G Prinz, D Pfeifer, K Bartholomé, N Chevalier, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 543-543<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13238719341800656349" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Plasma Alemtuzumab Levels at End of Treatment Correlate with Response and Response Duration in Patients with CLL Receiving Treatment for Residual Disease.</a><div class="gs_gray">WG Wierda, TJ Kipps, MJ Keating, JR Brown, JG Gribben, LZ Rassenti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2109-2109<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9495593239916371873" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WGv8Og3F3KgC" class="gsc_a_at">New therapies in chronic lymphocytic leukemia</a><div class="gs_gray">JC Byrd, F Awan, TS Lin, MR Grever</div><div class="gs_gray">Chronic Lymphocytic Leukemia, 185-204<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13239272276623553292" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:E2bRg1zSkIsC" class="gsc_a_at">Infectious complications in patients with chronic lymphocytic Leukemia</a><div class="gs_gray">E Anaissie</div><div class="gs_gray">Chronic Lymphocytic Leukemia, 281-312<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12505657324522789636" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Stem Cell Transplantation in CLL</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Chronic Lymphocytic Leukemia, 205-220<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10330579245100736032" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:48xauSegjOkC" class="gsc_a_at">New agents in chronic lymphocytic leukemia.</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Clinical advances in hematology &amp; oncology: H&amp;O 6 (6), 409-10, 468<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11671875636330296433" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">38: Alloanergized HLA-Mismatched Bone Marrow Transplantation–Low Incidence of Clinically Significant GVHD and Viral Infection Resulting in Long Term Disease Free Survival</a><div class="gs_gray">J Davies, J Gribben, L Brennan, L Nadler, E Guinan</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 14 (2), 16-17<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8286626460706209415" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PklR0melJeUC" class="gsc_a_at">Non-Hodgkin's Lymphomas: New Insights and Therapeutic Strategies</a><div class="gs_gray">BD Cheson</div><div class="gs_gray">Hematology/oncology clinics of North America 22 (5)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3362977362341977945" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:otzGkya1bYkC" class="gsc_a_at">HSCT for low-grade non-Hodgkin’s lymphoma in adults</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Haematopoietic stem cell transplantation. The EBMT handbook, 5th edn. ESH&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11320616827158625138" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">CD3+/CD56+ Cells, but Not Natural Killer T Cells, Are Increased in Peripheral Blood of Untreated Patients with Leukemia.</a><div class="gs_gray">R Le Dieu, D Taussig, F MacDougal, A Lister, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1815-1815<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13561425605436740991" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Impaired Actin Polymerization Results in Defective Immunological Synapse Formation in T Cells in Chronic Lymphocytic Leukemia.</a><div class="gs_gray">AG Ramsay, AM Lee, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 338-338<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10957890890212709369" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Transplantation in chronic lymphocytic leukemia</a><div class="gs_gray">R Le Dieu, JG Gribben</div><div class="gs_gray">Current hematologic malignancy reports 2 (1), 56-63<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17346483110431218195" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dFKc6_kCK1wC" class="gsc_a_at">Increased CD68 and Decreased CD4 Expressing Cells in Tissue Microarray (TMA) in Diagnostic Lymph Node Biopsies Are Associated with Poor Outcome in CLL/SLL.</a><div class="gs_gray">AM Lee, A Clear, M Calaminici, F Macdougall, L Goff, JG Gribben</div><div class="gs_gray">Blood 108 (11), 2781<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1082669217670911411" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KqnX2w3egDsC" class="gsc_a_at">Relative Value of CD38 and ZAP-70 Versus Immunoglobulin Mutation Status in Predicting Early Disease Progression in Chronic Lymphocytic Leukemia.</a><div class="gs_gray">LZ Rassenti, DS Neuberg, L Huynh, WG Wierda, JG Gribben, JR Brown, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 2778-2778<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12978800517796925834" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Relative value of CD38 and ZAP-70 versus immunoglobutin mutation status in predicting early disease progression in chronic lymphocytic leukemia.</a><div class="gs_gray">LZ Rassenti, DS Neuberg, L Huynh, WG Wierda, JG Gribben, JR Brown, ...</div><div class="gs_gray">Blood 108 (11), 786A-787A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2208313275671000192" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:fF_gHTpLxhAC" class="gsc_a_at">Allogeneic Stem Cell Transplantation for Non-Hodgkin's and Hodgkin's Lymphoma</a><div class="gs_gray">R Le Dieu, JG Gribben</div><div class="gs_gray">The Lymphomas, 239-248<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=365315435653812734" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">CLL cells in TCL1 transgenic mice induce similar defects in CD4 and CD8 T cells to those observed in patients with CLL.</a><div class="gs_gray">G Gorgun, TAW Holderried, R Ledieu, D Zahrieh, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 50-50<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16725922640636314325" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Compositions and methods for diagnosing and treating chronic lymphocytic leukemia</a><div class="gs_gray">D Drandi, J Gribben, C Lee, P Dal Cin</div><div class="gs_gray">US Patent App. 10/984,723<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11811280482467043438" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Temporal gene expression after BCR-crosslinking based upon Zap70 related genomic features.</a><div class="gs_gray">LD Vallat, Y Park, L Rassenti, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 2795-2795<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1786291027233258872" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.</a><div class="gs_gray">KJ Savage, AP Weng, JL Kutok, G Pinkus, JG Gribben</div><div class="gs_gray">Blood 100 (11), 364B-364B<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9345454518133225015" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Chronic lymphocytic leukemia antigens elicit specific immune responses in the autologous host.</a><div class="gs_gray">M Witzens, AM Krackhardt, S Harig, AJ Zauls, JW Donovan, JG Gribben</div><div class="gs_gray">Blood 96 (11), 513A-513A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15655168560921377419" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:u-coK7KVo8oC" class="gsc_a_at">REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAK BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTILY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM).</a><div class="gs_gray">M Ladetto, P Omedè, S Sametti, A Pileri, M Astolfi, L Giaccone, F Giaretta, ...</div><div class="gs_gray">ASH American Society of Hematology 42nd annual meeting 96, 154-155<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13661516964459083102" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LK8CI43ZvvMC" class="gsc_a_at">Shared immunoglobulin framework-derived peptides function as cytotoxic T cell epitopes expressed commonly in B cell malignancies.</a><div class="gs_gray">A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, ...</div><div class="gs_gray">Blood 94 (10), 629A-629A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11550076374471507154" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Graft-versus-leukemia effects, mixed chimerism and early T-cell reconstitution in two patients with advanced stage chronic lymphocytic leukemia after pone marrow&nbsp;…</a><div class="gs_gray">A Kraus, TR Spitzer, S McAfee, R Sackstein, H Toh, P Multani, C Colby, ...</div><div class="gs_gray">Blood 94 (10), 349A-349A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8924500862863795694" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Generation of autologous T cell responses against CLL cells: Implications for immunotherapy.</a><div class="gs_gray">A Krackhardt, A Trojan, JG Gribben</div><div class="gs_gray">Blood 94 (10), 601A-601A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4864409295221740647" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nZcligLrVowC" class="gsc_a_at">Phase I study of RhuCD40 ligand (RhuCD40L) in cancer patients.</a><div class="gs_gray">RH Vonderheide, J Dutcher, G Eckhardt, JG Gribben, V Perry, D Caron, ...</div><div class="gs_gray">Blood 94 (10), 63A-63A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=167095300466644685" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Prospective analysis of residual disease in childhood acute lymphoblastic leukemia: Detection, quantitation and the utility of bone marrow versus peripheral blood samples.</a><div class="gs_gray">JW Donovan, C Poor, D Bowers, S Waters, S Sallan, JG Gribben</div><div class="gs_gray">Blood 92 (10), 481A-481A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6421119021154758477" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ehil0879vHcC" class="gsc_a_at">A novel method for assessing the dynamics of residual disease in B-cell malignancies by real-time quantitative PCR.</a><div class="gs_gray">JW Donovan, M Ladetto, JG Gribben</div><div class="gs_gray">Blood 92 (10), 223A-223A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=958664208668800111" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BzfGm06jWhQC" class="gsc_a_at">In the presence of a T cell receptor (TCR) signal, rapamycin but not cyclosporin-A, inhibits CD28 and IL-2 mediated pathways resulting in the induction of anergy.</a><div class="gs_gray">VA Boussiotis, A Berezovskaya, EC Guinan, JG Gribben, DL Barber, ...</div><div class="gs_gray">Blood 90 (10), 2505-2505<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13515986747869445934" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Predictive value of clonality analysis in patients with non-Hodgkin's lymphoma (NHL) undergoing autologous bone marrow transplant (ABMT): A single institution study.</a><div class="gs_gray">S MachPascual, RD Legare, D Lu, M Kroon, D Neuberg, RM Stone, ...</div><div class="gs_gray">Blood 90 (10), 2626-2626<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12386222897416128793" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">PCR monitoring of response in patients treated with high-dose chemotherapy for low-grade lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Advances in Lymphoma Research, 141-160<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6315577476178028862" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Activation of follicular lymphoma through CD40 upregulates BCL-X (L) thereby promoting survival.</a><div class="gs_gray">P Ghia, VA Boussiotis, S Manie, AA Cardoso, JG Gribben, AS Freedman, ...</div><div class="gs_gray">Blood 88 (10), 2672-2672<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1148571920124241733" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">CD6 depleted allogeneic and syngeneic bone marrow transplantation (BMT) for non-Hodgkin's lymphoma.</a><div class="gs_gray">RJ Soiffer, D Neuberg, AS Freedman, EP Alyea, DC Fisher, ...</div><div class="gs_gray">Blood 88 (10), 2719-2719<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6487152569141171208" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Follicular lymphoma cells stimulated through CD40 can prime alloantigen-specific T cell responses against primary malignant cells</a><div class="gs_gray">JL Schultze, AA Cardoso, M Seamon, GJ Freeman, JG Gribben, ...</div><div class="gs_gray">Journal of Cancer Research and Clinical Oncology 121 (1), A8-A8<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7102560201716200127" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CLL UNDERGOING BMT USING CDRIII REGION-SPECIFIC OLIGONUCLEOTIDE PROBES</a><div class="gs_gray">A Provan, L BARTLETTPANDITE, P CORRADINI, LM Nadler, JG Gribben</div><div class="gs_gray">Blood 84 (10), A203-A203<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15423108649661061773" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jgBuDB5drN8C" class="gsc_a_at">CLONAL HEMATOPOIESIS IS PREDICTIVE OF SECONDARY MYELODYSPLASIA IN AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) FOR NON-HODGKINS-LYMPHOMA (NHL)</a><div class="gs_gray">R Legare, JG Gribben, L Busque, M Maragh, L NADLER, DG Gilliland</div><div class="gs_gray">Blood 84 (10), A495-A495<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12478491775539679583" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">MOST FOLLICULAR LYMPHOMAS DO NOT STIMULATE AN ALLOGENEIC T-CELL PROLIFERATIVE RESPONSE</a><div class="gs_gray">JL Schultze, AA Cardoso, M SEAMON, GJ FREEMAN, JG GRIBBEN, ...</div><div class="gs_gray">Blood 84 (10), A521-A521<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17770885718579037231" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:H7nrzBkawXsC" class="gsc_a_at">HUMAN ALLOANTIGEN-SPECIFIC CLONAL ANERGY TO LYMPHOBLASTOID-CELLS IS REVERSED FOLLOWING CULTURE WITH IL-2 OR IL-4</a><div class="gs_gray">V Boussiotis, G FREEMAN, J GRIBBEN, L NADLER</div><div class="gs_gray">Blood 82 (10), A304-A304<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16931453882204317193" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">ANTI-B4-BLOCKED RICIN (ANTI-B4-BR) THERAPY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR B-CELL NON-HODGKINS-LYMPHOMA (B-NHL)-UPDATE OF PHASE-I/II TRIALS</a><div class="gs_gray">ML Grossbard, S ODAY, JG Gribben, AS Freedman, SN Rabinowe, ...</div><div class="gs_gray">Blood 82 (10), A444-A444<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6257615659679417613" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">BLOCKADE OF THE B7 FAMILY OF COSTIMULATORY MOLECULES SIGNIFICANTLY REDUCES ALLOREACTIVE PRECURSOR T-CELLS CAPABLE OF INDUCING GVHD</a><div class="gs_gray">J GRIBBEN, V Boussiotis, G Freeman, G Gray, L Nadler</div><div class="gs_gray">Blood 82 (10), A456-A456<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3780483426816275952" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Double Autografting in First Remission Acute Myeloid Leukaemia</a><div class="gs_gray">AH Goldstone, JG Gribben, DC Linch</div><div class="gs_gray">Folia haematologica (Leipzig, Germany: 1928) 116 (3-4), 501-504<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2000342506784622298" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:E7VqQtBCVmcC" class="gsc_a_at">CENTRAL NERVOUS-SYSTEM INVOLVEMENT IN PATIENTS RECEIVING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS LYMPHOMA</a><div class="gs_gray">JG Gribben, AH Goldstone, L Dones</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (6), 863-863<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13253901086227026401" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QaSi33NTfwYC" class="gsc_a_at">AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELID LEUKEMIA-THE GLASGOW EXPERIENCE</a><div class="gs_gray">AK Burnett, JG Gribben, G Dolan</div><div class="gs_gray">INTERNATIONAL JOURNAL OF CELL CLONING 3 (4), 252-254<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16081421257956574521" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qQc65DSaYXMC" class="gsc_a_at">A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies</a><div class="gs_gray">GP Collins, TN Clevenger, KA Burke, B Yang, A MacDonald, ...</div><div class="gs_gray">Leukemia &amp; Lymphoma, 1-12<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:k6nH7jlkaTkC" class="gsc_a_at">Dynamic contrast-enhanced magnetic resonance imaging quantification of leukemia-induced changes in bone marrow vascular function</a><div class="gs_gray">AL Gomes, J Gribben, B Siow, D Passaro, D Bonnet</div><div class="gs_gray">haematologica 106 (8), 2281<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DrOLxFoABAwC" class="gsc_a_at">Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice</a><div class="gs_gray">FR Delvecchio, REA Fincham, S Spear, A Clear, M Roy-Luzarraga, ...</div><div class="gs_gray">Cellular and Molecular Gastroenterology and Hepatology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:n8FNryW2AHIC" class="gsc_a_at">Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia</a><div class="gs_gray">K Edwards, K Zaitseva, U Sayed, EV Volpi, A Nathwani, JG Gribben, ...</div><div class="gs_gray">British Journal of Haematology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:l7iSsH4_Im4C" class="gsc_a_at">Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE&nbsp;…</a><div class="gs_gray">R Greil, A Tedeschi, C Moreno, B Anz, L Larratt, M Simkovic, D Gill, ...</div><div class="gs_gray">Annals of Hematology 100 (7), 1733-1742<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qOpkhvVCMvUC" class="gsc_a_at">The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia</a><div class="gs_gray">MB Mansur, CL Furness, S Nakjang, A Enshaei, D Alpar, SM Colman, ...</div><div class="gs_gray">Cancer Medicine<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0iM-huCvmk0C" class="gsc_a_at">Building of The G0-CAR-T Initiative to Promote Use of Data Collected from Patients Treated With CAR-T Cells AT EU OR EBMT Affiliated Programs</a><div class="gs_gray">C Chabannon, S Terwel, JD Hoogenboom, G Basak, S Corbacioglu, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 43-44<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wE8AsS3ykUMC" class="gsc_a_at">Trends in Autologous Stem Cell Mobilisation Practices in Myeloma Patients in Ebmt Centers Between 2008 And 2017</a><div class="gs_gray">J Dillon, PJ Hayden, DJ Eikema, L Koster, D Blaise, E Nicholson, V Potter, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 327-328<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MtS25d97-7AC" class="gsc_a_at">OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY</a><div class="gs_gray">P Ghione, H Ghesquieres, S Bobillo, AR Patel, S Kanters, K Deighton, ...</div><div class="gs_gray">Hematological Oncology 39<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KPAPMsW7zc0C" class="gsc_a_at">The EHA2021 Annual Congress Award Winners: Celebrating Excellence in Hematology</a><div class="gs_gray">J Gribben, E Macintyre, P Sonneveld</div><div class="gs_gray">HemaSphere 5 (6)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0kLwNjf3oFwC" class="gsc_a_at">Predictive phosphoproteomic signatures for midostaurin plus chemotherapy response in FLT3 mutant positive acute myeloid leukaemia.</a><div class="gs_gray">AD Dokal, A Arruda, R Smith, C Greenhalgh, F Patella, ...</div><div class="gs_gray">Journal of Clinical Oncology 39 (15_suppl), 7019-7019<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Qh5Z_vBjo80C" class="gsc_a_at">Integrated OMICs unveil the bone-marrow microenvironment in human leukemia</a><div class="gs_gray">D Passaro, M Garcia-Albornoz, G Diana, P Chakravarty, ...</div><div class="gs_gray">Cell reports 35 (6), 109119<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:P-MJmu9ZMwQC" class="gsc_a_at">Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways</a><div class="gs_gray">J Edelmann, AD Dokal, E Vilventhraraja, K Holzmann, D Britton, ...</div><div class="gs_gray">Iscience 24 (2), 102089<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:n1qY4L4uFdgC" class="gsc_a_at">CKS1-dependent proteostatic regulation has dual roles combating acute myeloid leukemia whilst protecting normal hematopoiesis</a><div class="gs_gray">W Grey, A Rio-Machin, P Casado-Izquierdo, J Miettinen, F Copley, ...</div><div class="gs_gray">bioRxiv, 2020.12. 27.423419<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:INdAjOZKYREC" class="gsc_a_at">Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the&nbsp;…</a><div class="gs_gray">J de la Fuente, DJ Eikema, P Bosman, RF Wynn, M Diaz, PJ Shaw, ...</div><div class="gs_gray">Blood 136, 45-47<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0qX8s2k1IRwC" class="gsc_a_at">Immune System Deregulation Predicts Outcome in Diffuse Large B Cell Lymphoma (DLBCL)</a><div class="gs_gray">E Truelove, JG Taylor, AJ Clear, M Calaminici, JG Gribben</div><div class="gs_gray">Blood 136, 33-34<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Cy13deThEpcC" class="gsc_a_at">Multiplatform Profiling Characterizes Functional Networks in Genomically Stable and Instable Chronic Lymphocytic Leukemia</a><div class="gs_gray">J Bloehdorn, A Braun, BMC Jebaraj, A Taylor-Weiner, S Robrecht, ...</div><div class="gs_gray">Blood 136, 12-13<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WTSGYGHz1bkC" class="gsc_a_at">Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings</a><div class="gs_gray">JF Seymour, JG Gribben, MS Davids, A Mato, JP Sharman, A Cyr, ...</div><div class="gs_gray">Blood 136, 37-38<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HmWvvuJwtxYC" class="gsc_a_at">Subgroup analyses of patients aged&gt;= 70 years in AUGMENT: Phase III randomized study of Lenalidomide plus rituximab (R-2) vs rituximab plus placebo (R-placebo) in patients with&nbsp;…</a><div class="gs_gray">P La Rosee, U Graeven, JP Leonard, J Gribben, H Zhang, G Nowakowski, ...</div><div class="gs_gray">ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 68-68<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6ScxedgR18sC" class="gsc_a_at">Marrow Contamination: Immunological Treatment</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Autologous Stem Cell Transplantation, 137-145<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dT4-KZ621vcC" class="gsc_a_at">Targeting SET‐PP2A complex as a new avenue of treatment for Mixed Lineage Leukemia (MLL) treatment</a><div class="gs_gray">A Di Mambro, Y Arroyo, Y Calle, B Wrench, J Gribben, MT Esposito</div><div class="gs_gray">British Journal of Haematology 189 (S1), 51<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pe4chHNxNLUC" class="gsc_a_at">The Haematology Summit 2014-2019: evolution of a national medical education programme</a><div class="gs_gray">N Prynn, G Jackson, J Gribben, G Follows, L McDougall</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 62-63<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZYLUaBFA95QC" class="gsc_a_at">Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?</a><div class="gs_gray">JG Gribben, E de Vries, NI Cherny, P Sonneveld</div><div class="gs_gray">HemaSphere 4 (2)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:v7SMsomtfXcC" class="gsc_a_at">Ibrutinib plus venetoclax in Relapsed/Refractory CLL: The CLARITY Study</a><div class="gs_gray">T Munir, A Rawstron, K Brock, S Munoz-Vicente, F Yates, R Bishop, ...</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 61, 227-228<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:i6LplTXqhpIC" class="gsc_a_at">O123: 25 Years of Autologous Transplantation for Myeloma in Ebmt Centres-Changing Practice Patterns</a><div class="gs_gray">PJ Hayden, DJ Eikema, L Koster, H Goldschmidt, D Blaise, M Potter, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 130-132<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LzOrNEA7mwcC" class="gsc_a_at">Dynamic regulation of hierarchical heterogeneity in Acute Myeloid Leukemia serves as a tumor immunoevasion mechanism</a><div class="gs_gray">C Pospori, W Grey, S Gonzalez-Anton, SV Gibson, C Georgiou, F Birch, ...</div><div class="gs_gray">bioRxiv<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:plAW456RD7MC" class="gsc_a_at">CAR T Cells Derived from Healthy Mice Lead to Cytokine Release Syndrome (CRS) in the TCL1 Chronic Lymphocytic Leukemia Model; Mice with CLL Treated with Acalabrutinib or&nbsp;…</a><div class="gs_gray">R Sanderson, A Romero-Toledo, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mo9XK3BEATIC" class="gsc_a_at">Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT</a><div class="gs_gray">J Aries, S Charrot, J Ball, M Mee, S Theocharidis, S Van Gassen, S Iqbal, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Wqn_fehR_TUC" class="gsc_a_at">Treatment with Acalibrutinib, Ibrutinib and CD19 CAR T Cells Restore the Number of Granulocytic Myeloid Derived Supressor Cells in CLL-Bearing Mice</a><div class="gs_gray">A Romero-Toledo, R Sanderson, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:O0MA3yP7Y3UC" class="gsc_a_at">CRISPR/Cas9-Targeted De Novo DNA Methylation Is Maintained and Impacts the Colony Forming Potential of Human Hematopoietic CD34+ Cells</a><div class="gs_gray">EA Saunderson, K Rouault-Pierre, JG Gribben, G Ficz</div><div class="gs_gray">Blood 134, 2517<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ef2wPL15CskC" class="gsc_a_at">Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel</a><div class="gs_gray">F Bewicke-Copley, K Korfi, S Araf, EA Kumar, TEC Cummin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Sf6vrWCRp3YC" class="gsc_a_at">The Immune Micro-Environment in Diffuse Large B Cell Lymphoma Is Characterised By an Immunosuppressive Shift in T Cell Subsets</a><div class="gs_gray">E Truelove, F Seymour, JG Taylor, M Calaminici, AJ Clear, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rp474-M6Y4oC" class="gsc_a_at">Rituximab and Obinutuzumab Induce Direct B-Cell Death Via B-Cell Receptor (BCR) Signaling, but Rituximab Elicits Stronger BCR-Derived Pro-Survival Signals Diminishing Apoptosis</a><div class="gs_gray">J Edelmann, A Dokal, K Holzmann, DJ Britton, E Vilventhraraja, RJ Smith, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JaLtl8ASYokC" class="gsc_a_at">Beyond Exhaustion: The PDL1-PD1 Axis Shapes the Classical Hodgkin Lymphoma Microenvironment</a><div class="gs_gray">JG Taylor, AJ Clear, E Truelove, M Calaminici, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qkm5LKljiV4C" class="gsc_a_at">Lymphoma genetics</a><div class="gs_gray">JL Crombie, A Letai, JG Gribben</div><div class="gs_gray">Molecular Hematology, 101-110<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-c_eYhz9dBkC" class="gsc_a_at">The molecular biology of chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Molecular Hematology, 111-120<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:h-xndbdg2koC" class="gsc_a_at">Novel mass cytometry analysis identifies reciprocal changes in NKREG and CD4EM as the dominant early immune reconstitution signature associated with subsequent acute GVHD after&nbsp;…</a><div class="gs_gray">J Aries, J Ball, S Charrot, M Mee, S Van Gassen, S Iqbal, J Gribben, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 117-118<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Np1obAXpBq8C" class="gsc_a_at">S898 CD19+ RELAPSE POST CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IS DETERMINED BY T CELL FITNESS</a><div class="gs_gray">R Sanderson, A Romero-Toledo, J Gribben</div><div class="gs_gray">HemaSphere 3 (S1), 404-405<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2mikiJ1VBVsC" class="gsc_a_at">PS1252 PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO (AUGMENT)</a><div class="gs_gray">J Gribben, M Trneny, K Izutsu, NH Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">HemaSphere 3 (S1), 571-572<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Amrzk_ktLr0C" class="gsc_a_at">PS1000 POST-TRANSLATIONAL MODIFICATIONS OF PROTEIN PHOSPHATASE 2A (PP2A) IN MIXED LINEAGE LEUKEMIA (MLL)</a><div class="gs_gray">Y Arroyo-Berdugo, A Di Mambro, Y Calle-Patino, B Wrench, J Gribben, ...</div><div class="gs_gray">HemaSphere 3 (S1), 450<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-ZoC36zw86wC" class="gsc_a_at">PS1262 POST HOC ANALYSIS OF THE AUGMENT PHASE III RANDOMIZED STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE&nbsp;…</a><div class="gs_gray">C Thieblemont, JP Leonard, M Trneny, K Izutsu, NH Fowler, X Hong, ...</div><div class="gs_gray">HemaSphere 3 (S1), 577-578<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:V63Ir2N1OTwC" class="gsc_a_at">PF642 REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS A SAFE AND EFFECTIVE TREATMENT OPTION IN HIGH RISK MYELOMA PATIENTS–A SINGLE CENTRE EXPERIENCE</a><div class="gs_gray">A Jurgensen-Rauch, S Gibbs, M Farrell, J Cavenagh, L Eccersley, ...</div><div class="gs_gray">HemaSphere 3 (S1), 274<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xm1hsP5ya-EC" class="gsc_a_at">S899 INHIBITION OF C3 WITH APL-2 CONTROLS HAEMOLYSIS AND INCREASES HAEMOGLOBIN LEVELS IN SUBJECTS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA)</a><div class="gs_gray">M Gertz, E Roman, B Fattizzo, M Shum, W Hanna, G Ortega, D Liles, ...</div><div class="gs_gray">HemaSphere 3 (S1), 405<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UY3hNwcQ290C" class="gsc_a_at">PF241 TARGETING SET-PP2A INTERACTION AS A NOVEL THERAPEUTIC APPROACH FOR MIXED LINEAGE LEUKEMIA (MLL)</a><div class="gs_gray">A Di Mambro, Y Arroyo-Berdugo, Y Calle-Patino, B Wrench, J Gribben, ...</div><div class="gs_gray">HemaSphere 3 (S1), 72-73<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gL9scSG3K_gC" class="gsc_a_at">Efficacy and time to next treatment following lenalidomide/rituximab (R<sup>2</sup>) or rituximab/placebo in patients with R/R indolent NHL (AUGMENT).</a><div class="gs_gray">JG Gribben, K Izutsu, NH Fowler, X Hong, H Zhang, F Offner, ...</div><div class="gs_gray">Journal of Clinical Oncology 37 (15_suppl), 7514-7514<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:J-ba04ztB30C" class="gsc_a_at">SAT-LB056 Is AIP a Tumor Suppressor or an Oncogene? AIP as a Novel Regulator of the Oncogene BCL6 in Diffuse Large B Cell Lymphoma</a><div class="gs_gray">S BARRY, D Sun, U Stopka-Farooqui, E Aksoy, G Parsonage, ...</div><div class="gs_gray">Journal of the Endocrine Society 3 (Supplement_1), SAT-LB056<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VHM5RxzNINsC" class="gsc_a_at">Lenalidomide/rituximab (R2) versus rituximab/placebo efficacy by POD24 status and time to next treatment in patients with relapsed/refractory indolent NHL (AUGMENT)</a><div class="gs_gray">A Pinto, J Gribben, M Trneny, K Izutsu, NH Fowler, X Hong, H Zhang, ...</div><div class="gs_gray">47th Congress of the Italian Society of Hematology 104 (suppl. 2), 7-8<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:t9Ks5LMjN0QC" class="gsc_a_at">Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the Bloodwise TAP Clarity study</a><div class="gs_gray">T Munir, A Rawstron, K Brock, S Vicente, F Yates, R Bishop, D Macdonald, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_TjUWtciUekC" class="gsc_a_at">Phase III randomized AUGMENT study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with relapsed/refractory indolent non-hodgkin lymphoma</a><div class="gs_gray">J Gribben, M Trneny, K Izutsu, NH Fowler, X Hong, J Zhu, H Zhang, ...</div><div class="gs_gray">59th Annual Scientific Meeting of the British-Society-for-Hematology 185, 79-79<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RdUpO4xyVKMC" class="gsc_a_at">Ibrutinib plus Obinutuzumab Versus Chlorambucil plus Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL&nbsp;…</a><div class="gs_gray">C Moreno, R Greil, F Demirkan, A Tedeschi, B Anz, L Larratt, M Simkovic, ...</div><div class="gs_gray">BLOOD 132<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JavbeY_VQWIC" class="gsc_a_at">Anti-CD20 Monoclonal Antibodies Hijack the B-Cell Receptor Signaling Cascade Thereby Activating the NOTCH1 Signaling Pathway</a><div class="gs_gray">J Edelmann, DJ Britton, E Vilventhraraja, A Dokal, K Holzmann, ...</div><div class="gs_gray">Blood 132, 588<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:puFLaqDw8dcC" class="gsc_a_at">Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma</a><div class="gs_gray">E Truelove, F Seymour, J Matthews, JG Gribben</div><div class="gs_gray">Blood 132, 2863<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ibZ2AwG9z6wC" class="gsc_a_at">Immunoglobulin Variable Region Gene Sequences Reveal N-Glycosylation Motifs As an Early and Stable Event in Follicular Lymphoma Pathology</a><div class="gs_gray">M Odabashian, E Carlotti, S Araf, J Okosun, F Forconi, FK Stevenson, ...</div><div class="gs_gray">Blood 132, 4101<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oE_QS-WwsdAC" class="gsc_a_at">B-Cell Receptor Signaling Drives Glycolysis in Chronic Lymphocytic Leukemia Cells</a><div class="gs_gray">AJ Clear, A D'Avola, SG Agrawal, LZ Rassenti, TJ Kipps, JG Gribben, ...</div><div class="gs_gray">Blood 132, 3121<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7XUxBq3GufIC" class="gsc_a_at">The Treg/Th17 Axis Is Skewed in Classical Hodgkin Lymphoma By PDL1+ Ve but Not PDL1-Ve Lymphoma Cells and By Lymphoma MHC Class 2 Expression.</a><div class="gs_gray">JG Taylor, AJ Clear, J Matthews, M Calaminici, JG Gribben</div><div class="gs_gray">Blood 132, 4124<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2_BaaiyHPJIC" class="gsc_a_at">Exhausted CLL T Cells Mediated By PD1 Expression an Important Mechanism for CD19 CAR Efficacy in CLL in the Adoptive Transfer TCL1 Mouse Model</a><div class="gs_gray">R Sanderson, A Romero-Toledo, JG Gribben</div><div class="gs_gray">Blood 132, 4537<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CKf5m1HYVjMC" class="gsc_a_at">The Lancet Haematology Commission</a><div class="gs_gray">G Thanarajasingam, LM Minasian, F Baron, F Cavalli, RA De Claro, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Pqt4MY__2vwC" class="gsc_a_at">Adipocyte Induced Antagonism of ALL Growth Highlights a Novel Inhibitory Niche and Potential Therapeutic Opportunity</a><div class="gs_gray">N Warrick, F Miraki-Moud, A Aicher, LA McNaughton, P Casado-Izquierdo, ...</div><div class="gs_gray">Blood 130, 371<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:h9G0ZmjYpDoC" class="gsc_a_at">Increased Levels of Soluble RAGE in CLL Patient Plasma Has a Protective Effect on CLL Disease Progression</a><div class="gs_gray">F Norster, R Petty, JG Gribben, L Jia</div><div class="gs_gray">Blood 130 (Supplement 1), 4292-4292<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sYWwZaPVD1oC" class="gsc_a_at">Sustained Reduction of Intracellular Calcium Is Important to Maximise GA101-Mediated Direct Cell Death in B-Cell Lymphomas</a><div class="gs_gray">E Vilventhraraja, J Edelmann, F Norster, A Braun, JG Gribben, P Cutillas, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 1269&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JIEWM9yDoCIC" class="gsc_a_at">Response to the EZH2 Inhibitor Tazemetostat Is Independent of Cell of Origin Determined Via Hans Imunohistochemistry or Nanostring Lymphoma Subtyping Test in EZH2 Wild-Type&nbsp;…</a><div class="gs_gray">AA McDonald, F Morschhauser, V Ribrag, P McKay, G Salles, H Tilly, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2745&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Oo_WeVVXg5wC" class="gsc_a_at">Rituximab Activates NOTCH1 Signaling in CLL Cells and Induces Changes in the Cytokine Repertoire Favoring a Tumor-Protective Microenvironment</a><div class="gs_gray">J Edelmann, K Holzmann, D DiBella, E Vilventhraraja, SA Beers, M Cragg, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2996&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:f2PrUAIjnKUC" class="gsc_a_at">High-Resolution SNP-Array Profiling of Ultra-High Risk CLL Cases Reveals New Recurrent Genomic Alterations</a><div class="gs_gray">J Edelmann, K Holzmann, E Tausch, A Dolnik, TJ Blätte, S Ibach, J Saub, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 2992-2992<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bbjcffOLshcC" class="gsc_a_at">The Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: An Analysis By the EBMT Complications and&nbsp;…</a><div class="gs_gray">M Jagasia, HT Greinix, E Beohou, S van der Werf, D Niederwieser, ...</div><div class="gs_gray">Blood 130 (Supplement 1), 3324-3324<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lPDSu1ZU3VAC" class="gsc_a_at">p. P2514fs mutant NOTCH1 has longer lasting transcription factor activity due to slower inactivation and degradation</a><div class="gs_gray">J Edelmann, C Lu, T Klymenko, E Vilventhraraja, S Estenfelder, E Tausch, ...</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 58, 67-68<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:svGagg1hbZMC" class="gsc_a_at">The initial report of the bloodwise tap clarity study combining ibrutinib and venetoclax in relapsed, refractory CLL shows acceptable safety and promising early indications of&nbsp;…</a><div class="gs_gray">S Munoz-Vicente, R Bishop, P Hillmen, T Munir, A Rawstron, K Brock, ...</div><div class="gs_gray">LEUKEMIA &amp; LYMPHOMA 58, 239-239<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JdL-Xu2nR38C" class="gsc_a_at">ACUTE MYELOID LEUKEMIA ALTERS THE PERMEABILITY OF THE BONE MARROW VASCULAR MICROENVIRONMENT, FOSTERING DISEASE PROGRESSION AND DRUG RESISTANCE</a><div class="gs_gray">D Passaro, A Di Tullio, A Abarrategi, K Rouault-Pierre, K Foster, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 78-78<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wlzmIqt2EaEC" class="gsc_a_at">ALLORESPONSES OF HUMAN T-CELLS FROM ADULT PERIPHERAL BLOOD AND UMBILICAL CORD BLOOD ARE DIFFERENTIALLY IMPACTED BY LENALIDOMIDE-IMPLICATIONS FOR AHSCT</a><div class="gs_gray">C Besley, E Kotsiou, R Petty, A Sangaralingam, C Chelala, E Ghazaly, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 638-638<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZYsTHYU9jrMC" class="gsc_a_at">CYTOTOXIC LYMPHOCYTES IN NEWLY DIAGNOSED MYELOMA HAVE REVERSIBLE FUNCTIONAL AND PHENOTYPIC ABNORMALITIES THAT MAY OFFER THERAPUTIC OPPORTUNITIES</a><div class="gs_gray">F Seymour, J Cavenagh, J Gribben</div><div class="gs_gray">HAEMATOLOGICA 102, 498-498<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gkldIfsazJcC" class="gsc_a_at">PHOSPHOPROTEOMICS AND MASS CYTOMETRY SIGNATURES OF PRIMARY AML CELL DIFFERENTIATION ARE ASSOCIATED WITH SENSITIVITY TO KINASE INHIBITORS</a><div class="gs_gray">P Casado-Izquierdo, EH Wilkes, F Miraki-Moud, MM Hadi, A Rio-Machin, ...</div><div class="gs_gray">HAEMATOLOGICA 102, 203-203<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qSd0DAb9jMoC" class="gsc_a_at">INTRACELLULAR CALCIUM AND METABOLISM HAVE CRITICAL ROLES IN DETERMINING ANTI-CD20 ANTIBODY EFFICACY IN DLBCL</a><div class="gs_gray">E Vilventhraraja, J Gribben, A Braun</div><div class="gs_gray">HAEMATOLOGICA 102, 567-567<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6pF0wJmtdfAC" class="gsc_a_at">MICROENVIRONMENT SECRETED PROTEINS MEDIATE RESISTANCE TO TARGETED THERAPY IN PRIMARY AML CELLS</a><div class="gs_gray">A Dokal, J Gribben, P Cutillas</div><div class="gs_gray">HAEMATOLOGICA 102, 358-358<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RVqaWcrwK10C" class="gsc_a_at">Restoring leukemia cell function from the inside out</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 129 (24), 3137-3138<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4Wrxgq2JVp0C" class="gsc_a_at">YourTreatmentChoices: Fast Access to Trials Programme</a><div class="gs_gray">J Radford, J Gribben, P Johnson, R Malladi, S Neeson, B Asfaw, ...</div><div class="gs_gray">Hematological Oncology 35, 272-273<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mJbmKSuM8toC" class="gsc_a_at">Chronic lymphocytic leukemia</a><div class="gs_gray">FMC Lucas, J Gribben</div><div class="gs_gray">Clinical Manual of Blood and Bone Marrow Transplantation, 123-130<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:e0LTWoPxLYMC" class="gsc_a_at">No evidence for an increased GVHD risk associated with post-transplant Idelalisib given for relapse of chronic lymphocytic leukemia or lymphoma: First results of a survey by&nbsp;…</a><div class="gs_gray">P Dreger, A Boumendil, L Koster, C Scheid, J Passweg, H Veelken, ...</div><div class="gs_gray">Bone Marrow Transplantation 52 (Suppl1), S424-S425<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Mx5hWS9ctUkC" class="gsc_a_at">NUCLEAR LAMINA REGULATES SOMATIC HYPERMUTATION AND PROGRESSION OF B CELL MALIGNANCIES</a><div class="gs_gray">T Klymenko, J Bloehdorn, J Bahlo, S Robrecht, J Wang, K Fischer, ...</div><div class="gs_gray">Haematologica 102, 228-229<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:I2jIoRS3jIgC" class="gsc_a_at">Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells</a><div class="gs_gray">FMC Lucas, JG Gribben</div><div class="gs_gray">The Immune Synapse, 533-544<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IExZWSxeYXUC" class="gsc_a_at">THE ROLE OF WATCH AND WAIT IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: SINGLE CENTRE DATA FROM THE MODERN ERA</a><div class="gs_gray">A Navarro-Bailon, JG Taylor, J Matthews, S Montoto, JG Gribben</div><div class="gs_gray">HAEMATOLOGICA 101, 64-64<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1l3MdapXzAoC" class="gsc_a_at">Antibody Immunotherapy treatment for adults with B-Acute Lymphoblastic Leukaemia–A Real-World Analysis</a><div class="gs_gray">T Dexter, J Aries, B Sevillano, J Gribben, H Oakervee, J Cavenagh, ...</div><div class="gs_gray">N Eng J Med 375 (8), 740-53<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:GUYAmugLYisC" class="gsc_a_at">EXPLOITING OXIDATIVE PHOSPHORYLATION TO IMPROVE ANTIBODY THERAPY OF LYMPHOMA</a><div class="gs_gray">E Vilventhraraja, J Gribben, A Ivanov</div><div class="gs_gray">HAEMATOLOGICA 101, 574-575<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yCjxvIMm6_oC" class="gsc_a_at">PROTEOMIC ANALYSIS OF RELAPSE AML IDENTIFIES OPPORTUNITIES FOR THERAPEUTIC INTERVENTION IN INDIVIDUAL PATIENTS</a><div class="gs_gray">D Britton, P Casado, V Rajeeve, E Wilkes, R Smith, J Fitzgibbon, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 373-373<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:o9ULDYDKYbIC" class="gsc_a_at">HETEROTYPIC SIGNALLING BETWEEN BONE MARROW STROMAL CELLS AND BLASTS PROVIDES INSIGHT INTO THE CELLULAR COMMUNICATION IN ACUTE MYELOID LEUKAEMIA</a><div class="gs_gray">A Dokal, J Gribben, P Cutillas</div><div class="gs_gray">HAEMATOLOGICA 101, 369-369<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vofGIMt6cyEC" class="gsc_a_at">MICRORNAS HSA-LET-7A AND MIR-142-3P IN T CELLS IN PATIENTS PRESENTING WITH ACUTE MYELOID LEUKAEMIA-A MEANS OF REPAIRING TUMOUR-INDUCED T CELL DEFECTS?</a><div class="gs_gray">R Petty, X Zhang, C Ivan, G Calin, J Gribben, R Le Dieu</div><div class="gs_gray">HAEMATOLOGICA 101, 364-365<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MNNNGtAgD4EC" class="gsc_a_at">Minimal residual disease analysis in patients with follicular lymphoma treated with obinutuzumab plus bendamustine versus bendamustine alone in GADOLIN, a phase III study of&nbsp;…</a><div class="gs_gray">C Pott, D Belada, N Danesi, G Fingerle-Rowson, J Gribben, C Harbron, ...</div><div class="gs_gray">British Journal of Haematology 173, 93-94<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vkuYBMKU6wEC" class="gsc_a_at">lokale Zellexpression und Infl ammation</a><div class="gs_gray">C Pott, D Belada, N Danesi, G Fingerle-Rowson, J Gribben, C Harbron, ...</div><div class="gs_gray">British Journal of Haematology, 93-94<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cww_0JKUTDwC" class="gsc_a_at">In Chronic Lymphocytic Leukemia ΔCT7544-7545 Mutant NOTCH1 Maintains Transcription Factor Activity with Longer Lasting Effects Due to Slower Degradation</a><div class="gs_gray">J Edelmann, T Klymenko, C Lu, E Vilventhraraja, S Estenfelder, E Tausch, ...</div><div class="gs_gray">Blood 128 (22), 971<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:I-2NeQpV75MC" class="gsc_a_at">Intravital Microscopy Reveals Fundamental Differences in the Interaction of Stem Cells and T Acute Lymphoblastic Leukaemia with the Bone Marrow Microenvironment</a><div class="gs_gray">CL Celso, ED Hawkins, D Duarte, O Akinduro, RA Khorshed, D Passaro, ...</div><div class="gs_gray">Blood 128 (22), 5199<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-vzq6BoH5oUC" class="gsc_a_at">Alloresponses of Human T-Cells from Adult Peripheral Blood and Umbilical Cord Blood Are Differentially Impacted By Lenalidomide</a><div class="gs_gray">C Besley, E Kotsiou, R Petty, S Ajanthah, C Chelala, E Ghazaly, ...</div><div class="gs_gray">Blood 128 (22), 5714<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1wZ_wKGpLuwC" class="gsc_a_at">Differentiation Status Revealed By Shotgun Phosphoproteomics Determines Sensitivity of Primary AML Cells to Kinase Inhibitors</a><div class="gs_gray">P Casado, E Wilkes, MM Hadi, V Rajeeve, F Miraki-Moud, R Pike, ...</div><div class="gs_gray">Blood 128 (22), 840<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cTy_cm4PQvYC" class="gsc_a_at">Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease A Randomized Clinical Trial</a><div class="gs_gray">J Hawkey Christopher, M Allez, M Clark Miranda, M Labopin, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QtA78RmWg5MC" class="gsc_a_at">THE CLINICAL COURSE OF PATIENTS WITH FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: 187</a><div class="gs_gray">I El-Najjar, J Matthews, A Wilson, J Gribben, S Montoto</div><div class="gs_gray">Hematological Oncology 33<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oH8HCDhqVGsC" class="gsc_a_at">PHASE IB STUDY EXPLORING IL-6 RECEPTOR BLOCKADE TO PREVENT INFUSION-RELATED REACTIONS IN PATIENTS WITH PREVIOUSLY UNTREATED CLL RECEIVING OBINUTUZUMAB PLUS CHLORAMBUCIL: OT15</a><div class="gs_gray">C Freeman, G Fingerle-Rowson, M Dixon, A Knapp, S Wright, C Davies, ...</div><div class="gs_gray">Hematological Oncology 33, 328-329<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:iKswqCX-FLkC" class="gsc_a_at">DURABLE REMISSIONS AFTER SEQUENTIAL TRANSPLANTATION USING T-REPLETE NON-MYELOABLATIVE CONDITIONING FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA</a><div class="gs_gray">S Hassan, J Davies, M Smith, D Tsitsikas, H Oakervee, S Hallam, ...</div><div class="gs_gray">HAEMATOLOGICA 100, 278-278<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4QKQTXcH0q8C" class="gsc_a_at">Phenotypic and functional stability of regulatory T cells expanded after alloanergization with costimulatory molecule blockade</a><div class="gs_gray">E Kotsiou, E Guinan, J Gribben, J Davies</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S373-S373<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NU-BerS4NX4C" class="gsc_a_at">Radioimmunotherapy and BEAM chemotherapy versus BEAM as the conditioning regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a&nbsp;…</a><div class="gs_gray">L Bento, A Boumendil, H Finel, P Chevallier, S Amorim, H Monjanel, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S287-S288<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AFXcoJnoRH0C" class="gsc_a_at">Enhanced activation of an amino-terminally truncated isoform of voltage-gated proton channel HVCN1 enriched in malignant B cells</a><div class="gs_gray">E Hondares, M Brown, B Musset, D Morgan, VV Cherny, C Taubert, ...</div><div class="gs_gray">Biophysical Journal 108 (2), 20a<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4WewbtJKmRkC" class="gsc_a_at">Understanding the Psychometric Properties of the Impact of Cancer (IOC) Scale</a><div class="gs_gray">SJ Sarker, A Korszun, K Chowdhury, J Gribben, SAM Ayis</div><div class="gs_gray">ISCB36 Utrecht, Netherlands<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-BKJ5vZJwzMC" class="gsc_a_at">Blood First Edition Paper, prepublished online March 23, 2015; DOI 10.1182/blood-2015-01-622936</a><div class="gs_gray">F McClanahan, B Hanna, S Miller, AJ Clear, P Lichter, JG Gribben, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eFf2swCANGcC" class="gsc_a_at">Late Effects: An Evaluation of Contrasting Physical and Psychological Experiences Between Child and Adult Hodgkin Survivors</a><div class="gs_gray">SJ Sarker, GE George, K Chowdhury, G Levitt, J Kingston, A Lister, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1309-1309<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sJK75vZXtG0C" class="gsc_a_at">Lenalidomide Enhances Human Alloresponses By Increasing Proliferation of Effector Memory CD8 T Cells with Enhanced Polyfunctional Effector Capacity and a Unique Gene Expression&nbsp;…</a><div class="gs_gray">CM Besley, E Kotsiou, R Petty, A Sangaralingum, R Le Dieu, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1103-1103<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Nufq_to8ts0C" class="gsc_a_at">The Flavonoid Wogonin Reduces CLL Cell Survival <i>in Vitro</i> and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling</a><div class="gs_gray">C Dürr, B Hanna, F McClanahan, AJ Clear, T Zenz, S Stilgenbauer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1966-1966<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:S2WlVNSe3u4C" class="gsc_a_at">Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas</a><div class="gs_gray">A McCarthy, AJ Clear, J Marzec, R Coutinho, RD Petty, J Matthews, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3007-3007<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wGzT3bKASkAC" class="gsc_a_at">Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model</a><div class="gs_gray">B Hanna, F McClanahan, AJ Clear, S Miller, P Lichter, M Seiffert, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 717-717<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pUxgyZctzPYC" class="gsc_a_at">SKIP Is Underexpressed in AML Leading to Sphingosine Kinase Hypofunction</a><div class="gs_gray">E Ghazaly, P Smith, C Gnanaranjan, BD Young, S Joel, JG Gribben, ...</div><div class="gs_gray">Blood 124 (21), 5324<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Oo1CbQkBAzEC" class="gsc_a_at">ORAL FCR INDUCES HIGHER COMPLETE REMISSION RATES AND MRD NEGATIVITY IN UNTREATED CLL THAN PREVIOUS REPORTS OF INTRAVENOUS THERAPY: COMBINED RESULTS OF THE NCRI ADMIRE AND&nbsp;…</a><div class="gs_gray">T Munir, D Cohen, C Pocock, A Rawstron, L McParland, A Chalmers, ...</div><div class="gs_gray">HAEMATOLOGICA 99, 54-54<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hfzGNhXhx5MC" class="gsc_a_at">CLL INDUCES SEVERE SKEWING IN THE MYELOID COMPARTMENT IN PATIENTS AND IN THE TCL1 MOUSE MODEL</a><div class="gs_gray">B Hanna, F McClanahan, N Zaborsky, C Duerr, V Gschwend, ...</div><div class="gs_gray">HAEMATOLOGICA 99, 228-229<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IT1MJ6E3JesC" class="gsc_a_at">AUGMENT: A phase 3, randomized trial to compare efficacy and safety of lenalidomide plus rituximab versus placebo plus rituximab in patients with relapsed/refractory indolent&nbsp;…</a><div class="gs_gray">J Leonard, JG Gribben, M Trneny, P Scheinberg, N Kilavuz, M Patturajan, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), TPS8614-TPS8614<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CCeGMaHljPEC" class="gsc_a_at">Metabolomic analysis of pegylated arginine deiminase treatment in patients with malignant pleural mesothelioma.</a><div class="gs_gray">EA Ghazaly, P Luong, M Chmielewska-Kassassir, L Wozniak, ...</div><div class="gs_gray">Journal of Clinical Oncology 32 (15_suppl), 7587-7587<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=700&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:l6Q3WhenKVUC" class="gsc_a_at">Results of the randomised phase II NCRI ADMIRE trial of FC-R and FCM-R in previously untreated CLL: oral FCR is highly effective and safe but the addition of mitoxantrone does&nbsp;…</a><div class="gs_gray">A Bloor, D Cohen, C Pocock, A Rawstron, L McParland, A Chalmers, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:u3T1itk59dMC" class="gsc_a_at">Trisomy 12 chronic lymphocytic leukaemia cells exhibit functional upregulation of integrin signalling that is modulated byNOTCH1mutations: 38</a><div class="gs_gray">J Riches, C O'Donovan, S Kingdon, F McClanahan, A Clear, D Neuberg, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SrKkpNFED5gC" class="gsc_a_at">Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukaemia: 30</a><div class="gs_gray">F Manodoro, J Marzec, T Chaplin, F Miraki-Moud, E Moravcsik, ...</div><div class="gs_gray">British Journal of Haematology 165<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:I9gX6wnfuA8C" class="gsc_a_at">REDUCED INTENSITY ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA: PH-P522</a><div class="gs_gray">S Hassan, J Matthews, A Guy, M Farrell, D Taussig, M Smith, H Oakervee, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Tfl4UtY-dJUC" class="gsc_a_at">Genomic characterization of primary ultra high-risk and refractory chronic lymphocytic leukemia: Results from the CLL2O trial</a><div class="gs_gray">J Edelmann, C Haferlach, J Saub, V Teleanu, C Florence, V Leblonde, ...</div><div class="gs_gray">Oncol. Res. Treat. 37, 220-221<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EBV337fEn3EC" class="gsc_a_at">Lenalidomide potentiates human T cell alloresponses by selectively increasing proliferation of alloreactive CD8+ cells which exhibit a novel gene expression profile&nbsp;…</a><div class="gs_gray">C Besley, E Kotsiou, R Petty, A Sangaralingam, R LeDieu, J Gribben, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:i_7YvbSbtFEC" class="gsc_a_at">Phenotypic and functional characterisation of alloantigenspecific regulatory T cells expanded afterin vitroanergisation with co-stimulatory molecule blockade: 625</a><div class="gs_gray">E Kotsiou, J Gribben, J Davies</div><div class="gs_gray">Immunology 140<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7nQzp1YiEc4C" class="gsc_a_at">Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors</a><div class="gs_gray">A Korszun, SJ Sarker, K Chowdhury, C Clark, P Greaves, R Johnson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2943-2943<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WzTVkKNmPSkC" class="gsc_a_at">Intraclonal Complexity Of CLL Fractions In Cell Proliferation Rates, Gene Expression Signatures, and Responses To Autologous T-Cell Help In Peripheral blood and Secondary&nbsp;…</a><div class="gs_gray">SS Chen, TM Herndon, C Emson, JC Riches, F McClanahan, T Tong, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 115-115<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:idthP5jqfYAC" class="gsc_a_at">Trisomy 12 CLL Cells Have High Surface Expression Of Integrins Involved In Lymphocyte Trafficking But This Does Not Translate Into Improved LFA-1-Mediated Motility</a><div class="gs_gray">CJ O'Donovan, AG Ramsay, F McClanahan, L Rassenti, TJ Kipps, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 4159-4159<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NtCmTCuxid4C" class="gsc_a_at">NK Cells From CLL Patients Exhibit Down-Regulation Of Interferon Response Genes That Can Be Reversed With Lenalidomide</a><div class="gs_gray">JC Riches, A Sangaralingam, T Chaplin, F McClanahan, S Iqbal, ...</div><div class="gs_gray">Blood 122 (21), 4131<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M_lZXyI38BkC" class="gsc_a_at">Loss of Imprinting at the 14q32 Domain Leads to MicroRNA Overexpression in Acute Promyelocytic Leukemia</a><div class="gs_gray">F Manodoro, J Marzec, J Wang, T Chaplin, JV Jovanovic, M Eva, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2494-2494<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:p-HGrieyzrAC" class="gsc_a_at">HIV STATUS DOES NOT INFLUENCE THE OUTCOME OF PATIENTS DIAGNOSED WITH DLBCL TREATED WITH R-CHOP IN THE HAART ERA</a><div class="gs_gray">R Coutinho, M Flook, A Pria, S Gandhi, K Bailey, P Fields, K Cwynarski, ...</div><div class="gs_gray">HAEMATOLOGICA 98, 129-129<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CLhUwle04lcC" class="gsc_a_at">THE TH-INFILTRATE OF HODGKIN LYMPHOMA HAS A UNIQUE PHENOTYPE RICH IN ACTIVATION/PROLIFERATION MARKERS, CENTRAL MEMORY &amp; TH1-POLARISED CELLS, WITHOUT EVIDENCE OF SENESCENCE&nbsp;…</a><div class="gs_gray">P Greaves, S Iqbal, A Wilson, J Matthews, M Calaminici, J Gribben</div><div class="gs_gray">HAEMATOLOGICA 98, 221-221<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZOYfmFL0FrgC" class="gsc_a_at">A SIMPLE, ACCESSIBLE NEW TOOL TO DEFINE HIGH RISK PATIENTS IN CLASSICAL HODGKIN LYMPHOMA BASED ON VALIDATION OF PRE-EXISTING BIOMARKERS</a><div class="gs_gray">P Greaves, A Wilson, J Matthews, J Gribben</div><div class="gs_gray">HAEMATOLOGICA 98, 67-68<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:37Fl7vPTsUIC" class="gsc_a_at">CSF-1R INHIBITION DEPLETES TUMOUR-ASSOCIATED MACROPHAGES AND IS A RATIONAL NOVEL CLINICAL STRATEGY IN AGGRESSIVE B-LYMPHOMAS: 158</a><div class="gs_gray">S Hallam, J Candido, L Drew, R Wilkinson, R Thompson, A Clear, A Owen, ...</div><div class="gs_gray">Hematological Oncology 31, 149-150<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BFa5h04uPMwC" class="gsc_a_at">A DIFFUSE LARGE B-CELL LYMPHOMA ASSOCIATED MACROPHAGE TRANSCRIPTOME ANALYSIS REVEALS A UNIQUE M1-M2 POLARIZATION PROFILE THAT CHALLENGES CURRENT CONCEPTS ON THE LYMPHOMA&nbsp;…</a><div class="gs_gray">R Coutinho, A Newman, G Rossignoli, W Day, T Chaplin, J Marzek, ...</div><div class="gs_gray">Hematological Oncology 31<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:U3qCfcK-7lkC" class="gsc_a_at">THE STRUCTURE OF STEPWISE CLONAL EVOLUTION EVENTS SHAPING FOLLICULAR LYMPHOMA CODING GENOMES: 061</a><div class="gs_gray">J Okosun, C Bodor, J Wang, S Araf, M Bozek, S Iqbal, J Matthews, ...</div><div class="gs_gray">Hematological Oncology 31<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KsTgnNRry18C" class="gsc_a_at">Melphalan 200 mg/m2 vs 140 mg/m2 as Conditioning Regimens for Autologous Stem Cell Transplantation in Multiple Myeloma: P-94</a><div class="gs_gray">S HASSAN, M JULVE, J MATTHEWS, M FARRELL, A GUY, R POPAT, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma &amp; Leukemia 13<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g8uWPOAv7ggC" class="gsc_a_at">Multiple myeloma: a comparison of two melphalan conditioning regimens (200 mg/m2 versus 140 mg/m2) for autologous stem cell transplantation: P763</a><div class="gs_gray">M Julve, S Hassan, J Matthews, M Farrell, A Guy, R Popat, M Smith, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hQUaER0FWQ4C" class="gsc_a_at">Bendamustine for non-Hodgkin lymphoma</a><div class="gs_gray">J Gribben</div><div class="gs_gray">Expert review of hematology 6 (2), 123-125<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LGlY6t8CeOMC" class="gsc_a_at">TNFRSF14 aberrations are associated with death from acute GvHD after reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation for follicular lymphoma: P634</a><div class="gs_gray">J Okosun, A Clear, S Iqbal, J Matthews, J Gribben, J Fitzgibbon, J Davies</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">Capping of body surface area is not necessary for dosing of high dose chemotherapy and autologous stem cell rescue in patients with body surface area&gt; 2m2: P770</a><div class="gs_gray">L Bento, D Anderson, J Davies, L Dark, J Gribben, S Montoto</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:L_l9e5I586QC" class="gsc_a_at">Clinical audit of HLA typing performed on adult patients not receiving an allograft at time of testing: P488</a><div class="gs_gray">N Burlinson, D McCloskey, J Gribben</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Self-reported sexual functioning and fertility in long survivors of haematological malignancy: a neglected area of need in the late-effects clinic: 137</a><div class="gs_gray">P Greaves, S Sarker, K Chowdhury, R Johnson, J Matthews, R Matthews, ...</div><div class="gs_gray">British Journal of Haematology 161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Genetics of teenage and young adult t-cell acute lymphoblastic leukaemia: 168</a><div class="gs_gray">F van Delft, M Mansur, C Furness, L Minto, J Irving, S Iqbal, E Noronha, ...</div><div class="gs_gray">British Journal of Haematology 161<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SpPTWFSNUtQC" class="gsc_a_at">insideblood®</a><div class="gs_gray">L Gattinoni, NP Restifo</div><div class="gs_gray">BLOOD 121 (4)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">A shot in the arm for radiotherapy</a><div class="gs_gray">P Greaves, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 121 (2), 246-248<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TewouNez5YAC" class="gsc_a_at">Assessment of Bone Marrow Involvement by FDG-PET in Patients with Follicular Lymphoma</a><div class="gs_gray">IE Najjar, T Szyszko, AM Dowell, J Matthews, JG Gribben, S Montoto</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 5108-5108<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:U5uP8zs9lfgC" class="gsc_a_at">The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.</a><div class="gs_gray">A Korszun, R Johnson, SJ Sarker, C Kashfia, C Clark, P Greaves, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3174-3174<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:feST4K8J0scC" class="gsc_a_at">Genetics of Teenage and Young Adult Acute Lymphoblastic T-Cell Leukaemia.</a><div class="gs_gray">FW Van Delft, CL Furness, MB Mansur, L Minto, J Irving, S Iqbal, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2521-2521<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:L7vk9XBBNxgC" class="gsc_a_at">Characterizing Immunophenotypic and Functional Pseudo-Exhaustion in T Cells From CLL Patients: The Impact of Lenalidomide</a><div class="gs_gray">JC Riches, JK Davies, F McClanahan, R Fatah, S Iqbal, S Agrawal, ...</div><div class="gs_gray">Blood 120 (21), 564<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2Q0AJrNhS-QC" class="gsc_a_at">The Relative Significance of <i>ZAP</i>-70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results&nbsp;…</a><div class="gs_gray">R Claus, AS Ruppert, DM Lucas, M Zucknick, LZ Rassenti, A Greaves, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3865-3865<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BAanoTsO0WEC" class="gsc_a_at">Inhibitory Ligands CD200, CD270, CD274 and CD276 Are Expressed On Eμ-TCL1 Transgenic Mouse Splenocytes and Are of Potential Relevance to Impaired T-Cell Function in Vivo</a><div class="gs_gray">F McClanahan, C Ghirelli, P Greaves, JC Riches, R Coutinho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 313-313<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Anergic Response to B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia: The Differing Roles of IgD and IgM in the Microenvironment and Peripheral Blood.</a><div class="gs_gray">T Butler, A Montoya, AJ Clear, R Coutinho, DC Taussig, P Cutillas, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2889-2889<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Impact of Tumor Infiltrating T Cells in Patients with Diffuse Large B-Cell Lymphoma</a><div class="gs_gray">S Kiaii, AJ Clear, JG Gribben</div><div class="gs_gray">Blood 120 (21), 1572<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Whole Genome Sequencing in Sequential Biopsies Reveals the Genetic Evolution of Follicular Lymphoma to Transformed Follicular Lymphoma</a><div class="gs_gray">J Okosun, C Bödör, J Wang, S Araf, J Marzec, S Iqbal, J Matthews, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 145-145<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Assessment of Bone Marrow Involvement by FDG-PET in Patients with Follicular Lymphoma</a><div class="gs_gray">I El-Najjar, T Szyszko, A Mc Dowell, J Matthews, JG Gribben, S Montoto</div><div class="gs_gray">Blood 120 (21), 5108<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">The Diffuse Large B-Cell Lymphoma Infiltrating Macrophage Transcriptome Signature Is Enriched for Both M1 and M2 Genes and Provides an Excellent Platform for Functional&nbsp;…</a><div class="gs_gray">R Coutinho, AM Newman, G Rossignoli, W Day, F Miraki-Moud, T Chaplin, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 790-790<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:naSTrk-c4S8C" class="gsc_a_at">Immunotherapeutic Approaches Have the Potential to Brighten the Future Not Only for Patients With del (17p13. 1), but for All CLL Patients</a><div class="gs_gray">F McClanahan, JG Gribben</div><div class="gs_gray">Oncology 26 (11), 1055<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rCzfLUpcSPoC" class="gsc_a_at">AUTOCRINE IL-6 PRODUCTION CORRELATED WITH SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS</a><div class="gs_gray">F Liu, L Jia, T Farren, J Gribben, S Agrawal</div><div class="gs_gray">HAEMATOLOGICA 97, 517-517<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FwTEoIZreccC" class="gsc_a_at">PHOSPHOPROTEOMIC ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND B-CELL RECEPTOR SIGNALING SUGGESTS NOVEL THERAPEUTIC TARGETS</a><div class="gs_gray">T Butler, D Taussig, P Cutillas, J Gribben</div><div class="gs_gray">HAEMATOLOGICA 97, 49-49<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LNjCCq68lIgC" class="gsc_a_at">USE OR RITUXIMAB IN ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) POST ALLOGENEIC HEMATOPOIETIC CELL-TRANSPLANTATION</a><div class="gs_gray">S Patel, J Cavenagh, J Gribben, J De Vos</div><div class="gs_gray">HAEMATOLOGICA 97, 726-727<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nbnL2fqDbzcC" class="gsc_a_at">IDENTIFICATION OF AN EXPANDED POPULATION OF TERMINALLY DIFFERENTIATED CD8+ T CELLS WITH A NOVEL PHENOTYPIC AND FUNCTIONAL PROFILE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA</a><div class="gs_gray">J Riches, J Davies, F McClanahan, S Iqbal, R Fatah, S Agrawal, ...</div><div class="gs_gray">HAEMATOLOGICA 97, 451-451<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KKBjqD86ppkC" class="gsc_a_at">THE MICROENVIRONMENT IN CLASSICAL HODGKIN LYMPHOMA SHOWS EVIDENCE OF A TH1 AND NOT TH2 RESPONSE WITH TBET EXPRESSION BEING ASSOCIATED WITH IMPROVED SURVIVAL AND EBV STATUS</a><div class="gs_gray">P Greaves, A Clear, A Owen, A Wilson, J Matthews, M Calaminici, ...</div><div class="gs_gray">HAEMATOLOGICA 97, 455-455<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XR3BWSlh_xcC" class="gsc_a_at">LOW-DOSE ETOPOSIDE AND CYTARABINE: A PALLIATIVE TREATMENT OPTION IN PATIENTS WITH REFRACTORY/RELAPSED DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR INTENSIVE SALVAGE CHEMOTHERAPY</a><div class="gs_gray">S Hassan, S Montoto, J Gribben, J De Vos</div><div class="gs_gray">HAEMATOLOGICA 97, 654-654<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lOG7zRu2uA8C" class="gsc_a_at">MULTIPLE INHIBITORY LIGANDS INDUCE T CELL IMMUNOLOGICAL SYNAPSE DYSFUNCTION IN HEMATOLOGIC MALIGNANCY THAT CAN BE BLOCKED WITH LENALIDOMIDE-DEFINING A REVERSIBLE IMMUNE EVASION&nbsp;…</a><div class="gs_gray">G Ramsay, A Clear, R Fatah, J Gribben</div><div class="gs_gray">HAEMATOLOGICA 97, 230-230<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era</a><div class="gs_gray">C Orkin, S Montoto, K Shaw, J Okosun, S Gandhi, P Fields, A Wilson, ...</div><div class="gs_gray">Hiv Medicine 13<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">Management without radiotherapy may be an acceptable approach for stage 1 follicular lymphoma</a><div class="gs_gray">D Wrench, J Matthews, S Montoto, JG Gribben, TA Lister</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 157, 52-52<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Treatment of acute myeloid leukaemia in the elderly: a retrospective analysis 166</a><div class="gs_gray">P Jasani, F MacDougall, M Smith, J Cavenagh, T Lister, J Gribben, ...</div><div class="gs_gray">British Journal of Haematology 157, 64-65<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g_UdREhPGEoC" class="gsc_a_at">ÉPREUVE DE LECTURE CRITIQUE D’ARTICLE Drs Nadia Nathan et Pierre Loulergue</a><div class="gs_gray">S Montoto, K Shaw, J Okosun, S Gandhi, P Fields, A Wilson, M Shanyinde, ...</div><div class="gs_gray">J Clin Oncol 30, 4111-4116<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RMgMIBzvq-4C" class="gsc_a_at">PMC3822977.</a><div class="gs_gray">A Bühler, CC Oakes, RA Larson, NE Kay, DF Jelinek, TJ Kipps, ...</div><div class="gs_gray">blood 8, 447417<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:isU91gLudPYC" class="gsc_a_at">Autografting CLL: the game is over!(vol 117, pg 6057, 2011)</a><div class="gs_gray">E Montserrat, JG Gribben, CLL Autografting</div><div class="gs_gray">BLOOD 118 (26), 6993-6993<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:E8ajGqO0XoUC" class="gsc_a_at">Continuous CD4+ T Cell Lines Derived From the Classical Hodgkin Lymphoma Microenvironment: A Challenge to the Assumption of Anergy</a><div class="gs_gray">P Greaves, S Iqbal, DC Taussig, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 3645-3645<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:n3vGvpFsckwC" class="gsc_a_at">Neither the FLIPI Nor the FLIPI2 Accurately Segregates Low-Risk From Intermediate-Risk Follicular Lymphoma Patients in Terms of Progression-Free Survival</a><div class="gs_gray">I El-Najjar, J Matthews, J Gribben, S Montoto</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2663-2663<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oPLKW5k6eA4C" class="gsc_a_at">Impact of Tumor Infiltrating T Cells in Patients with Follicular Lymphoma At Diagnosis</a><div class="gs_gray">S Kiaii, AJ Clear, A Sangaralingam, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 769-769<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Continuous CD4+ T Cell Lines Derived From the Classical Hodgkin Lymphoma Microenvironment: A Challenge to the Assumption of Anergy</a><div class="gs_gray">DC Taussig, JG Gribben</div><div class="gs_gray">BLOOD 118 (21), 1556-1557<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mUJArPsKIAAC" class="gsc_a_at">Chronic Lymphocytic Leukemia Cells Co-Opt CD200, CD270, CD274 and CD276 to Induce Impaired Actin Polarization At the T Cell Immune Synapse</a><div class="gs_gray">AG Ramsay, AJ Clear, A Davenport, R Fatah, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 802-802<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:U_HPUtbDl20C" class="gsc_a_at">T-Cells From Patients with CLL Exhibit Phenotypic and Transcription Factor Profiles of Exhaustion Independent of CMV Serostatus</a><div class="gs_gray">JC Riches, J Davies, S Iqbal, R Fatah, S Agrawal, AG Ramsay, ...</div><div class="gs_gray">Blood 118 (21), 1780<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Br1UauaknNIC" class="gsc_a_at">HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era</a><div class="gs_gray">S Montoto, K Shaw, J Okosun, S Gandhi, P Fields, A Wilson, M Shanyinde, ...</div><div class="gs_gray">Blood 118 (21), 3646<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QoJ_w57xiyAC" class="gsc_a_at">2.17 Activation of STAT3 Increases Mitochondrial Respiration and Protects Mitochondria from Oxidative Damage in Chronic Lymphocytic Leukemia</a><div class="gs_gray">L Jia, N Uddin, JG Gribben</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 11, S170-S171<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yY3RG6sOEgwC" class="gsc_a_at">2.46 Signal Transducer and Activator of Transcription 3 and Nuclear Factor κB Activation Regulate Autocrine Interleukin-6 Production and Indicate the Prognosis of CLL</a><div class="gs_gray">F Liu, L Jia, T Farren, J Gribben, S Agrawal</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 11, S188-S189<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Hck25ST_3aIC" class="gsc_a_at">NEW EVIDENCE FOR MECHANISM OF ACTION OF IMIDS (R) IN LYMPHOMAS, FOCUS ON MCL</a><div class="gs_gray">J Gribben</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 254-255<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">TOTAL NUMBER OF B CELLS, BUT NOT T CELLS AT DIAGNOSIS IN THE CLASSICAL HODGKIN LYMPHOMA MICROENVIRONMENT IS PREDICTIVE OF SURVIVAL</a><div class="gs_gray">P Greaves, A Clear, A Owen, J Matthews, F Macdougall, A Wilson, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 153-153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w0F2JDEymm0C" class="gsc_a_at">DEFECTS AND ABNORMALITIES IN INFILTRATING T CELLS IN PATIENTS WITH FOLLICULAR LYMPHOMA AT DIAGNOSIS</a><div class="gs_gray">S Kiaii, AJ Clear, D Davis, AG Ramsay, A Sangaralingam, JG Gribben</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 84-84<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">THE NUMBER OF PREVIOUS TREATMENT LINES HAS NO IMPACT ON THE OUTCOME AFTER HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL RESCUE WITH BEAM FOR RELAPSED FOLLICULAR LYMPHOMA</a><div class="gs_gray">S Montoto, J Matthews, D Anderson, A Lister, J Gribben</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 115-115<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1xBWf43XMUgC" class="gsc_a_at">Outcome after high-dose therapy with autologous stem cell rescue with BEAM for relapsed follicular lymphoma.</a><div class="gs_gray">S Montoto, J Matthews, D Anderson, TA Lister, JG Gribben</div><div class="gs_gray">Journal of Clinical Oncology 29 (15_suppl), e18512-e18512<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ifOnle78iJkC" class="gsc_a_at">FDG-PET/CT staging in follicular lymphoma: effect on FLIPI score: 109</a><div class="gs_gray">I El-Najjar, T Szyszko, J Matthews, J Gribben, N Avril, S Montoto</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Survey of breast screening in long-term survivors treated with supra-diaphragmatic irradiation for lymphoma: 106</a><div class="gs_gray">R Johnson, P Greaves, M Powell, S Vinnicombe, A Wilson, S Sarker, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated&nbsp;…</a><div class="gs_gray">P Hillmen, J Gribben, G Follows, D Milligan, H Sayala, P Moreton, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wUn16MOA3RoC" class="gsc_a_at">The microenvironment differentially impairs passive and active immunotherapy in Chronic lymphocytic leukemia-Potential therapeutic synergism of CXCR4 antagonists</a><div class="gs_gray">K Zirlik, M Buchner, P Brantner, G Prinz, M Burger, C Baer, C Dierks, ...</div><div class="gs_gray">Wiley-Blackwell<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3x-KLxxGyuUC" class="gsc_a_at">098 THE NUMBER OF PREVIOUS TREATMENT LINES HAS NO IMPACT ON THE OUTCOME AFTER HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL RESCUE WITH BEAM FOR RELAPSED FOLLICULAR LYMPHOMA</a><div class="gs_gray">S Montoto, J Matthews, D Anderson, A Lister, J Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:gmHTDCtJMcoC" class="gsc_a_at">Eradication of polymerase chain reaction detectable immunoglobulin</a><div class="gs_gray">CS Zwicky, AB Maddocks, N Andersen, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3MwzVuqRcA0C" class="gsc_a_at">Eradication of polymerase chain reaction-detectable chronic</a><div class="gs_gray">LM Nadler, JG Gribben, D Provan, L Bartlett-Pandite, C Zwicky, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0sTkTiv_uMkC" class="gsc_a_at">All advanced stage non-Hodgkin's lymphomas with a polymerase</a><div class="gs_gray">LM Nadler, JG Gribben, A Freedman, SD Woo, K Blake, RS Shu, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:4Yq6kJLCcecC" class="gsc_a_at">Adverse Prognostic Features in Chronic Lymphocytic Leukemia-Sarah Schellhorn Mougalian, Susan O'Brien MD Anderson Cancer Center</a><div class="gs_gray">JG Gribben, BD Cheson</div><div class="gs_gray">Oncology-Melville 25 (8), 692<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:27LrP4qxOz0C" class="gsc_a_at">Autografting CLL: the game is over! Blood. 2011; 117 (23): 6057-6058.</a><div class="gs_gray">E MONTSERRAT, JG GRIBBEN</div><div class="gs_gray">Blood 118 (26)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">The gene for B7, a costimulatory signal for T-cell activation, maps to</a><div class="gs_gray">GJ Freeman, CM Disteche, JG Gribben, DA Adler, AS Freedman, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Azgs6IHzeyYC" class="gsc_a_at">The Role of Stem-cell Transplantation in Chronic Lymphocytic Leukemia</a><div class="gs_gray">S Hallam, JG Gribben</div><div class="gs_gray">Leukemias: Principles and Practice of Therapy 23, 315<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:c59VksA5Vz4C" class="gsc_a_at">Physician Scientists In Hematology: Hematologists' Experiences of Research and Recruitment to Academia-A Mixed Methods, Qualitative Approach</a><div class="gs_gray">T Butler, JG Gribben, A Hodgson</div><div class="gs_gray">Blood 116 (21), 2570<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nPT8s1NX_-sC" class="gsc_a_at">Targeting Chronic Lymphocytic Leukemia with Cord Blood NK Cells In NSG Model</a><div class="gs_gray">D Xing, W Decker, S Li, S Robinson, N Shah, H Yang, RE Champlin, ...</div><div class="gs_gray">Blood 116 (21), 2453<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Defective LFA-1 Mediated T Cell Motility In Chronic Lymphocytic Leukemia Is Mediated by Defects In the Rho GTPase Signaling Pathway</a><div class="gs_gray">AG Ramsay, R Evans, L Svensson, S Kiaii, N Hogg, JG Gribben</div><div class="gs_gray">Blood 116 (21), 914<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">Differential Gene Expression Profile Identifies Defects and Abnormalities In Infiltrating T Cells In Patients with Follicular Lymphoma at Diagnosis</a><div class="gs_gray">S Kiaii, AJ Clear, AG Ramsay, A Sangaralingam, JG Gribben</div><div class="gs_gray">Blood 116 (21), 141<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.</a><div class="gs_gray">P Greaves, S Montoto, J Matthews, A Wilson, DLP Brown, D Lillington, ...</div><div class="gs_gray">Blood 116 (21), 3459<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:O0nohqN1r9EC" class="gsc_a_at">A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma</a><div class="gs_gray">P Greaves, A Wilson, J Matthews, DLP Brown, S Montoto, JG Gribben, ...</div><div class="gs_gray">Blood 116 (21), 2388<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells</a><div class="gs_gray">F Liu, L Jia, T Farren, JG Gribben, S Agrawal</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 116 (21), 3598-3598<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BmWJbWwHJAwC" class="gsc_a_at">EZH2 MUTATION IN FOLLICULAR LYMPHOMA</a><div class="gs_gray">C O'Riain, P Smith, A Clear, D Wrench, M Gupta, C Bodor, A Matolcsy, ...</div><div class="gs_gray">HAEMATOLOGICA 95, 167-167<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DrR-2ekChdkC" class="gsc_a_at">SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA</a><div class="gs_gray">J Wrench, C Skibola, J Matthews, JB Cazier, S Iqbal, E Carlotti, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">BONE MARROW FAILURE IN ACUTE MYELOID LEUKEMIA IS INDUCED BY A BLOCK IN DIFFERENTIATION OF NORMAL HEMATOPOIETIC STEM CELLS</a><div class="gs_gray">D Taussig, F Miraki-Moud, A Lister, D Bonnet, J Gribben</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 13-13<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Fludarabine/cyclophosphamide non-myeloablative allogeneic stem cell transplantation for lymphoid malignancies: 175</a><div class="gs_gray">R Auer, F MacDougall, H Oakervee, J Cavenagh, J Gribben, T Lister</div><div class="gs_gray">British Journal of Haematology 149<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nWoA1JPTheMC" class="gsc_a_at">The activity of novel, potent, selective PI3K/mTOR pathway inhibitors in B-cell malignancies</a><div class="gs_gray">S Jueliger, L Maharaj, S Iyengar, E Ghazaly, P Cutillas, R Auer, ...</div><div class="gs_gray">Cancer Research 70 (8 Supplement), 4489-4489<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2l5NCbZemmgC" class="gsc_a_at">Lymphoma genetics</a><div class="gs_gray">AG Letai, JG Gribben</div><div class="gs_gray">Molecular Hematology, 117<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kF1pexMAQbMC" class="gsc_a_at">Detection of minimal residual disease in hematological malignancies</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Molecular Hematology, 57<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Mobilized peripheral blood stem cells compared with bone marrow for related reduced-intensity transplantation in acute myeloid leukaemia in complete remission: a retrospective&nbsp;…</a><div class="gs_gray">A Nagler, M Labopin, A Shimoni, G Mufti, JJ Cornelissen, D Blaise, ...</div><div class="gs_gray">Bone Marrow Transplantation 45, S21-S22<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:5VjbC5aozO0C" class="gsc_a_at">Expression of Surface IgG Is High in Chronic Lymphocytic Leukaemia, and Co-Expression with IgM Confers a Worse Prognosis.</a><div class="gs_gray">T Butler, C Wiseman, T Farren, JG Gribben, SG Agrawal</div><div class="gs_gray">Blood 114 (22), 4371<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BCdnXsLIVDwC" class="gsc_a_at">Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.</a><div class="gs_gray">FT Liu, L Jia, T Farren, J Giustiniani, A Bensussan, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (22), 4372-4372<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_IsBomjs8bsC" class="gsc_a_at">CD160 Expression in B-Cell Lymphoproliferative Disorders: Derivation and Validation of a New Three-Antigen Scoring System Improving Diagnostic Precision in B-Cell Malignancies.</a><div class="gs_gray">TW Farren, FT Liu, C Stephens, D Tsitsikas, MG Macey, M Jenner, ...</div><div class="gs_gray">Blood 114 (22), 4382<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Ex Vivo IL-2 Expansion of CB-NK Cells Promotes Synergistic LFA-1 and CD2 Engagement at the NK Cell Lytic Immune Synapse; Implications for Adoptive CB-NK Cell Therapy in Acute&nbsp;…</a><div class="gs_gray">D Xing, AG Ramsay, W Decker, S Li, S Robinson, H Yang, CM Bollard, ...</div><div class="gs_gray">Blood 114 (22), 3029<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Impaired Natural Killer Cells Immune Synapse Formation in Acute Myeloid Leukemia.</a><div class="gs_gray">D Xing, AG Ramsay, W Decker, S Li, S Robinson, H Yang, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 114 (22), 2663-2663<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1_W9tMSvGuwC" class="gsc_a_at">The Microenvironment Differentially Impairs Passive and Active Immunotherapy in B-CLL-Potential Therapeutic Synergism of CXCR4 Antagonists: V552</a><div class="gs_gray">M Buchner, P Brantner, G Prinz, M Burger, C Baer, J Gribben, ...</div><div class="gs_gray">Onkologie 32, 152-153<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=800&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jKT558fuBk8C" class="gsc_a_at">Spleen Tyrosine Kinase (SYK) Inhibition prevents CLL-Stroma Interactions: P449</a><div class="gs_gray">M Buchner, C Baer, G Prinz, J Gribben, H Jumaa, H Veelken, K Zirlik</div><div class="gs_gray">Onkologie 32<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vnF2_uLGgtgC" class="gsc_a_at">Treatment of respiratory syncytial virus infection with nebulised ribavirin and the humanised monoclonal antibody palivizumab in eight haemopoietic stem cell transplant recipients</a><div class="gs_gray">DA Tsitsikas, H Oakervee, J Cavenagh, S Agrawal, J Gribben, F Mattes</div><div class="gs_gray">Bone Marrow Transplantation 43 (S1), S252-S252<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:q-HalDI95KYC" class="gsc_a_at">Removal of Tumor Cells from the Hematopoietic Graft</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, 605-617<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pYKElYtJMmwC" class="gsc_a_at">Defective Immune Synapse Formation Of Umbilical Cord Blood-Derived Natural Killer Cell S Is Abrogated By Ex Vivo Expansion</a><div class="gs_gray">D Xing, AG Ramsay, JG Gribben, WK Decker, S Li, SN Robinson, H Yang, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 15 (2), 117-118<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YlPif8NxrbYC" class="gsc_a_at">Generation Of CLL-Specific CTL Effectors From Partially HLA-Matched Umbilical Cord Blood Grafts Using CD154-Transduced CLL Cell S As APCs</a><div class="gs_gray">WK Decker, S Li, D Xing, SN Robinson, H Yang, D Steiner, R Lapushin, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 15 (2), 123<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lbI08cpqPnQC" class="gsc_a_at">Chronic lymphocytic leukemia</a><div class="gs_gray">R Le Dieu, JG Gribben</div><div class="gs_gray">Hematopoietic Stem Cell Transplantation: In Clinical Practice<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:m4fbC6XIj1kC" class="gsc_a_at">Acute myeloid leukemia 25 Alan K Burnett and Steven Knapper Chapter 4 Chronic myeloid leukemia 35 John M Goldman and Tariq I Mughal Chapter 5 Acute lymphoblastic leukemia in&nbsp;…</a><div class="gs_gray">N Gdkbuget, D Hoelzer, K Baird, AS Wayne, ZY Lim, GJ Mufti, F van Rhee, ...</div><div class="gs_gray">Hematopoietic Stem Cell Transplantation: In Clinical Practice<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8gBurD7jEYQC" class="gsc_a_at">A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction</a><div class="gs_gray">AG Ramsay, G Gorgun, TAW Holderried, D Zahrieh, F Liu, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 30-30<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TesyEGJKHF4C" class="gsc_a_at">Differential Gene Expression Profile Identifies the Nature of T Cell Defects in AML Patients at Diagnosis.</a><div class="gs_gray">R Le Dieu, AG Ramsay, D Taussig, R Mitter, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 1186-1186<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sfnaS5RM6jYC" class="gsc_a_at">Extended Focal Imaging Reveals An Improved Gauge of Angiogenic Activity and Highlights the Role of Angiogenesis in Survival and Time to Transformation in Follicular Lymphoma</a><div class="gs_gray">AJ Clear, AM Lee, KJ Morris, M Calaminici, F Macdougall, LK Goff, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2822-2822<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RJOyoaXV5v8C" class="gsc_a_at"><i>Ex Vivo</i> Expansion of Cord Blood Natural Killer Cells Overcomes Impaired Immune Synapse Formation and Effector Function in Acute Myeloid Leukemia</a><div class="gs_gray">D Xing, AG Ramsay, JG Gribben, WK Decker, JK Burt, S Li, SN Simon, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2905-2905<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death!.</a><div class="gs_gray">SG Agrawal, FT Liu, J Giustiniani, L Jia, JG Gribben, A Bensussan</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 2088-2088<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KaMxkj08jr0C" class="gsc_a_at">Defective T Cell Migration in Chronic Lymphocytic Leukemia Is Repaired by Lenalidomide</a><div class="gs_gray">AG Ramsay, L Svensson, N Hogg, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 3117-3117<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rpSJNIKeXWsC" class="gsc_a_at">Molecular Pathogenesis</a><div class="gs_gray">A Bottoni, CM Croce, GA Calin</div><div class="gs_gray">Chronic Lymphocytic Leukemia, 51-60<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:o-PowTg_VKEC" class="gsc_a_at">Syk tyrosine kinase is overexpressed in B-CLL and protects CLL cells from apoptosis: P219</a><div class="gs_gray">M Buchner, C Dierks, S Fuchs, G Prinz, D Pfeifer, K Bartholomae, ...</div><div class="gs_gray">Onkologie 31, 82-83<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">TP53 MUTATION IDENTIFIES A HIGH RISK GROUP OF PATIENTS AT DIAGNOSIS OF FOLLICULAR LYMPHOMA AND IS ASSOCIATED WITH SHORTER TIME TO DISEASE PROGRESSION AND OVERALL SURVIVAL</a><div class="gs_gray">D O'Shea, C O'Riain, C Taylor, R Waters, E Carlotti, F MacDougall, ...</div><div class="gs_gray">HAEMATOLOGICA 93, 356-356<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EaFouW7jFu4C" class="gsc_a_at">Changes in follicular lymphoma are related to time to transformation to diffuse large B-cell lymphoma</a><div class="gs_gray">D de Jong, AM Lee, M Hauptmann, S Heisterkamp, M Calaminici, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 111-111<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ndLnGcHYRF0C" class="gsc_a_at">Transforming the outlook for CLL patients</a><div class="gs_gray">J Gribben</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 262-262<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rTD5ala9j4wC" class="gsc_a_at">SNP array genotyping in 182 diagnostic follicular lymphoma cases identifies sites of AUPD associated with overall survival and risk of transformation</a><div class="gs_gray">D O'Shea, C O'Riain, F MacDougall, J Gribben, BD Young, A Rosenwald, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 111-111<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">Examination of changes in tumour microenvironment of follicular lymphoma using serial sample tissue microarrays</a><div class="gs_gray">AM Lee, AJ Clear, KJ Morris, MR Calaminici, J Matthews, JG Gribben, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 179-179<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">The impact of tumour microenvironment in diagnostic follicular lymphoma samples using tissue microarrays</a><div class="gs_gray">AM Lee, AJ Clear, KJ Morris, MR Calaminici, J Matthews, JG Gribben, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 126-126<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:L1USKYWJimsC" class="gsc_a_at">MDM2 309 and TP53 ARG72PRO SNP genotypes do not predict clinical outcome of follicular lymphoma</a><div class="gs_gray">D Wrench, R Waters, J Matthews, M Calaminici, E Carlotti, S Iqbal, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 19, 178-178<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Detection of minimal residual disease in hematological</a><div class="gs_gray">D Provan, JG Gribben</div><div class="gs_gray">Molecular Hematology 10 (10), 53<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:oTdOBqtIf_kC" class="gsc_a_at">DOMINANCE OF NAÏVE AND CENTRAL MEMORY CD4+ T CELLS IN THE CLASSICAL HODGKIN LYMPHOMA MICROENVIRONMENT PROVIDES A DISTINCTIVE SIGNATURE WITH IMPLICATIONS FOR PATHOGENESIS AND&nbsp;…</a><div class="gs_gray">P Greaves, S Iqbal, G Rosignoli, J Matthews, A Wilson, D Taussig, ...</div><div class="gs_gray">17TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION AMSTERDAM, THE&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:s85pQhAUCrAC" class="gsc_a_at">Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Commentary</a><div class="gs_gray">R GITENDRA WICKREMASINGHE, FT LIU, SG AGRAWAL, ...</div><div class="gs_gray">Blood 112 (9)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RtRctb2lSbAC" class="gsc_a_at">DEPLETION OF TUMOUR ASSOCIATED MACROPHAGES SIGNIFICANTLY RETARDS THE PROGRESSION OF AN AGGRESSIVE AND CHEMORESISTANT MODEL OF B-CELL NON HODGKIN LYMPHOMA</a><div class="gs_gray">L Hallam, J Candido, E Maniati, R Thompson, N Van Rooijen, ...</div><div class="gs_gray">16TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION LONDON, UNITED KINGDOM&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Non-Hodgkin Lymphoma-Clinical</a><div class="gs_gray">R Coutinho, M Flook, A Pria, S Gandhi, K Bailey, P Fields, K Cwynarski, ...</div><div class="gs_gray">18TH CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCIATION STOCKHOLM, SWEDEN JUNE&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Transplantation in Chronic Lymphocytic Leukemia</a><div class="gs_gray">R Le Dieu, JG Gribben</div><div class="gs_gray">Hematopoietic Stem Cell Transplantation, 137-147<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CdxZDUztZiMC" class="gsc_a_at">055 METHYLATION PROFILING IN 158 CASES OF PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL)</a><div class="gs_gray">C O’Riain, D O’Shea, Y Yang, J Gribben, J Afari, CA Mein, T Crook, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Vno172sVVMwC" class="gsc_a_at">Temporal Proteomic Analysis of CLL B Cell Response to Antigen Receptor Stimulation.</a><div class="gs_gray">L Vallat, C Pionneau, F Jacob, F Davi, V Leblond, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1134-1134<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7Frjd3zlGBUC" class="gsc_a_at">High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia.</a><div class="gs_gray">C Wiseman, J Giustiniani, L Mikkelsen, M Macey, L Goff, J Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 4685-4685<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:xm0LlTxljI0C" class="gsc_a_at">Stereotypie IGHV3-21/IGLV3-21 antibodies expressed in high-risk chronic lymphocytic leukemia bind peptostreptococcus magnus protein</a><div class="gs_gray">LEM Ghia, LZ Rassenti, GF Widhopf, GJ Silverman, DS Neuberg, ...</div><div class="gs_gray">BLOOD 110 (11), 227A-228A<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:orDZ08hpP44C" class="gsc_a_at">Angiogenesis Assessed in Tissue Microarrays of Diagnostic Follicular Lymphoma Correlates with Outcome.</a><div class="gs_gray">AJ Clear, AM Lee, KJ Morris, M Calaminici, F Macdougall, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 2609-2609<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:R-LXmdHK_14C" class="gsc_a_at">Stereotypic IGHV3-21/IGLV3-21 Antibodies Expressed in High-Risk Chronic Lymphocytic Leukemia Bind Peptostreptococcus Magnus Protein L.</a><div class="gs_gray">EM Ghia, LZ Rassenti, GF Widhopf, GJ Silverman, DS Neuberg, ...</div><div class="gs_gray">Blood 110 (11), 740<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">Bax Degradation Activity Is a Novel Poor Prognosis Marker of Chronic Lymphocytic Leukemia.</a><div class="gs_gray">SG Agrawal, FT Liu, C Wiseman, S Shirali, H Liu, D Lillington, MQ Du, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3087-3087<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jSAVyFp_754C" class="gsc_a_at">CLL Cell Proliferation and IL-6 Production Are Regulated by CD160-MHC Class I Interactions Offering New Therapeutic Targets.</a><div class="gs_gray">J Giustiniani, C Wiseman, T Farren, JG Gribben, SG Agrawal</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1126-1126<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">SAGE Analysis Demonstrates Increased Expression of TOSO Contributing to Fas Mediated Resistance in CLL.</a><div class="gs_gray">R Proto-Siqueira, RA Panepucci, FP Careta, EG Rizzatti, A Lee, A Clear, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1121-1121<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">A Novel Non-Invasive Method of Detecting Galactomannan in Suspected Pulmonary Aspergillosis.</a><div class="gs_gray">SR Doffman, LJ Griffiths, C Lim, S Vinnicombe, M Wilks, JG Gribben, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3862-3862<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:silx2ntsSuwC" class="gsc_a_at">Do we need allogeneic transplantation in HL?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 19-19<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g30IDTdgJMgC" class="gsc_a_at">Interactions with stromal cells protect CLL cells from spontaneous apoptosis but not from T-cell mediated cytotoxicity: P612</a><div class="gs_gray">M Büchner, M Burger, P Brantner, G Prinz, R Mertelsmann, J Gribben, ...</div><div class="gs_gray">Onkologie 30<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Lo8V22OuN40C" class="gsc_a_at">Increased Proteasomal Degradation of Bax is a Common Feature of Poor Prognosis Chronic Lymphocytic Leukemia</a><div class="gs_gray">AC Newland, JG Gribben, L Jia</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YPNY0knpFBYC" class="gsc_a_at">Utilisation of Stem Cell Transplantation for Lymphoplasmacytic Lymphoma in the UK.</a><div class="gs_gray">MH Gilleece, R Pearce, DC Linch, M Wilson, K Towlson, S Mackinnon, ...</div><div class="gs_gray">Blood 108 (11), 2980<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:yTLRzDEmwhEC" class="gsc_a_at">Study of VH3-21 in a Large Cohort of Chronic Lymphocytic Leukemia Patients Reveals Evidence for Antigen Selection and Confirms Its Predictive Value for Early Disease Progression.</a><div class="gs_gray">EM Ghia, LZ Rassenti, GF Widhopf, DS Neuberg, MJ Keating, WG Wierda, ...</div><div class="gs_gray">Blood 108 (11), 2774<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pQTOvowfQioC" class="gsc_a_at">Stromal Cells Protect B-CLL Cells from Killing by Antigen-Specific Cytotoxic T Cells.</a><div class="gs_gray">K Zirlik, M Burger, P Brantner, G Prinz, M Buchner, JG Gribben, H Veelken</div><div class="gs_gray">Blood 108 (11), 2814<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Long-Term Follow-Up of Autologous Bone Marrow Transplantation for Follicular Lymphoma in First Remission: Bone Marrow Involvement at Harvest and PCR Detectable Disease after Ex&nbsp;…</a><div class="gs_gray">JR Brown, JG Gribben, Y Feng, D Neuberg, P Mauch, LM Nadler, ...</div><div class="gs_gray">Blood 108 (11), 3041<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Dynamic Assessment of Apoptosis for In Vitro Design of Bortezomib Combination Therapies for Lymphoid Malignancies.</a><div class="gs_gray">LC Wallis, MJ Streetly, R Auer, J Gribben, D Zhang, WD Hankins, ...</div><div class="gs_gray">Blood 108 (11), 2494<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Increased CD69 and decreased CD4 expressing cells in tissue microarray (TMA) in diagnostic lymph node biopsies are associated with poor outcome in CLL/SLL.</a><div class="gs_gray">AM Lee, A Clear, M Calaminici, F Macdougall, L Goff, JG Gribben</div><div class="gs_gray">BLOOD 108 (11), 787A-787A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hB2aVRuWZNwC" class="gsc_a_at">Cytotoxic T cells against heteroclitic peptides kill primary tumor cells independent of the native peptide binding affinity to HLA-A2: V236</a><div class="gs_gray">K Zirlik, D Zahrieh, D Neuberg, J Gribben</div><div class="gs_gray">Onkologie 29<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:kUhpeDhEZMUC" class="gsc_a_at">Of mice and men...</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood 108 (4), 1115-1116<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Q_E8KsG3g9MC" class="gsc_a_at">Transplantation for low-grade lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Hematology Meeting Reports (formerly Haematologica Reports) 2 (7)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:X4-KO54GjGYC" class="gsc_a_at">insideblood</a><div class="gs_gray">A Dispenzieri</div><div class="gs_gray">J Neurol Neurosurg Psychiatry 77 (8), 973-976<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Original Reports-HEMATOLOGIC MALIGNANCIES-Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic&nbsp;…</a><div class="gs_gray">JC Byrd, JG Gribben, BL Peterson, MR Grever, G Lozanski, DM Lucas, ...</div><div class="gs_gray">Journal of Clinical Oncology 24 (3), 437-443<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WC23djZS0W4C" class="gsc_a_at">Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. Commentary</a><div class="gs_gray">JG GRIBBEN, AJ JOHNSON, DM LUCAS, N MUTHUSAMY, LL SMITH</div><div class="gs_gray">Blood 108 (4)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:m92CDrhVnKEC" class="gsc_a_at">Successful generation of cytotoxic T-cells that kill CLL cells using heteroclitic peptides is independent of the native peptide binding affinity to HLA-A* 0201.</a><div class="gs_gray">K Mauerer, G Gorgun, D Zahrieh, JG Gribben</div><div class="gs_gray">Blood 106 (11), 54<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">In vivo demonstration of donor idiotype specific T cells that kill primary CLL cells post allogeneic transplant.</a><div class="gs_gray">R Ledieu, G Gorgun, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 62-62<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Expression of T Cell Co-Stimulator (ICOS) and Its Ligand and Disease Progression in B-Cell Chronic Lymphocytic Leukemia.</a><div class="gs_gray">T Fukuda, DS Neuberg, L Huynh, LZ Rassenti, TL Toy, KR Rai, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2943-2943<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eAlLMO4JVmQC" class="gsc_a_at">HLA-C mismatch is associated with inferior outcome after unrelated donor non-myeloablative hematopoietic stem cell transplantation.</a><div class="gs_gray">VT Ho, HT Kim, S Windawi, D Liney, E Milford, J Gribben, C Cutler, SJ Lee, ...</div><div class="gs_gray">Blood 106 (11), 835<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">Discrimination of Long and Short Survival in Follicular Lymphoma (FL) Patients by Incidence of FOXP3 and Perifollicular Incidence of CD4 and CD7 Using Immunohistochemistry on&nbsp;…</a><div class="gs_gray">LK Goff, AM Lee, A Clear, M Calaminici, AJ Davies, S Jordan, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 603-603<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MnogvFdIBdwC" class="gsc_a_at">Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells</a><div class="gs_gray">TAW Holderried, D Zahrieh, D Neuberg, JG Gribben</div><div class="gs_gray">American Society for Clinical Investigation<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TY5xIG7f_2sC" class="gsc_a_at">MABCAMPATH®: INCREASING SURVIVAL IN CLL: COMBINATION THERAPY WITH MABCAMPATH®: MOVING FORWARD</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Annals of Occupational Hygiene 16<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KS-xo-ZNxMsC" class="gsc_a_at">Combination therapy with MabCampath (R): Moving forward</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">ANNALS OF ONCOLOGY 16, 255-255<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Hematopoietic stem cell transplantation in non-Hodgkin lymphoma</a><div class="gs_gray">AJ Davies, JG Gribben</div><div class="gs_gray">Current Opinion in Organ Transplantation 10 (1), 35-39<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:__bU50VfleQC" class="gsc_a_at">Management of Haematological Malignancies</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">The Cancer Handbook<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Lymphoid Neoplasms</a><div class="gs_gray">AG Letai, JG Gribben</div><div class="gs_gray">Molecular Hematology, 105-114<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eIKNFFVQvJAC" class="gsc_a_at">TRANSPLANTATION-Brief report-Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell&nbsp;…</a><div class="gs_gray">A Craiu, Y Saito, A Limon, HM Eppich, DP Olson, N Rodrigues, GB Adams, ...</div><div class="gs_gray">Blood 105 (5), 2235<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-yGd096yOn8C" class="gsc_a_at">T cell deficiency in chronic lymphocytic leukemia</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">LEUKEMIA AND LYMPHOMA 46, S13<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NXYAu82O0W8C" class="gsc_a_at">A Phase II Study of Xcellerated T Cells™ in Patients with Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma (NHL).</a><div class="gs_gray">NL Bartlett, JG Gribben, RV Boccia, MS Milder, DM Aboulafia, J Castro, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 4640-4640<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:natZJ_-F0IUC" class="gsc_a_at">Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.</a><div class="gs_gray">K Mauerer, D Zahrieh, G Gorgun, A Li, J Zhou, L Rassenti, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 970-970<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hNSvKAmkeYkC" class="gsc_a_at">Reprogramming the Transcriptional Response of Chronic Lymphocytic Leukemia (CLL) Cells: Influencing the Temporal Gene Regulatory Network.</a><div class="gs_gray">LD Vallat, CA Kemper, Y Park, LZ Rassenti, JW Fisher III, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1128-1128<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jlhcAiayVhoC" class="gsc_a_at">Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II-Implications for Ig Peptide Vaccination Strategies.</a><div class="gs_gray">K Mauerer, D Zahrieh, S Ansen, A Li, Z Xia, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 960-960<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mel-f30kHHgC" class="gsc_a_at">Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.</a><div class="gs_gray">J Zhou, Z Xia, A Li, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1910-1910<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">A phase II study of Xcellerated T cells (TM) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma (NHL).</a><div class="gs_gray">NL Bartlett, JC Gribben, RV Boccia, MS Milder, DM Aboulafia, J Castro, ...</div><div class="gs_gray">BLOOD 104 (11), 244B-244B<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Molecular Analysis of T-Cell Receptor Gene Rearrangements in Children with T-Cell Acute Lymphoblast Leukemia on DFCI ALL Consortium Protocol 95-01.</a><div class="gs_gray">A Li, J Zhou, H Wang, MA Goldwasser, C Lyons, SE Sallan, LB Silverman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1084-1084<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Gene Expression Profiling Identifies Similar CD4<sup>+</sup> and CD8<sup>+</sup> T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with&nbsp;…</a><div class="gs_gray">V Rizouli, D Zahrieh, G Gorgun, TAW Holderried, C Croce, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 180-180<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Autologous Bone Marrow Transplantation for Follicular Lymphoma in First Remission: Long Term Follow up of Two Sequential Trials with Standard Dose and High Dose CHOP Induction.</a><div class="gs_gray">AS Freedman, JG Gribben, D Neuberg, S Li, H Kim, P Mauch, LM Nadler</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 5243-5243<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Cell Contact with CLL Cells Induces Defects in T Cell Differentiation and Effector Pathways: Impact of Silencing Specific Cytokine Production.</a><div class="gs_gray">TAW Holderried, G Gorgun, JG Gribben</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 955-955<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Killing malignant but not normal B cells</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood 104 (3), 601-601<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:N6_Y7JlWxwsC" class="gsc_a_at">1 9 Tumor Contamination of Stem Cell Products</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Stem Cell Transplantation for Hematologic Malignancies, 417<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9NZAP19TdFAC" class="gsc_a_at">Death of follicular lymphoma cells—the long and the short of it</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Blood 103 (2), 374-374<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:JP7YXuLIOvAC" class="gsc_a_at">Graft Purging in Autologous Bone Marrow Transplantation: A Promise Not Quite Fulfilled-The Article Reviewed</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Oncology-Melville 18 (7), 876-876<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:lvd772isFD0C" class="gsc_a_at">Tumor Contamination of Stem Cell Products</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Stem Cell Transplantation for Hematologic Malignancies, 417-429<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6ZzL7HXColQC" class="gsc_a_at">Impact of binding affinity to HLA* A0201 on both generation of cytotoxic T cells and their effector function to kill peptide pulsed APCs and CLL cells.</a><div class="gs_gray">K Mauerer, G Gorgun, D Drandi, JG Gribben</div><div class="gs_gray">BLOOD 102 (11), 230A-231A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PlWzFYVEG4EC" class="gsc_a_at">Application of molecular markers for minimal residual disease detection in neuroblastoma using real-time PCR technology.</a><div class="gs_gray">JB Zhou, AH Li, L Diller, JG Gribben</div><div class="gs_gray">BLOOD 102 (11), 215B-216B<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:c_xDhezhKKUC" class="gsc_a_at">Second hematopoietic stem cell transplantation using a nonmyeloablative approach: Low toxicity using a fludarabine and intravenous busulfan regimen.</a><div class="gs_gray">EP Alyea, HT Kim, DC Fisher, J Gribben, VT Ho, C Cutler, S Windawi, ...</div><div class="gs_gray">BLOOD 102 (11), 461B-461B<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">VH gene usage, incomplete DJ (H) recombinations and MLL rearrangements in infant with B-lineage acute lymphoblastic leukemia: Implications for leukemic transformation occurring&nbsp;…</a><div class="gs_gray">AH Li, S Armstrong, M Rue, HJ Wang, JB Zhou, LB Silverman, SE Sallan, ...</div><div class="gs_gray">BLOOD 102 (11), 140A-140A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Comparable progression free survival and overall survival for patients&gt; 50 years of age receiving allogeneic nonmyeloablative and myeloablative transplantation.</a><div class="gs_gray">EP Alyea, HT Kim, V Ho, C Cutler, J Gribben, D DeAngelo, SJ Lee, J Ritz, ...</div><div class="gs_gray">BLOOD 102 (11), 703A-703A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Gene expression profiling reveals defects in genes regulating T cell diffentiation and effector pathways in T cells in patients with CLL.</a><div class="gs_gray">G Gorgun, D Zahrieh, D Drandi, D Neuberg, J Gribben</div><div class="gs_gray">BLOOD 102 (11), 232A-232A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dAp6zn-oMfAC" class="gsc_a_at">Indolent B-cell malignancies: Immune recognition and antiself</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Leukemia &amp; lymphoma 44 (sup3), S77-S83<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UmS_249rOGwC" class="gsc_a_at">Prognostic markers in CLL by array-based comparative genomic hybridization.</a><div class="gs_gray">C Lee, D Drandi, P Dal Cin, J Gribben</div><div class="gs_gray">AMERICAN JOURNAL OF HUMAN GENETICS 73 (5), 218-218<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Utility of PCR Assessment of Minimal Residual Disease After Stem Cell Transplantation in Non-Hodgkin’s Lymphoma</a><div class="gs_gray">AM Krackhardt, JG Gribben</div><div class="gs_gray">Leukemia and Lymphoma, 201-222<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Successful Purging of Stem Cell Products Using CD34 Selection</a><div class="gs_gray">G St A, S Ash, J Donovan, J Temel, A Zuckerman, J Fang, G Pierson, ...</div><div class="gs_gray">Transplantation in Hematology and Oncology II, 116-129<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rOcdG6UcVlcC" class="gsc_a_at">Gene expression profiling demonstrates differential regulation of genes controlling cell cycle progression following CD40 activation in healthy B cells compared to CLL cells.</a><div class="gs_gray">CS Gricks, AJ Zauls, D Zahrieh, S Chiaretti, AM Krackhardt, D Neuberg, ...</div><div class="gs_gray">BLOOD 100 (11), 99A-99A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PQEM9vzQD9gC" class="gsc_a_at">Utilization of Ig heavy-chain variable, diversity and joining gene segments in childhood acute lymphoblastic leukemia.</a><div class="gs_gray">AH Li, D Neuberg, D Zuckerman, A Zuckerman, LB Silverman, SE Sallan, ...</div><div class="gs_gray">BLOOD 100 (11), 760A-761A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Telomere length loss in hematopoietic stem cells following two consecutive chemotherapy-induced mobilizing regimens</a><div class="gs_gray">I Ricca, M Compagno, M Ladetto, M Dell'Aquila, P Bandesan, P Omede, ...</div><div class="gs_gray">BLOOD 100 (11), 146B-146B<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Sequence analysis of clonal IgH and TCR gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: Implications for clinical utility of PCR&nbsp;…</a><div class="gs_gray">AH Li, D Zuckerman, A Zuckerman, LB Silverman, SE Sallan, JG Gribben</div><div class="gs_gray">BLOOD 100 (11), 68A-68A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Induction of autologous Th1 response against CLL cells by addition of exogenous interferon during generation of antigen presenting cells gamma.</a><div class="gs_gray">G Gorgun, JG Gribben</div><div class="gs_gray">BLOOD 100 (11), 591A-591A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Oral fludarabine (FMP) is highly active in patients (pts) with previously untreated chronic lymphocytic leukemia (CLL), and leads to increased STAT1 levels in vivo.</a><div class="gs_gray">JW Friedberg, DA Dong, SG Li, H Kim, K Stephans, K Noonan, D Neuberg, ...</div><div class="gs_gray">BLOOD 100 (11), 388A-388A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DOLguN9Lh8sC" class="gsc_a_at">Successful Purging of Stem Cell Products Using CD34 Selection</a><div class="gs_gray">G PIERSON, A Ross, L DILLER, J GRIBBEN</div><div class="gs_gray">Transplantation in Hematology and Oncology II 2, 116<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Immunotherapy in the B-cell lymphomas</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Cytotherapy 4 (5), 439-440<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Early Neutrophil Engraftment Provides a Functional Assessment of Long-Term Hematopoietic Reconstitution Following Autologous Bone Marrow Transplant.</a><div class="gs_gray">A Zubair, D Zahrein, D Neuberg, J Gribben, A Freedman, J Ritz</div><div class="gs_gray">Transfusion 42<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=900&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:69ZgNCALVd0C" class="gsc_a_at">ORIGINAL REPORTS-Hematologic Malignancies-Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of&nbsp;…</a><div class="gs_gray">OM Howard, JG Gribben, DS Neuberg, M Grossbard, C Poor, MJ Janicek, ...</div><div class="gs_gray">Journal of Clinical Oncology 20 (5), 1288-1294<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Identification of novel tumor-associated antigens in CLL-Implications for immunotherapy in CLL</a><div class="gs_gray">A Krackhardt, M Witzens, J Zauls, P Barrett, M Chessia, J Gribben</div><div class="gs_gray">Annals of Oncology 13<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jMZTt8odoasC" class="gsc_a_at">Cd40 Ligand Therapy of Lymphoma Patients</a><div class="gs_gray">R Vonderheide, J Dutcher, J Anderson, S Eckhardt, D Caron, J Gribben</div><div class="gs_gray">Journal of Clinical Oncology 19 (23), 4352-4353<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:YB4bud6kWLwC" class="gsc_a_at">Risk factors for CMV reactivation after T-cell depleted allogeneic bone marrow transplantation.</a><div class="gs_gray">TS Lin, D Zahrieh, E Weller, ER Alyea, DC Fisher, JG Gribben, ...</div><div class="gs_gray">BLOOD 98 (11), 480A-481A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Neutrophil engraftment is a better predictor of long-term hematopoietic function than number of CD34 positive cells infused.</a><div class="gs_gray">AC Zubair, AS Freedman, JG Gribben, J Friedberg, J Ritz, IJ Webb</div><div class="gs_gray">BLOOD 98 (11), 323B-323B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Differential expression of newly identified CLL-associated antigenes: Ientification of a novel antigen with cancer-testis like expression pattern and genes with tumor&nbsp;…</a><div class="gs_gray">AM Krackhardt, M Witzens, AJ Zauls, P Barrett, M Chessia, JG Gribben</div><div class="gs_gray">BLOOD 98 (11), 731A-731A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:VRfTbSk87rEC" class="gsc_a_at">ORIGINAL REPORTS-Hematologic Oncology-CD6+ Donor Marrow T-Cell Depletion as the Sole Form of Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Bone Marrow&nbsp;…</a><div class="gs_gray">RJ Soiffer, E Weller, EP Alyea, P Mauch, IL Webb, DC Fisher, ...</div><div class="gs_gray">Journal of Clinical Oncology 19 (4), 1152-1159<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:I8rxH6phXEkC" class="gsc_a_at">SPECIAL DEPARTMENTS-Correspondence-In Reply</a><div class="gs_gray">RH Vonderheide, JP Dutcher, JE Anderson, SG Eckhardt, DA Caron, ...</div><div class="gs_gray">Journal of Clinical Oncology 19 (23), 4350<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rCNdntzdTkkC" class="gsc_a_at">REAL TIME PCR IN MULTIPLE MYELOMA: QUANTITATIVE ANALYSIS OF TUMOR CONTAMINATION OF STEM CELL HARVESTS</a><div class="gs_gray">M Ladetto, P Omedè, S Sametti, A Pileri, D Drandi, L Giaccone, F Volpato, ...</div><div class="gs_gray">ASH American Society of Hematology 43nd annual meeting, 300-300<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nqdriD65xNoC" class="gsc_a_at">Regular Articles-Immunology-Generation of Cytotoxic T Lymphocytes against Native and Altered Peptides of Human Leukocyte Antigen-A? 0201 Restricted Epitopes from the Human&nbsp;…</a><div class="gs_gray">A Trojan, M Witzens, JL Schultze, RH Vonderheide, S Harig, ...</div><div class="gs_gray">Cancer Research 61 (12), 4761-4765<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rLGzs9wiiwIC" class="gsc_a_at">JM1, isolation and characterization of a novel CLL antigen recognized by autologous and syngeneic IgG antibodies.</a><div class="gs_gray">AM Krackhardt, M Witzens, JW Donovan, M Chessia, S Harig, JG Gribben</div><div class="gs_gray">BLOOD 96 (11), 513A-513A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cBPnxVikjH8C" class="gsc_a_at">An extensively valitaded real-time quantitative PCR approach shows a correlation between tumour burden (tb) and successful ex vivo purging in follicular lymphoma (FL) patients.</a><div class="gs_gray">M Ladetto, S Sametti, JW Donovan, D Ferrero, M Astolfi, M Mitterer, ...</div><div class="gs_gray">BLOOD 96 (11), 583A-+<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:x21FZCSn4ZoC" class="gsc_a_at">T cell responses in CLL: Superiority of TH2 responses might contribute to reduced cytotoxic autologous antitumor responses.</a><div class="gs_gray">AM Krackhardt, S Harig, M Witzens, P Barrett, R Broderick, JG Gribben</div><div class="gs_gray">BLOOD 96 (11), 28A-28A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Identification of tumor associated genes in CLL by subtractive hybridization.</a><div class="gs_gray">AM Krackhardt, M Witzens, JW Donovan, M Chessia, S Harig, JG Gribben</div><div class="gs_gray">BLOOD 96 (11), 165B-165B<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Comparative outcomes of cyclosporine/methotrexate and CD6+ T cell depletion (TCD) as graft-vs-host disease (GVHD) prophylaxis for allogeneic bone marrow transplantation (BMT&nbsp;…</a><div class="gs_gray">RJ Soiffer, E Weller, SJ Lee, EP Alyea, RL Schlossman, JG Gribben, ...</div><div class="gs_gray">BLOOD 96 (11), 415A-415A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Analysis of residual disease levels in pediatric acute lymphoblastic leukemia by TaqMan quantitative PCR.</a><div class="gs_gray">JW Donovan, A Zuckerman, S Waters, L Silverman, S Sallan, JG Gribben</div><div class="gs_gray">BLOOD 96 (11), 314A-314A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:eGYfIraVYiQC" class="gsc_a_at">Induction of cytotoxic T-cell responses against immunoglobulin derived peptides modified at HLA-A2 binding residues.</a><div class="gs_gray">S Harig, M Witzens, A Trojan, AM Krackhardt, R Broderick, P Barrett, ...</div><div class="gs_gray">BLOOD 96 (11), 830A-830A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:UuEBAcK4md4C" class="gsc_a_at">Overexpression of ribosomal proteins in chronic lymphocytic leukemia identified by subtractive hybridization.</a><div class="gs_gray">M Witzens, AM Krackhardt, S Harig, JW Donovan, JG Gribben</div><div class="gs_gray">BLOOD 96 (11), 168B-168B<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Detection of minimal residual disease and assessment of stem cell purging by TaqMan real time PCR quantitation of GAGE expression in patients with neuroblastoma.</a><div class="gs_gray">S Ash, JW Donovan, J Temel, A Zuckerman, SD Grupp, L Diller, ...</div><div class="gs_gray">BLOOD 96 (11), 187A-187A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Og1tA8FjbJAC" class="gsc_a_at">Molecular Immunological Modulation of Target Cells to Enhance the GVL Effect</a><div class="gs_gray">JL Schultze, JG Gribben</div><div class="gs_gray">BASIC AND CLINICAL ONCOLOGY 22, 315-340<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:bFuYayV9R1gC" class="gsc_a_at">Eradication of Disease and Development of Tumor Immunity in B Cell Malignancies: B7 Mediated Costimulation and the Immune Response</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">PQDT-Global<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:W2uZP3ddy8sC" class="gsc_a_at">Comparative rates of engraftment, GVHD, and disease relapse following CD6+ T cell depleted BMT from HLA matched related and unrelated donors.</a><div class="gs_gray">R Soiffer, E Weller, E Alyea, D Fisher, A Freedman, J Gribben, ...</div><div class="gs_gray">BLOOD 94 (10), 563A-563A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:9DLIHnF0jcYC" class="gsc_a_at">Analysis of circulating mononuclear cell, antibody and cytokine levels in phase I cancer patients treated with recombinant human CD40 ligand (AVREND (TM)).</a><div class="gs_gray">R Armitage, D Ulrich, B Macduff, RH Vonderheide, J Dutcher, G Eckhardt, ...</div><div class="gs_gray">BLOOD 94 (10), 66A-66A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Generation of cytotoxic T cells against immunogenic peptides from heat shock proteins: Implications for immunotherapy of cancer.</a><div class="gs_gray">M Witzens, A Trojan, S Harig, JG Gribben</div><div class="gs_gray">BLOOD 94 (10), 438A-438A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Gene therapy of Fanconi Anemia: Correction of mitomycin C sensitivity in human bone marrow progenitor colonies using a VSV-G pseudotyped retrovirus vector.</a><div class="gs_gray">E Nisbet-Brown, J Denham, E Guinan, J Gribben, J Wagner, R Mulligan, ...</div><div class="gs_gray">BLOOD 94 (10), 365A-365A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Cytokine profile of CD40-activated B-CLL: Opportunities to refine cellular vaccines in B cell malignancies.</a><div class="gs_gray">JL Schultze, B Maecker, M von Bergwelt-Baildon, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 94 (10), 634A-634A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Cytotoxic T cells generated against HLA-A2 binding peptides kill peptide pulsed targets and tumor cells expressing c-myc, but not bcl-1 or bcl-2.</a><div class="gs_gray">M Witzens, A Trojan, S Harig, JG Gribben</div><div class="gs_gray">BLOOD 94 (10), 438A-438A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Bone marrow transplant for lymphoma: where is the field going?</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">Biochimica et biophysica acta 1423 (3), C31-45<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BOlwja0KXvYC" class="gsc_a_at">CLINICAL OBSERVATIONS INTERVENTIONS AND THERAPEUTIC TRIALS-Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma</a><div class="gs_gray">AS Freedman, D Neuberg, P Mauch, RJ Soiffer, KC Anderson, DC Fisher, ...</div><div class="gs_gray">Blood 94 (10), 3325-3333<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">REAL-TIME PCR FOR QUANTITATIVE EVALUATION OF RESIDUAL DISEASE IN MULTIPLE MYELOMA (MM) USING THE IMMUNOGLOBULIN HEAVY CHAIN (IgH) GENE REARRANGEMENT</a><div class="gs_gray">M LADETTO, JW DONOVAN, A PILERI, JG GRIBBEN</div><div class="gs_gray">HAEMATOLOGICA-PAVIA THEN ROMA- 84 (9; SUPP/1), 19-19<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">ORIGINAL REPORTS-Hematologic Oncology-Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma</a><div class="gs_gray">JW Friedberg, D Neuberg, RM Stone, E Alyea, H Jallow, A LaCasce, ...</div><div class="gs_gray">Journal of Clinical Oncology 17 (10), 3128-3135<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:KTwcwpFFj4wC" class="gsc_a_at">B cells maintain Th1 cell polarization: The production of IL-12 by naive and memory B cells is regulated by T cell signals CD40L, IFN-gamma and IL-10.</a><div class="gs_gray">JL Schultze, S Michalak, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 92 (10), 699A-699A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Low likelihood of CD8 (+) T cell responses against peptides derived from Ig heavy chain rearrangements in B-cell malignancies.</a><div class="gs_gray">AH Trojan, JL Schultze, RH Vonderheide, M Ladetto, JW Donovan, ...</div><div class="gs_gray">Blood 92 (10), 514A-514A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">PTPROt, an alternatively spliced B-lymphoid protein tyrosine phosphatase: Regulation and functional analyses.</a><div class="gs_gray">RCT Aguiar, S Kharbanda, Y Yakushijin, JG Gribben, GJ Freeman, ...</div><div class="gs_gray">BLOOD 92 (10), 700A-700A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Impact of CD6 (+) T-cell depletion on GVHD, engraftment, and outcome in patients undergoing allogeneic BMT from unrelated donors</a><div class="gs_gray">R Soiffer, E Alyea, E Weller, P Mauch, A Freedman, D Fisher, ...</div><div class="gs_gray">BLOOD 92 (10), 290A-290A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">The B7/CD28: CTLA4 pathway in T cell activation and transplantation tolerance</a><div class="gs_gray">GJ Freeman, VA Boussiotis, JG Gribben, AH Sharpe, LM Nadler</div><div class="gs_gray">Pathologie Biologie 46 (2), 128-129<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:L24QuVWYgZ0C" class="gsc_a_at">Dose escalation of total body irradiation (TBI) in recipients of CD6 depleted allogeneic bone marrow: Toxicity and anti-tumor effects.</a><div class="gs_gray">RJ Soiffer, P Mauch, D Neuberg, E Alyea, D Fisher, R Schlossman, ...</div><div class="gs_gray">BLOOD 90 (10), 1011-1011<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nPTYJWkExTIC" class="gsc_a_at">Low level expression of B7-1 and B7-2 by germinal center lymphomas is sufficient to prevent tolerance but not to induce anti-tumor immunity.</a><div class="gs_gray">JL Schultze, DM Dorfman, S Michalak, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 90 (10), 1837-1837<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Induction of alloantigen specific anergy via ex vivo blockade of the B7-CD28 pathway: Results of a pilot clinical trial demonstrate engraftment and absence of severe GVHD after&nbsp;…</a><div class="gs_gray">EC Guinan, LM Nadler, VA Boussiotis, LL Brennan, IJ Webb, JG Gribben</div><div class="gs_gray">BLOOD 90 (10), 486-486<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PuYkdpj8xa4C" class="gsc_a_at">Norma S. Kenyon and Camillo Ricordi</a><div class="gs_gray">JG Gribben, LM Nadler, RK Zwerner, TR Russell</div><div class="gs_gray">Cell Separation Methods and Applications, 103<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:t-hv7AR41mYC" class="gsc_a_at">Indolent B-Cell Non-Hodgkin's Lymphomas</a><div class="gs_gray">J Gribben</div><div class="gs_gray">Oncology-Huntington 11 (12), 1901-1901<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:R6EwkKsDylYC" class="gsc_a_at">induces apoptosis of</a><div class="gs_gray">CD GiMMi, BW MORRISON, BA MAINPRICE, JG GRIBBEN, ...</div><div class="gs_gray">NATURE MEDICINE 2 (12)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WWeOtg8bX_EC" class="gsc_a_at">Advantages of human CD40 activated dendritic cells for presentation of human tumor antigens</a><div class="gs_gray">JL Schultze, S Michalak, MJ Seamon, JC Delgado, JG Gribben, ...</div><div class="gs_gray">BLOOD 88 (10), 636-636<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:BJrgspguQaEC" class="gsc_a_at">Resistance of mantle cell lymphoma but not B-cell CLL to immunologic purging.</a><div class="gs_gray">NS Andersen, J Borus, C Poor, AS Freedman, L Pandite, LM Nadler, ...</div><div class="gs_gray">BLOOD 88 (10), 1916-1916<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Molecular characterization of secondary non-Hodgkin's lymphomas occurring after ABMT for lymphoma.</a><div class="gs_gray">JG Gribben, NS Anderson, AS Freedman, LM Nadler</div><div class="gs_gray">BLOOD 88 (10), 2709-2709<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:C33y2ycGS3YC" class="gsc_a_at">Prevention of anergy is not dependent upon cellular proliferation but rather on activation of distinct signaling pathways.</a><div class="gs_gray">VA Boussiotis, DL Barber, GJ Freeman, BJ Lee, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 88 (10), 2010-2010<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Pre-B all cells produce functional TGF-beta 1 that inhibits both early hematopoiesis acid T cell activation thereby facilitating leukemia cell growth.</a><div class="gs_gray">AA Cardoso, M Seamon, HA Afonso, D McCullough, SE Sallan, ...</div><div class="gs_gray">BLOOD 88 (10), 2652-2652<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Prevalence of clonal hematopoiesis in 60 patients with non-Hodgkin's lymphoma (NHL) at the time of autologous bone-marrow transplantation (ABMT).</a><div class="gs_gray">S MachPascual, D Lu, JG Gribben, DG Gilliland, RD Legare</div><div class="gs_gray">BLOOD 88 (10), 2710-2710<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Potential for adoptive therapy for pre-B cell leukemia: Ex vivo generation of anti-leukemia specific autologous CD8+ cytolytic T cells.</a><div class="gs_gray">AA Cardoso, MJ Seamon, HM Afonso, SE Sallan, VA Boussiotis, ...</div><div class="gs_gray">BLOOD 88 (10), 835-835<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Induction of human T cell clonal energy results in resistance whereas CD28 costimulation primes for susceptibility to Fas-mediated programmed cell death.</a><div class="gs_gray">VA Boussiotis, BJ Lee, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 88 (10), 1177-1177<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:In6cVmBjs0IC" class="gsc_a_at">Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to</a><div class="gs_gray">JG Gribben, LM Nadler, AA Cardoso, JL Schultze, VA Boussiotis, ...</div><div class="gs_gray">Blood 88 (1), 41-48<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wSy_KLzO7YEC" class="gsc_a_at">Lack of PCR amplifiable minimal residual disease predicts freedom from relapse following autologous bone marrow transplantation for B-cell malignancies.</a><div class="gs_gray">JG Gribben, LM Nadler</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE MEDICINE 44 (3), A201-A201<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Characterization of molecular signals that prevent the induction of anergy</a><div class="gs_gray">JG Gribben, V Boussiotis, XY Ke, G Freeman, LM Nadler</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE MEDICINE 44 (3), A201-A201<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Differential association of T cell receptor (TCR) with protein tyrosine kinases is critical for selective signaling resulting in anergy or productive immunity.</a><div class="gs_gray">VA Boussiotis, DL Barber, GJ Freeman, BJ Lee, JG Gribben, LM Nadler</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE MEDICINE 44 (3), A202-A202<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Prevention of T cell clonal anergy is directly linked to Jak3 kinase activation.</a><div class="gs_gray">VA Boussiotis, DL Barber, GJ Freeman, BJ Lee, JG Gribben, LM Nadler</div><div class="gs_gray">JOURNAL OF INVESTIGATIVE MEDICINE 44 (3), A202-A202<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:anDooRL1HQEC" class="gsc_a_at">Complete blockade of B7 family-mediated costimulation is necessary to induce human host disease and extend the donor pool</a><div class="gs_gray">JG GRIBBEN</div><div class="gs_gray">Blood 87, 4887-4893<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3_f9JqYsqVQC" class="gsc_a_at">BONE MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: MINIMAL DISEASE STATUS USING PCR AMPLIFICATION OF IgH CORRELATES WITH CLINICAL OUTCOME: 148\506</a><div class="gs_gray">D Provan, C Zwicky, D Neuberg, A Maddocks, P Corradini, R Soiffer, ...</div><div class="gs_gray">Cancer Detection &amp; Prevention 20 (5)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hHIA4WEVY-EC" class="gsc_a_at">insideblood</a><div class="gs_gray">LJ Bendall</div><div class="gs_gray">Cancer 73 (2), 183-188<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WwIwg2wKZ0QC" class="gsc_a_at">Follicular lymphomas express low but detectable levels of B7 costimulatory molecules: A possible mechanism for tumor cell immune tolerance</a><div class="gs_gray">DM Dorfman, JL Schultze, A Shahsafaei, JG Gribben, GJ Freeman, ...</div><div class="gs_gray">LABORATORY INVESTIGATION 74 (1), 640-640<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Bone marrow transplantation in low grade lymphomas</a><div class="gs_gray">JG Gribben, A Freedman, LM Nadler</div><div class="gs_gray">ONKOLOGE-BERLIN- 2 (1), S13-S19<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:6VlyvFCUEfcC" class="gsc_a_at">On human B cell malignancies BB1 appears to be a molecule distinct from B7-1 which provides a negative signal to T cells.</a><div class="gs_gray">AA Cardoso, JL Schultze, MJ Seamon, GJ Freeman, JG Gribben, ...</div><div class="gs_gray">BLOOD 86 (10), 1268-1268<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AZju0d2GQJ0C" class="gsc_a_at">T cell clonal anergy and immunity involve distinct signaling pathways regulated by the differential association of the T cell receptor (TCR) with protein tyrosine kinases.</a><div class="gs_gray">VA Boussiotis, DL Barber, GJ Freeman, BY Lee, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 86 (10), 1699-1699<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:QVtou7C4vgoC" class="gsc_a_at">Signaling through CD40L does not prevent the induction of T cell anergy: A paradox</a><div class="gs_gray">VA Boussiotis, KT Hall, JG Gribben, GJ Fremman, LM Nadler</div><div class="gs_gray">BLOOD 86 (10), 631-631<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Cell clonal anergy results in upregulation of anti-apoptosis survival proteins and absence of Fas expression</a><div class="gs_gray">VA Boussiotis, GJ Freeman, BY Lee, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 86 (10), 2476-2476<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">Induction and amplification of anti-follicular lymphoma specific cytolytic T cells in vitro: Potential for adoptive transfer</a><div class="gs_gray">JL Schultze, AA Cardoso, MJ Seamon, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 86 (10), 2398-2398<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">Bystander antigen presenting cells repair defective antigen presentation by pre-B acute lymphoblastic leukemia (B-ALL) cells</a><div class="gs_gray">AA Cardoso, JL Schultze, MJ Seamon, YA Boussiotis, GJ Freeman, ...</div><div class="gs_gray">BLOOD 86 (10), 173-173<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Anergic T cell clones do not respond to IL-12: Evidence that alloantigen specific anergy might not be reversed in vivo by IL-12</a><div class="gs_gray">VA Boussiotis, DL Barber, GJ Freeman, BY Lee, JG Gribben, LM Nadler</div><div class="gs_gray">BLOOD 86 (10), 2288-2288<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">PCR detection of clonal immunoglobulin gene rearrangement predicts for relapse after autologous bone marrow transplantation for non-Hodgkin's lymphoma</a><div class="gs_gray">CS Zwicky, AS Freedman, LM Nadler, JG Gribben</div><div class="gs_gray">BLOOD 86 (10), 1154-1154<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wvYxNZNCP7wC" class="gsc_a_at">Chop dose intensification with G-CSF in untreated advanced follicular lymphoma (FL) patients markedly depletes stem cell reserve for ABMT</a><div class="gs_gray">A Freedman, D Neuberg, M Kroon, J Gribben, L Pandite, R Soiffer, ...</div><div class="gs_gray">BLOOD 86 (10), 835-835<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Mechanistic characterization of signals that induce and prevent the induction of T cell anergy</a><div class="gs_gray">XY Ke, VA Boussiotis, C Gimmi, GJ Freeman, LM Nadler, JG Gribben</div><div class="gs_gray">BLOOD 86 (10), 2478-2478<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">B7-1 (-) B7-2 (-) pre-B all do not generate alloantigen specific immunity but rather induce T cell anergy: A mechanism to escape anti-tumor immunity</a><div class="gs_gray">AA Cardoso, JL Schultze, VA Boussiotis, MJ Seamon, GJ Freeman, ...</div><div class="gs_gray">BLOOD 86 (10), 1732-1732<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">FOLLICULAR LYMPHOMAS CAN BE INDUCED TO PRESENT ALLOANTIGEN EFFICIENTLY-A CONCEPTUAL-MODEL TO IMPROVE THEIR TUMOR IMMUNOGENICITY (VOL 92, PG 8200, 1995)</a><div class="gs_gray">JL SCHULTZ, AA CARDOSA, GJ FREEMAN, MJ SEAMON, J DALEY, ...</div><div class="gs_gray">PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF&nbsp;…<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:1taIhTC69MYC" class="gsc_a_at">Correction: Follicular Lymphomas Can be Induced to Present Alloantigen Efficiently: A Conceptual Model to Improve Their Tumor Immunogenicity</a><div class="gs_gray">JL Schultze, AA Cardosa, GJ Freeman, MJ Seamon, J Daley, GS Pinkus, ...</div><div class="gs_gray">Proceedings of the National Academy of Science 92 (23), 10818<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:qCpRzq7zkD8C" class="gsc_a_at">Current Opinion in</a><div class="gs_gray">CA Schiffer, RJ Jones, MP Strout, MA Caligiuri, T Büchner, LB Silverman, ...</div><div class="gs_gray">Transplantation 45 (2)<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:iyewoVqAXLQC" class="gsc_a_at">Antigen-presenting function of B-cell precursor malignant cells can be modulated by crosslinking of CD40</a><div class="gs_gray">AA Cardoso, JL Schultze, D Provan, GJ Freeman, M Seamon, JG Gribben, ...</div><div class="gs_gray">Journal of Cancer Research and Clinical Oncology 121 (1), A7-A7<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Minimal residual disease in non-Hodgkin's lymphoma</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">FORUM TRENDS IN EXPERIMENTAL AND CLINICAL MEDICINE 5, 650-667<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wKETBy42zhYC" class="gsc_a_at">Induction of Alloantigen Specific T Cell Anergy by Inhibition of the B7: CD28 Pathway</a><div class="gs_gray">VA Boussiotis, GJ Freeman, JG Gribben, LM Nadler</div><div class="gs_gray">Normal and Malignant Hematopoiesis, 205-218<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:PuOEWVtPfzwC" class="gsc_a_at">B7-1 AND B7-2 DO NOT DELIVER IDENTICAL COSTIMULATORY SIGNALS SINCE B7-2 BUT NOT B7-1 COSTIMULATES IL-4 PRODUCTION IN CD4+ CD45RA+ (NAIVE) T-CELLS</a><div class="gs_gray">GJ FREEMAN, VA BOUSSIOTIS, JG GRIBBEN, GM BERNSTEIN, XY KE, ...</div><div class="gs_gray">BLOOD 84 (10), A511-A511<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:U0iAMwwPxtsC" class="gsc_a_at">FEASIBILITY OF IDENTIFYING PATIENT-SPECIFIC PROBES TO ASSESS MINIMAL RESIDUAL DISEASE IN MALIGNANCIES OF B-CELL ORIGIN</a><div class="gs_gray">A PROVAN, L BARTLETTPANDITE, K ANDERSON, LM NADLER, ...</div><div class="gs_gray">BLOOD 84 (10), A452-A452<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:3_LpOwP6eMYC" class="gsc_a_at">B7-2 IS THE MAJOR COSTIMULATORY SIGNAL RESPONSIBLE FOR THE INITIATION OF ALLOANTIGEN RECOGNITION LEADING TO GVHD</a><div class="gs_gray">JG GRIBBEN, EC GUINAN, VA BOUSSIOTIS, XY KE, GS GRAY, ...</div><div class="gs_gray">BLOOD 84 (10), A397-A397<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">B7 FAMILY COSTIMULATION CAN PREVENT BUT CANNOT REVERSE ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY</a><div class="gs_gray">VA BOUSSIOTIS, GJ FREEMAN, GM BERNSTEIN, GS GRAY, ...</div><div class="gs_gray">BLOOD 84 (10), A96-A96<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">COMMON GAMMA-CHAIN SIGNALING IS SUFFICIENT TO PREVENT ALLOANTIGEN-SPECIFIC T-CELL CLONAL ANERGY</a><div class="gs_gray">VA BOUSSIOTIS, DL BARBER, T NAKARAI, GJ FREEMAN, JG GRIBBEN, ...</div><div class="gs_gray">BLOOD 84 (10), A111-A111<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:mKu_rENv82IC" class="gsc_a_at">EXPRESSION AND INDUCTION OF B7 COSTIMULATORY MOLECULES ON B-CELL PRECURSOR MALIGNANCIES-IMPLICATIONS FOR ANTITUMOR IMMUNITY</a><div class="gs_gray">AA CARDOSO, JL SCHULTZE, M SEAMON, A PROVAN, GJ FREEMAN, ...</div><div class="gs_gray">BLOOD 84 (10), A378-A378<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:-jrNzM816MMC" class="gsc_a_at">PCR AMPLIFICATION OF REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN (IGH) GENES FOR MINIMAL RESIDUAL DISEASE DETECTION IN B-CELL MALIGNANCIES</a><div class="gs_gray">C VOENA, P CORRADINI, M ASTOLFI, M LADETTO, JG GRIBBEN, ...</div><div class="gs_gray">BLOOD 84 (10), A526-A526<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:M0leSnx2MbUC" class="gsc_a_at">HUMAN B7-2, A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES T-CELL PROLIFERATION</a><div class="gs_gray">G FREEMAN, J GRIBBEN, V BOUSSIOTIS, G GRAY, L NADLER</div><div class="gs_gray">BLOOD 82 (10), A188-A188<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">B7 BUT NOT ICAM-1 COSTIMULATION PREVENTS THE INDUCTION OF ALLOANTIGEN-SPECIFIC TOLERANCE IN UNPRIMED HUMAN T-CELLS</a><div class="gs_gray">V BOUSSIOTIS, G FREEMAN, J GRIBBEN, L NADLER</div><div class="gs_gray">BLOOD 82 (10), A304-A304<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">ANTIGEN-PRESENTING CELLS ISOLATED FROM B7-1 DEFICIENT MICE USE AN ALTERNATIVE CTLA4 COUNTER-RECEPTOR, B7-2, TO COSTIMULATE T-CELL ACTIVATION</a><div class="gs_gray">G FREEMAN, F BORRIELLO, R HODES, J GRIBBEN, G GRAY, ...</div><div class="gs_gray">BLOOD 82 (10), A323-A323<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">ALTHOUGH EXPRESSING B7 FAMILY MOLECULES, HUMAN MONOCYTES DO NOT COSTIMULATE VIA THE B7-CD28/CTLA4 PATHWAY</a><div class="gs_gray">J GRIBBEN, A LUNDBERG, N SPECTOR, G FREEMAN, L NADLER</div><div class="gs_gray">BLOOD 82 (10), A122-A122<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">insideblood</a><div class="gs_gray">E Montserrat, JG Gribben</div><div class="gs_gray">Blood 82 (23), 1366-1377<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:pYRxIbzCxX0C" class="gsc_a_at">Immunologic Purging of Marrow Assessed by Polymerase Chain Reaction</a><div class="gs_gray">J Gribben, L Nadler</div><div class="gs_gray">The New England Journal of Medicine 326 (17), 1163-1164<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Hemolytic-uremic syndrome following bone marrow transplantation in</a><div class="gs_gray">KC Anderson, T Takvorian, SN Rabinowe, RJ Soiffer, NJ Tarbell, ...</div><div class="gs_gray">Blood 77 (8), 1837-1844<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:RfUwGJFMQ-0C" class="gsc_a_at">A Unique Case of Three Autografts for Acute Myelogenous Leukaemia with Subsequent Long Term Survival in Second Remission</a><div class="gs_gray">SH Lim, AK McMillan, J Gribben, MC Galvin, AH Goldstone</div><div class="gs_gray">Leukemia &amp; lymphoma 5 (2-3), 207-209<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dMpQl7XwOw4C" class="gsc_a_at">Clinical and Immunological Assessment of High Dose Combination Therapy and Autologous Bone Marrow Transplantation in the Haematological Malignancies</a><div class="gs_gray">JG Gribben</div><div class="gs_gray">PQDT-Global<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:X0DADzN9RKwC" class="gsc_a_at">RADIOTHERAPY AFTER INTENSIVE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR RESISTANT HODGKINS-DISEASE</a><div class="gs_gray">AK MCMILLAN, JG GRIBBEN, JS TOBIAS, DC LINCH, AH GOLDSTONE</div><div class="gs_gray">BRIT J CANCER 61 (1), 168-168<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:7H_jS4BsgvYC" class="gsc_a_at">PRELIMINARY STUDIES OF RECOMBINANT GM-CSF IN MAN</a><div class="gs_gray">S DEVEREUX, DC COSTA, J GRIBBEN, MF SPITTLE, AM JELLIFFE, ...</div><div class="gs_gray">BRIT J CANCER 57 (2), 231-231<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:vVJNg6_NJEsC" class="gsc_a_at">BONE-MARROW TRANSPLANTATION IN LYMPHOBLASTIC LYMPHOMA IN REMISSION-AUTOLOGOUS VERSUS ALLOGENIC</a><div class="gs_gray">JG GRIBBEN, AH GOLDSTONE, L DONES, P ERNST</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (6), 862-863<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:37UQlXuwjP4C" class="gsc_a_at">AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA</a><div class="gs_gray">JG GRIBBEN, AH GOLDSTONE, DC LINCH, JDM RICHARDS, L DONES</div><div class="gs_gray">BRIT J CANCER 56 (6), 871-872<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">SALVAGE THERAPY IN RELAPSED HODGKINS-DISEASE BY HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)-OUTCOME AND INDICATIONS</a><div class="gs_gray">JG GRIBBEN, AH GOLDSTONE, DC LINCH, RL SOUHAMI, ...</div><div class="gs_gray">BRIT J CANCER 56 (6), 872-872<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:za7pDTvVV8kC" class="gsc_a_at">Reduction of Catheter Sepsis in Marrow Transplant Recipients by Prophtlactic</a><div class="gs_gray">AS Mackinnon, OJ Garden, JG Gribben, HJG Burns, SJ Hutchieson, ...</div><div class="gs_gray">Clinical Science 71 (s15), 22P-23P<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uEM9VtRl8xsC" class="gsc_a_at">Leukaemia and radiation</a><div class="gs_gray">RH Lawson</div><div class="gs_gray">British Medical Journal (Clinical research ed.) 287 (6406), 1722<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1000&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:cSdaV2aYdYsC" class="gsc_a_at">Successful Treatment of Multiresistant Pseudomonas Peritonitis with Combination of Azlocillin and Amikacin</a><div class="gs_gray">ACT Leung, J Gribben, JD Sleigh, JMB Jones</div><div class="gs_gray">Scottish medical journal 28 (1), 69-70<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:_u2aKJ9e-CoC" class="gsc_a_at">https://www. jbc. org/cgi/doi/10.1074/jbc. RA119. 010467 The latest version is at</a><div class="gs_gray">EA Ghazaly, F Miraki-Moud, P Smith, C Gnanaranjan, L Koniali, A Oke, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zaHkCSmj5XkC" class="gsc_a_at">phenotypic characterisation of regulatory t cells in dogs reveals signature transcripts conserved in humans and mice</a><div class="gs_gray">MR Goulart, J Gribben, D Xia, OA Garden</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:dj1AAMDQi3QC" class="gsc_a_at">A. Background</a><div class="gs_gray">MR Townsend, DM Townsend</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DTjSuSUbmXsC" class="gsc_a_at">A CASE OF MYELOMATOUS MENINGITIS</a><div class="gs_gray">K Alizadeh, J Gribben, S Qureshi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uoeYKOKFegwC" class="gsc_a_at">European Society for Medical Oncology Volume 15, No. 6 June 2004</a><div class="gs_gray">JA Kahn, JJ Dignam, EP Mamounas, M von Bergwelt-Baildon, B Maecker, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nj26e0utjpAC" class="gsc_a_at">Redefine expectations for your patients with venetoclax</a><div class="gs_gray">J Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:654Jc7Ppz2kC" class="gsc_a_at">Understanding the Immunodeficiency in Chronic Lymphocytic Leukemia</a><div class="gs_gray">JC Riches, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:WTQy_8Ay2UsC" class="gsc_a_at">Temporal genetic program following B-cell receptor cross-linking: altered</a><div class="gs_gray">LD Vallat, Y Park, C Li, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Y0RG-0fxPaAC" class="gsc_a_at">Cytotoxic T-cells generated against heteroclitic peptides kill primary tumor</a><div class="gs_gray">KM Zirlik, D Zahrieh, D Neuberg, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:DwFgw5hZUzMC" class="gsc_a_at">Follicular Lymphoma</a><div class="gs_gray">A Darby, JG Gribben</div><div class="gs_gray">Lymphoma, 315<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:Zbx7W2Xs4QsC" class="gsc_a_at">Erratum: Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer</a><div class="gs_gray">J Okosun, RL Wolfson, J Wang, S Araf, L Wilkins, BM Castellano, ...</div><div class="gs_gray">Nature 201, 6<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:uQVPmWFBlwUC" class="gsc_a_at">Cited References</a><div class="gs_gray">P Hillmen, JG Gribben, GA Follows</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:SgM-ki2adj0C" class="gsc_a_at">Tuesday, March 28th</a><div class="gs_gray">M Jagasia, E Beohou, S Van der Werf, D Niederwieser, P Dreger, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:nroGzMJTTpEC" class="gsc_a_at">10. New Treatments</a><div class="gs_gray">A M_Krackhardt, M Witzens, J Zauls, P Barrett, M Chessia, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:wBLCggQE-ToC" class="gsc_a_at">The presence of TP53 mutation at diagnosis of follicular lymphoma</a><div class="gs_gray">TA Lister, J Fitzgibbon, E Campo, TC Greiner, WC Chan, RD Gascoyne, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:X5YyAB84Iw4C" class="gsc_a_at">Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma</a><div class="gs_gray">M Calaminici, J Gribben, TA Lister, J Fitzgibbon</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:c1AJUTjuCtUC" class="gsc_a_at">OVERCOMING IMMUNODEFICIENCY IN CHRONIC LYMPHOCYTIC LEUKAEMIA: CURRENT KNOWLEDGE AND PERSPECTIVES</a><div class="gs_gray">F McClanahan, J Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:rbGdIwl2e6cC" class="gsc_a_at">Our thanks to those who have helped with this issue of Expert Review of Hematology. Listed below are the authors, referees and others who have kindly given their time, effort&nbsp;…</a><div class="gs_gray">S Bates, J Bennett, B Board, J Boelens, P Brown, D Buchheidt, W Carroll, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:XDrR66g3YHsC" class="gsc_a_at">B7 But Not Intercellular Adhesion Molecule-1 Costimulation Prevents the Induction of Human Alloantigen-specitlc Tolerance By Vassiliki A. Boussiotis, Gordon J. Freeman,* Gary&nbsp;…</a><div class="gs_gray">J Gribben, LM Nadler</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:ymY9cBF3mdcC" class="gsc_a_at">Differential Association of Protein Tyrosine Kinases with the T Cell Receptor Is Linked to the Induction of Anergy and Its Prevention by B7 Family-mediated Costimulation&nbsp;…</a><div class="gs_gray">JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:zUl2_INMlC4C" class="gsc_a_at">insideblood</a><div class="gs_gray">JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">TIMING OF AUTOLOGOUS BONE MARROW TRANSPLANTATION IN HODGKIN'S DISEASE</a><div class="gs_gray">AH Goldstone, JG Gribben, AK McMillan, DC Linch</div><div class="gs_gray">Autologous Bone Marrow transplantation, 269<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">CANCER AND LEUKEMIA GROUP B CALGB 100701/BMT CTN 0804 PHASE II STUDY OF REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLANT FOR HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)</a><div class="gs_gray">EP Alyea, RT Maziarz, J Gribben, SM Devine, R Larson, MA Caligiuri, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">insideblood</a><div class="gs_gray">AG Ramsay, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=zTBFoCoAAAAJ&amp;cstart=1100&amp;pagesize=100&amp;citation_for_view=zTBFoCoAAAAJ:NDuN12AVoxsC" class="gsc_a_at">insideblood</a><div class="gs_gray">E Carlotti, JG Gribben</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–1125</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>